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ABSTRACT 
Desinia B. Miller: Ozone Induces Systemic Metabolic Derangement Through Neuronal 
Stress Mechanisms 
(Under the direction of Urmila Kodavanti) 
 
 Diabetes is reported to be the seventh leading cause of death in the United States with 
90% of the cases characterized as type II diabetes. The conventional risk factors associated 
with diabetes are genetics, sedentary lifestyle, and high fat/high caloric diet. However, 
recently air pollution, such as ground level ozone, has also been postulated to contribute to 
diabetes, but there is limited scientific evidence. Ground level ozone is produced through the 
interaction of volatile organic compounds, nitric oxides and ultraviolet radiation. Ozone is 
known to cause pulmonary injury/inflammation but its link to peripheral metabolic effects 
have not been characterized. Through inhalation studies involving humans and rodent 
models, we examined if and how ozone exposure may change metabolism and contribute to 
insulin resistance, which can lead to type II diabetes. In our rodent studies, we observed that 
ozone exposure increases blood glucose, inhibits insulin secretion and widely affects glucose, 
protein and lipid metabolism. Our clinical ozone exposure study shows that humans present 
similar effects to rodents, especially in lipid metabolism. These types of changes over time 
have been linked to insulin resistance. Through surgical intervention, we also demonstrate 
that adrenal-derived stress hormones are essential for these ozone-induced metabolic and 
pulmonary effects. Further, our data indicates that these acute ozone-induced pulmonary, 
stress and metabolic effects persist during weekly episodic exposure subchronic exposure, 
but is reversible if the exposure discontinues for one week.
iv 
 
No insulin resistance is observed in liver or muscle after subchronic ozone exposure while a 
decrease in β-cell insulin secretion. Overall, these data provide insight into the mechanism of 
how ozone may impair systemic metabolic homeostasis through a hormonal stress response 
without producing peripheral insulin resistance after subchronic exposure. 
     
 v 
 
ACKNOWLEDGEMENTS 
First and foremost, I would like to thank God for always having my back and 
directing my life.  I would next like to give my sincerest gratitude to my doctoral advisor Dr. 
Urmila Kodavanti for her mentorship, unyielding support and encouragement, patience, 
motivation and belief in me all throughout my dissertation. Her guidance has assisted me in 
successfully matriculating in my research and developing into a mature scientist. Because of 
her, I have won many scientific awards and have three first author publications with two 
currently in development. I would also like to express my thanks to my dissertation 
committee for their guidance on the direction on my project and offering various perspectives 
which has challenged and made my research project stronger. 
To my lab mates Virginia Bass, Andres Henriquez, Samantha Snow, thanks for your 
encouragement, the laughs, and assisting me scientifically and emotionally through my 
doctoral dissertation. I am also very grateful for the United States Environmental Protection 
Agency (US EPA) in Research Triangle Park for their support of my research through access 
to state of the art core facilities and the collaboration with other fellow scientists. 
Specifically, I want to express my appreciation for Ian Gilmour, Mette Schladweiler, Debora 
Andrews, and Judy Richards in assisting in experimental design and completion, which has 
been greatly valuable in the effectiveness of my research. 
 vi 
 
Thanks to University of North Carolina (UNC)-Chapel Hill and the Tibbs program 
for their outpouring support even before joining the curriculum in toxicology doctoral 
program. I specifically would like to thank Patrick Brandt, Ashalla Freedman, Jessica 
Harrell, and Joshua Hall for all of the long office discussions and friendship that have been 
optimal in my scientific and personal development. I would like to thank Dr. Ilona Jaspers 
for giving me the first taste of what scientific research is like at UNC-Chapel Hill. I would 
like to also thank Marila Cordeiro-Stone for consulting and leading me to fulfill my Ph.D. 
requirements in a timely manner. I would like to thank my fellow peers/friends that have 
matriculated through this Ph.D. process with me: Philip Wages, Natalie Holman, Nicole 
Kurhanewicz, and Dana Walsh.  
To my friends outside the Ph.D. program: Arnica Sanders, Ashley Cooke, and Carla, 
Perry- thank you so much for the encouragement, laughs, girls night out and being my stress 
relievers. Each of you have been vital to my personal and professional growth. Last but not 
least, I would like to thank my family (Lanina Johnson, Willie Johnson, Lawrence Jr. Chavis, 
Kela Chavis, Tamara Johnson, Cherie Mclean, Calvin Mclean, Dorothy Chavis, Lawrence 
Chavis Sr., Otis Miller, Talina Miller (Our Angel in Heaven), etc.,) for all of their 
encouragement and support through these last five years. Your love and ever inspiring words 
have served as a beacon of light throughout my Ph.D. journey. I would finally like to thank 
my amazing husband for his uncompromising support, patience, honesty through the good 
and difficult times. Your love and encouragement have kept me positively grounded and 
keeps pushing me to my full potential. I could not have asked for a greater life partner that 
has always seen the best in me and instilled in me to never give up. For you, I am forever 
grateful.
 vii 
 
PREFACE 
Explanation of my contribution to each chapter and the acknowledgement of other 
contributors: 
Chapter 1: I was the sole author of the Introduction. The text was reviewed and revised by 
Urmila Kodavanti. 
Chapter 2: This chapter was reprinted from Miller D.B., Karoly E.D., Jones J.C., Ward 
W.O., Vallanat B.D., Andrews D.L., Schladweiler M.C., Snow S.J., Bass 
V.L., Richards J.E., Ghio A.J., Cascio W.E., Ledbetter A.D., Kodavanti U.P., : 
“Inhaled Ozone (O3) Induces Changes in Serum Metabolomic and Liver 
Transcriptomic Profiles in Rats”, Toxicol Appl Pharmacol. 2015. 286, 65-79. I 
conceived the hypothesis and study design, assisted in or completed the sample 
analysis, and wrote the manuscript. Ed Karoly and Janice Jones from Metabolon INC 
.performed the metabolomic assessment of serum samples and statistical analysis. 
Beena Vallanat performed liver transcriptomic analysis, while William Ward assisted 
with the statistical analysis of transcriptomic data. Mette Schladweiler assisted with 
the necropsies and sample collection. Samantha Snow and Virginia Bass helped with 
metabolic endpoints. Judy Richards helped with analysis of bronchoalveolar lavage 
fluid (BALF) and serum lipids. Wayne Casio and Andrew Ghio reviewed and revised 
the manuscript. Allen Ledbetter performed and monitored exposures. Urmila 
Kodavanti was the senior author and oversaw the study design, data analysis and 
interpretation, and manuscript preparations.  
 viii 
 
Chapter 3: This chapter was reprinted from Miller D.B., Ghio A.J., Karoly E.D., Bell, L.N., 
Snow S.J., Madden, M.C., Soukup J., Cascio W.E., Gilmour M.I., Kodavanti U.P., 
Ozone Exposure Increases Circulating Stress Hormones and Lipid Metabolites in 
Humans. Am. J. Respir. Crit. Care Med. 2016. Copyright © 2016 American Thoracic 
Society. http://www.atsjournals.org/doi/abs/10.1164/rccm.201508-
1599OC?url_ver=Z39.88-
2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed#.V I conceived the 
hypothesis and study design, assisted in the analysis, and wrote the manuscript. 
Andrew Ghio preformed the human inhalation study and provided the human serum 
samples to our lab. Ed Karoly and Lauren Bell from Metabolon INC. performed the 
metabolomics and statistical analysis of serum samples. Samantha Snow assisted with 
statistical analysis of supplemental data and revision of this manuscript. Joleen 
Soupkup assisted with analysis of inflammatory mediators in the serum. Wayne 
Cascio and Michael Madden assisted with the preparation of the manuscript. Urmila 
Kodavanti was the senior author and oversaw the study design, data analysis and 
interpretation, and manuscript preparation. 
Chapter 4: This chapter was reprinted from Miller D.B., Snow S.J., Schladweiler 
M.C., Richards J.E., Ghio A.J., Ledbetter A.D., and Kodavanti U.P., Acute Ozone-
Induced Pulmonary and Systemic Metabolic Effects are Diminished in 
Adrenalectomized Rats. 2016. Tox Sci. 
http://toxsci.oxfordjournals.org/content/150/2/312.long I conceived the hypothesis 
and study design, assisted in or completed the sample analysis, and wrote the 
manuscript.  Charles River’s veterinarian surgeons performed all sham, adrenal 
 ix 
 
demedullation and adrenalectomy surgeries. Samantha Snow assisted with the 
surgeries and revision of this manuscript. Mette Schladweiler organized the 
necropsies and assisted with tissue and blood sample collection.  Judy Richards 
assisted with analysis of BALF and serum lipids. Andrew Ghio reviewed and revised 
the manuscript. Allen Ledbetter performed and monitored all air and ozone exposures 
and performed whole body plethysmography on animals. Urmila Kodavanti was the 
senior author and oversaw the study design, data analysis and interpretation, and 
manuscript preparation. 
Chapter 5: The findings in this chapter are unpublished. I conceived the hypothesis and study 
design, and assisted with all sample analysis. Samantha Snow and Andres Henriquez 
helped with metabolic endpoints. Mette Schladweiler organized the necropsies and 
assisted with tissue and blood sample collection. Judy Richards assisted with analysis 
of BALF and serum lipids. Allen Ledbetter performed and monitored all exposure 
chambers. Urmila Kodavanti was the senior author and oversaw the study design, 
data analysis and interpretation, and manuscript preparation. 
Chapter 6: I was the sole author of the Discussion Chapter. The text was reviewed and 
revised by Urmila Kodavanti.
 x 
 
TABLE OF CONTENTS 
LIST OF TABLES ................................................................................................................ xvii 
LIST OF FIGURES ............................................................................................................. xviii 
CHAPTER 1 ............................................................................................................................. 1 
INTRODUCTION .................................................................................................................... 1 
1.1 Air pollution health effects: historical perspective ......................................................... 1 
1.2 Air pollution regulation and human health .................................................................. 2 
1.3 PM pollution: ............................................................................................................... 2 
1.5 Air pollution and respiratory effects ............................................................................ 4 
1.9 Proposed mechanisms of air pollutant-induced                                                             
systemic and cardiovascular effects ....................................................................... 11 
1.9.1 Evidence for systemic translocation of air pollution components .......................... 11 
1.9.2 The evidence  for systemic inflammation induced                                                      
by inhaled pollutants .............................................................................................. 12 
1.9.3 Autonomic involvement in regulation of cardiac                                       
physiological changes ............................................................................................ 13 
1.10 Air pollution and neuronal effects ........................................................................... 14 
1.11 Air pollution and metabolic effects: diabetes .......................................................... 16 
1.12 Systemic inflammation in insulin resistance ........................................................... 17 
1.13 Air pollutants and diabetes ...................................................................................... 18 
1.14 Neuronal involvement in air pollution-induced systemic effects ............................ 20 
1.15 Summary and dissertation content ........................................................................... 24 
 xi 
 
1.16 REFERENCES ........................................................................................................ 30 
CHAPTER 2 .................................................................................................................... 46 
INHALED OZONE INDUCES CHANGES IN SERUM                                  
METABOLOMIC AND LIVER TRANSCRIPTOMIC PROFILES IN RATS .................... 46 
2.1 Introduction ................................................................................................................... 46 
2.2 Materials and Methods .................................................................................................. 49 
2.2.1 Animals ................................................................................................................... 49 
2.2.2  Ozone generation and animal exposures ............................................................... 49 
2.2.3  Glucose tolerance testing (GTT) ........................................................................... 50
2.2.4  Necropsy and sample collection ............................................................................ 51 
2.2.5  Serum analysis ....................................................................................................... 52 
2.2.6 1 Metabolomic analysis .......................................................................................... 52
2.2.6.2 Sample accessioning ............................................................................................ 52 
2.2.6.3 UPLC/MS/MS ..................................................................................................... 53 
2.2.6.4 GC/MS ................................................................................................................. 53 
2.2.6.5 Quality assurance (QA)/quality control (QC) ...................................................... 54 
2.2.6.7 Statistical analysis of metabolomic data .............................................................. 55 
2.2.7.1 Gene Array ........................................................................................................... 55 
2.2.7.2 Normalization and determination of differentially                                       
expressed genes ...................................................................................................... 56 
2.2.7.3 Functional gene list preparation ........................................................................... 57 
2.2.7.4 Real time PCR confirmation of gene array findings ........................................... 58 
2.2.8.1 General statistical analysis ................................................................................... 58 
 xii 
 
2.3 Results ........................................................................................................................... 59 
2.3.1 Ozone induces pulmonary injury and inflammation in a                                  
concentration-dependent manner ........................................................................... 59 
2.3.2 Ozone exposure induces concentration-and time-dependent                        
hyperglycemia and glucose intolerance ................................................................. 59 
2.3.3 Ozone exposure alters the serum metabolic hormones and lipids .......................... 60 
2.3.4 Metabolomic analysis ............................................................................................. 61 
2.3.5 Metabolomic analysis: Ozone impairs glucose homeostasis                                           
through perturbation of glycolytic pathways ......................................................... 62 
2.3.6 Metabolomic analysis: Ozone exposure increases serum amino acids .................. 63 
2.3.7 Metabolomic analysis: Ozone exposure increases serum                                               
free fatty acids (FAA) and cholesterol while decreasing bile acids ....................... 63 
2.3.8 Liver transcriptomic profiling reveals its role in homeostatic                                     
control of ozone-induced systemic metabolic alterations ...................................... 64 
2.4 Discussion ..................................................................................................................... 68 
2.5 REFERENCES ............................................................................................................. 93 
CHAPTER 3 ........................................................................................................................... 98 
OZONE EXPOSURE INCREASES CIRCULATING                                                        
STRESS HORMONES AND LIPID METABLITES IN HUMANS .................................... 98 
3.1 Introduction ................................................................................................................... 98 
3.2 Materials and Methods ................................................................................................ 100 
3.2.1 Original study design: study population and ozone exposure .............................. 100 
3.2.2 Serum samples and metabolomic analysis ........................................................... 101 
3.3 Results ......................................................................................................................... 103 
3.3.1 Demographics of human subjects ......................................................................... 103 
3.3.2 Ozone exposure increases circulating cortisol but                                                       
does not change cytokines or HOMA-IR ............................................................. 104 
 xiii 
 
3.3.3 Correlations of subject characteristics with individual                                                          
metabolites and ozone-induced changes .............................................................. 104 
3.3.4 Ozone exposure changes the profile of circulating metabolites ........................... 105 
3.3.5 Ozone exposure increases circulating free fatty acids                                              
and lysolipids in humans ...................................................................................... 105 
3.3.6 Ozone exposure during intermittent exercise increases                                        
fatty acid oxidation in human. .............................................................................. 106 
3.3.7 Ozone exposure increased polyunsaturated fatty acids in the serum. .................. 107 
3.4 Discussion ................................................................................................................... 108 
3.5 REFERENCES ........................................................................................................... 122 
CHAPTER 4 ......................................................................................................................... 161 
ACUTE OZONE-INDUCED PULMONARY AND SYSTEMIC                        
METABOLIC EFFECTS ARE DIMINISHED IN ADRENALECTOMIZED RATS ........ 127 
4.1 Introduction ................................................................................................................. 127 
4.2 Materials and Methods ................................................................................................ 130 
4.2.1 Animals ................................................................................................................. 130 
4.2.2 Animal surgery and recovery protocol ................................................................. 130 
4.2.3 Ozone generation and animal exposures .............................................................. 132 
4.2.4 Glucose tolerance test (GTT) ................................................................................ 133 
4.2.5 Whole body plethysmography .............................................................................. 133 
4.2.6 Necropsy and sample collection ........................................................................... 134 
4.2.7 Plasma and serum snalysis.................................................................................... 134 
4.2.8 Statistics ................................................................................................................ 135 
4.3 Results ......................................................................................................................... 136 
4.3.1 Body weights ........................................................................................................ 136 
4.3.2 ADREX, DEMED and ozone impacted circulating                                                 
adrenal-derived hormones .................................................................................... 136 
 xiv 
 
4.3.3 Acute ozone-induced glucose intolerance is inhibited by ADREX ...................... 137 
4.3.4 Acute ozone-induced increases in circulating lipids                                                        
and protein metabolites are reduced in rats with prior ADREX .......................... 137 
4.3.5 Ozone-induced ventilatory changes are reduced in ADREX rats ........................ 138 
4.3.6 Ozone-induced lung injury and inflammation are                                              
diminished by DEMED and ADREX .................................................................. 139 
4.4 Discussion ................................................................................................................... 141 
4.5 REFERENCES ........................................................................................................... 155 
CHAPTER 5 ......................................................................................................................... 161 
SUBCHRONIC OZONE EXPOSURE: SYSTEMIC METABOLIC                   
DERANGEMENT, PULMONARY EFFECTS AND INSULIN INSUFFICENCY ........... 161 
5.1 Introduction ................................................................................................................. 161 
5.2 Materials and Methods ................................................................................................ 164 
5.2.1 Animals ................................................................................................................. 164 
5.2.2 Ozone generation and animal exposures .............................................................. 164 
5.2.3 Intraperitoneal glucose tolerance test (IPGTT) .................................................... 165 
5.2.4 Blood collection for insulin measurement during IPGTT .................................... 165 
5.2.5 Intraperitoneal insulin tolerance test (IPITT) ....................................................... 166 
5.2.6 Intraperitoneal pyruvate tolerance test (IPPTT) ................................................... 166 
5.2.7 Necropsy and sample collection ........................................................................... 167 
5.2.8  Blood collection, complete blood count (CBC), and                                                 
tissue collection .................................................................................................... 167 
5.2.9 Bronchoalveolar lavage and bronchoalveolar lavage fluid(BALF)                              
processing for pulmonary injury and inflammation assessment .......................... 167 
5.2.10 Serum and plasma analysis ................................................................................. 168 
5.2.11 Insulin signaling assessment in liver and muscle ............................................... 169 
5.2.12 General Statistics ................................................................................................ 169 
 xv 
 
5.3 Results ......................................................................................................................... 170 
5.3.1 Acute and subchronic episodic ozone exposure                                                            
induces glucose intolerance without impacting insulin tolerance. ....................... 170 
5.3.2 Acute ozone increases hepatic gluconeogenesis ................................................... 170 
5.3.3 Acute and subchronic episodic ozone exposure                                                         
attenuates glucose-activated pancreatic β-cell insulin secretion .......................... 171 
5.3.4 Subchronic episodic ozone exposure does not produce                                         
liver or muscle insulin resistance ......................................................................... 172 
5.3.5 Subchronic episodic ozone exposure alters                                                        
circulating stress hormone levels ......................................................................... 173 
5.3.6 The effect of subchronic ozone exposure on                                                            
circulating proinflammatory cytokines and metabolic biomarkers ...................... 173 
5.3.7 Subchronic episodic ozone exposure induces lung injury                                       
and inflammation ................................................................................................. 174 
5.4 Discussion ................................................................................................................... 176 
5.5 REFERENCES ........................................................................................................... 194 
CHAPTER 6 ......................................................................................................................... 200 
OVERALL CONCLUSIONS AND SIGNIFICANCE ........................................................ 200 
6.1 Air pollution and metabolism/diabetes .................................................................... 200 
6.2 Proposed mechanisms of pollutant-induced                                                                            
metabolic dysfunction and insulin resistance ......................................................... 201 
6.3 The potential involvement of the CNS and stress-response pathway ...................... 202 
6.4 Project goals ............................................................................................................. 205 
6.5 Acute ozone exposure induces peripheral                                                         
metabolic alterations in rats .................................................................................... 206 
6.6 Acute ozone exposure increases circulating stress hormones                                    
and induces metabolic alterations in humans .......................................................... 208 
6.7 Adrenal-derived stress hormones are required for                                                      
acute ozone-induced metabolic effects ................................................................... 209 
 xvi 
 
6.8 Adrenal-derived stress hormones are required for                                                          
acute ozone-induced pulmonary injury and inflammation ..................................... 210 
6.9 The role of pulmonary afferent C-fibers in mediating ozone-induced                                 
activation of neuronal stress response through TRPA1 and TRPV1 ...................... 213 
6.10 Long-term episodic subchronic ozone exposure effects on stress                                         
and metabolic outcomes ......................................................................................... 214 
6.11 Summary/conclusions and implications on human health..................................... 216 
6.12 REFERENCES ......................................................................................................... 222 
APPENDIX A. ...................................................................................................................... 228 
CHAPTER TWO .................................................................................................................. 228 
APPENDIX B. ...................................................................................................................... 241 
CHAPTER THREE .............................................................................................................. 241
 xvii 
 
LIST OF TABLES 
Table 2.1. Metabolomic analysis: ozone-induced changes in serum metabolites 
                 for glucose and amino acid metabolism................................................................. 77 
 
Table 2.2 Metabolomic analysis: ozone exposure increases circulating FFA.. ...................... 78 
Table 2.3 Metabolomic analysis: ozone exposure alters circulating metabolites              
indicative of impairment in cholesterol and bile acid metabolism. ....................... 80 
Table 3.1 Demographics of study participants.. ................................................................... 114 
Table 3.2a. Acute ozone exposure increases circulating                                                                   
free fatty acids and monoacylglycerols in humans... ........................................... 115 
 
Table 3.2b.Ozone exposure elevates circulating lysolipid and                                 
sphingolipid metabolites in humans.................................................................... 116 
 
Table 3.3. Ozone exposure during intermittent exercise increases                                   
circulating -oxidation metabolites in humans..... ............................................... 117 
 
Table 4.1 Effect of surgery and ozone exposure on body weights in rats……………….....147 
 
Table 5.1 Serum levels of proinflammatory cytokine biomarkers                                            
in WKY rats after subchronic exposure to air or 1.00 ppm ozone………………183 
 
 
  
 
 
 
 
 
 
 
 
 xviii 
 
LIST OF FIGURES 
Figure 1.1 Ozone-induced lung effects. .................................................................................. 26 
Figure 1.2 Pollutant-induced peripheral effects ...................................................................... 27 
Figure 1.3 Proposed mechanism(s) of stress-mediated effects of ozone ................................ 28 
Figure 2.1 Ozone-induced cellular and inflammatory responses in the lung                             
are associated with hyperglycemia and glucose intolerance in WKY rats. .......... 81 
Figure 2.2 Acute ozone exposure induces reversible hyperglycemia                                       
and glucose intolerance. ........................................................................................ 83 
Figure 2.3 Acute ozone exposure alters circulating mediators, metabolic                        
hormones and lipids in rats.. ................................................................................. 84 
Figure 2.4 Altered transcription levels of genes involved in glucose                             
metabolism in the livers of ozone-exposed rats.. .................................................. 85 
Figure 2.5 Acute ozone exposure modulates the expression of genes                                
involved in liver mitochondrial function. ............................................................. 87 
Figure 2.6 Modification of steroid metabolism genes in the livers                                           
of rats after ozone exposure. ................................................................................. 89 
Figure 2.7 Ozone exposure alters expression of genes involved in                                    
amino acid metabolism in the liver. ...................................................................... 91 
Figure 2.8 Ozone-induced increases in expression of selected genes                                   
confirmed using RT-PCR.. ................................................................................... 92 
Figure 3.1 Acute two hour ozone exposure increases serum levels                                          
of stress hormones, cortisol and corticosterone, in humans . .............................. 118 
Figure 3.2 Ozone altered lipid metabolism pathways in humans ......................................... 119 
Figure 3.3 Acute ozone exposure increases circulating                                          
polyunsaturated lipids in humans .................................................................. .…120 
Figure 4.1 Experimental Timeline ........................................................................................ 148 
Figure 4.2 Changes in the levels of circulating hormones after air or                                 
ozone exposure in SHAM, DEMED, or ADREX rats. ....................................... 149 
 xix 
 
Figure 4.3 Changes in glucose tolerance after air or ozone exposure                                            
in SHAM, DEMED, or ADREX rats.. ................................................................ 150 
Figure 4.4 Changes in circulating metabolites after air or ozone                                           
exposure in SHAM, DEMED, or ADREX rats.. ................................................ 151 
Figure 4.5 Ozone-induced changes in lung minute volume and PenH,                                     
an index of labored breathing, in SHAM, DEMED and ADREX rats. .............. 152 
Figure 4.6 Lung injury in rats as determined by analysis of bronchoalveolar                    
lavage fluid  after ozone exposure in SHAM, DEMED, or ADREX rats .......... 153 
Figure 4.7 Lung inflammation as determined by analysis of cells                                             
in bronchoalveolar lavage fluid (BALF) after                                                              
air or ozone exposure in SHAM, DEMED, or ADREX rats.  . .......................... 154 
Figure 5.1 Experimental design. ........................................................................................... 184 
Figure 5.2 Acute and subchronic ozone exposures induce hyperglycemia                             
and glucose intolerance without impairing insulin tolerance. . .......................... 185 
Figure 5.3 Acute and subchronic ozone exposures induce hepatic gluconeogenesis. .......... 186 
Figure 5.4 Acute and subchronic ozone exposure inhibits                                                          
glucose-stimulated β-cell insulin secretion. ........................................................ 187 
Figure 5.5 The effect of subchronic ozone exposure and                                                       
1wk recovery on insulin signaling in liver and muscle tissue  ............................. 188 
Figure 5.6 Subchronic ozone exposure changes circulating stress hormones. ..................... 189 
Figure 5.7 Subchronic ozone-induced changes in serum metabolic markers. ...................... 190 
Figure 5.8 Subchronic ozone induced lung injury as determined by                                       
the assessment of bronchoalveolar lavage fluid. .................................................. 192 
Figure 5.9 Subchronic ozone induced lung inflammation as                                                      
determined by the assessment of bronchoalveolar lavage fluid. ......................... 193 
Figure 6.1 TRPA1 and TRPV1 antagonism does not alter                                                            
acute ozone-induced pulmonary injury nor glucose intolerance ........................ 219 
Figure 6.2 Proposed mechanism(s) of overall ozone-induced stress                                           
mediated pulmonary, cardiovascular and metabolic responses. ................. ……221
 xx 
 
LIST OF ABBREVIATIONS 
1-D  One Day 
2-D  Two Day 
Aco-2  Aconitase-2 
ACTH             Adrenocorticotropic Hormone  
ADREX Total Bilateral Adrenalectomy  
AgRP  Agouti-Related Peptide  
AKT  Protein Kinase B 
ANOVA Analysis of Variance 
ANS  Autonomic Nervous System 
APD  Action Potential Duration 
AUC  Area Under The Curve 
BCAA  Branched Chain Amino Acids  
BN  Brown Norway Rat  
CAA  Clean Air Act 
CaMKII Calmodulin Kinase II 
CNS  Central Nervous System  
CRH  Corticotrophin Releasing Hormone  
CV  Cardiovascular 
DEMED Adrenal Demedullation  
DAVID Database for Annotation Visualization and Integrated Discovery  
DEG  Differentially Expressed Genes  
EI  Electrospray Ionization  
 xxi 
 
ELF  Epithelial Lining Fluid 
EPA  Environmental Protection Agency 
ER  Endoplasmic Reticulum  
FA  Filtered Air 
FFA  Free Fatty Acids 
GTT  Glucose Tolerance Test 
HDL-C High Density Lipoprotein- Cholesterol 
HOMA-IR Homeostatic Model Assessment of Insulin Resistance 
HPA  Hypothalamus Pituitary Adrenal  
HRV  Heart Rate Variability  
IL-1β   Interleukin-Beta 
IL-6  Interleukin-6  
IPA  Ingenuity Pathway Analysis  
I.P.  Intraperitoneal  
IRS  Insulin Receptor Substrate 
ITT  Insulin Tolerance Test 
JNK  C-Jun-NH2-terminal kinase  
KEGG  Kyoto Encyclopedia of Genes and Genomes 
LC  Locus Coeruleus 
LDL-C Low Density Lipoprotein -Cholesterol  
LIMS  Laboratory Information Management System  
LIT  Linear Ion Trap  
LTQ  Linear Trap Quadrupole  
 xxii 
 
MANOVA Multiple Analysis of Variance 
NAAQS National Ambient Air Quality Standards 
NOD  Nucleotide-Binding Oligomerization Domain  
NLR  NOD-like Receptors  
NO  Nitric Oxide  
NPY  Neuropeptide Y  
NTS  Nucleus Tractus Solitarus 
O3   Ozone  
PCR  Polymerase Chain Reaction 
PenH  Enhanced Pause 
PFKB1 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 
PM  Particulate Matter 
PM10  Coarse Particulate Matter 
PM2.5  Fine Particulate Matter 
PM0.1  Ultrafine Particulate Matter 
PNS  Parasympathetic Nervous System 
Ppargc1a Peroxisome Proliferator Activated Receptor Gamma c1a 
PPM  Parts Per Million 
PVN  Paraventricular Nucleus 
PTT  Pyruvate Tolerance Test 
RAR  Rapidly Adapting Stretch Receptors  
RI  Retention Time/Index  
ROS  Reactive Oxygen Species 
 xxiii 
 
SAR  Slowly Adapting Receptors  
RSD  Relative Standard Deviation 
SHAM  Sham Surgery  
SNS  Sympathetic Nervous System 
TCA  Tricarboxylic Acid  
TLR  Toll-Like Receptor  
TRPA1 Transient Receptor Ankrin 1 
TRPV1 Transient Receptor Vallinoid 1 
TNF-α  Tumor Necrosis Factor α 
TID  Type 1 Diabetes 
TIID  Type 2 Diabetes 
UF  Ultrafine 
UPLC  Ultra-Performance Liquid Chromatography  
UPR  Unfolded Protein Response 
VOC  Volatile Organic Compounds 
WBC  White Blood Cell 
WKY  Wistar Kyoto Rat 
WHO  World Health Organization 
 
 1 
 
CHAPTER 1 
 
INTRODUCTION 
1.1 Air pollution health effects: historical perspective 
 For over a century, atmospheric pollution has been recognized to impact human 
health. In 1930, a dense fog, composed of various concentrated air pollutants, filled the 
Meuse Valley in Belgium, which resulted in 60 deaths and severely impaired the population 
with adverse respiratory effects over three days (Nemery et al., 2001). The respiratory signs 
and symptoms—dyspnea, pulmonary edema, laryngeal irritation—were diminished once the 
fog dissipated. Another key air pollution event occurred in a small industrial town, Donora, 
Pennsylvania, where over 50% of the population of 14,000 displayed respiratory function 
decrements as a result of thermal inversion that confined incomplete industrial combustion 
products near the ground (American Thorarcic Society, 1996). Similarly, the Great Smog of 
London occurred in 1952 where anticyclone wind conditions accumulated particulate and 
sulfur pollutants, from coal burning and vehicular emissions, into a fog that killed 4,000 
people over three days (American Thoracic Society, 1996). The death toll of this severe air 
pollution episode rose to over 12,000 in subsequent weeks. These three tragic events—Meuse 
Valley, Belgium, Donora, Pennsylvania, and London, England—brought awareness of the 
potential burden of high levels of air pollution, incited epidemiological studies on adverse 
health effects, and prompted new emission regulations.  
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1.2 Air pollution regulation and human health  
  The World Health Organization (WHO) reported in 2012 that there were 7 million 
premature deaths worldwide associated with air pollution (World Health Organization, 
2012). Increases in air pollution have been linked to adverse health effects as evidenced by 
increases in hospitalization, morbidity, and mortality for respiratory and cardiovascular 
diseases in humans (Schwela, 2000).  In 1970, the United States Environmental Protection 
Agency (US EPA) mandated the Clean Air Act (CAA) to reduce air pollution emissions by 
implementing air standards and developing mitigation strategies and practices (EPA, 2010). 
Based on scientifically-determined guidelines, the US EPA established the National Ambient 
Air Quality Standards (NAAQS)  to protect the  health of the general and most susceptible 
populations from six criteria air pollutants: carbon monoxide, sulfur dioxide, nitrogen oxides, 
lead, particulate matter (PM)  and ozone (EPA, 2011). Of the six common pollutants, 
ambient PM and ozone are the most ubiquitous and have been linked to majority of health 
outcomes. 
1.3 PM pollution:  
 The primary respirable ambient PM are derived from natural and man-made sources: 
anthropogenic activities, incomplete combustion of fuels, vehicular emissions, unpaved 
roads, biomass burning, wild fires, volcanic eruptions, etc (Poschl, 2005).  Ambient PM are 
composed of a complex mixture of solid particles, which can vary broadly in shape, size and 
chemical composition based on emission sources, geographical location, and meteorological 
conditions (i.e. season and weather).  Respirable PM are classified based on their 
aerodynamic diameters: coarse particles (PM10: 2.5 m--10 m), fine particles (PM2.5: 2.5 
m-0.1m), and ultrafine particles (UFP: <0.1m). The US EPA currently designated 
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NAAQS for PM2.5 and PM10 are 35 g/m3 and 150 g/m3, respectively, averaged over a 24 
hour period (EPA, 2012).  Common constituents of PM include inorganic and organic 
substances: sulfate, nitrate, ammonium, black and elemental carbon, sea salt, mineral dust, 
pollen, and plant components (Poschl, 2005). Gaseous pollutants are in dynamic interaction 
with PM surface chemicals and often form secondary particles in the atmosphere through 
condensation and nucleation (Poschl, 2005). Ambient particles can also undergo 
photochemical aging or transformation in the atmosphere by coagulation (the combination of 
more than two particles) (Poschl, 2005).  This process in the air can increase gaseous 
pollutants, such as ozone.  
1.4 Ozone   
 Ozone is a triatomic oxygen molecule and is a strong oxidizing agent. Stratospheric 
ozone, located in the upper atmosphere, protects the earth from harmful sun rays, while 
tropospheric ozone, the closest atmospheric layer to the earth’s surface, can have harmful 
effects on living organisms, including plants and animals, due to its high oxidative potential. 
Ground level ozone is formed through a secondary photochemical reaction of ultraviolent 
radiation with ambient nitrogen oxides (NO) and volatile organic compounds (VOC). These 
precursor chemicals can be produced by naturally occurring processes, agricultural activities, 
anthropogenic fuel combustion, and vehicular and industrial emissions (Ciencewicki et al., 
2008).  Due to the need of ultraviolent radiation, ozone concentrations can fluctuate during 
various seasons and throughout the day.  Levels are generally high during daylight hours and 
in the summer with warmer temperatures. The current US EPA NAAQS for ozone is set at 
0.070 parts per million (ppm) averaged over an eight hour period but is currently under 
review for revision of current standards (EPA, 2012). 
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1.5 Air Pollution and respiratory effects  
  The respiratory system is the primary and initial contact to inhaled pollutants, and as 
a result, bears many of the toxic effects caused by air pollutants. Over the years, numerous 
epidemiological studies have shown a positive association between air pollution exposure 
and increased hospitalizations, morbidity, and mortality related to respiratory conditions in 
humans (Schwartz, 1996;  Verhoeff et al., 1996;  Vigotti et al., 1996;  Burnett et al., 1997;  
Laumbach and Kipen, 2012). PM and ozone have also been observed to exacerbate 
respiratory abnormalities in people with pre-existing conditions such as asthma, pneumonia, 
and chronic obstructive pulmonary disease (Trasande and Thurston, 2005;  Kim et al., 2013a;  
Kim et al., 2013b).  Controlled acute human exposures and animal studies, especially with 
ozone and PM, have demonstrated decrements of lung function, airway hyperresponsiveness, 
lung injury, and inflammation (Schwela, 2000;  Triantaphyllopoulos et al., 2011;  Laumbach 
and Kipen, 2012).   
 Due to the high oxidation potential of particulate and gaseous pollutants, oxidative 
stress is considered the primary driver of pollutant-induced pulmonary injury and 
inflammation. Inhalation studies have demonstrated that gaseous and particulate pollutants 
can increase reactive oxygen species (ROS) in the lung that can: (1) alter DNA, protein and 
lipids, (2) stimulate endogenous production of ROS, and (3) induce inflammatory pathways 
(Ciencewicki, et al., 2008) (Figure 1.1). It is hypothesized that when antioxidant protective 
mechanisms are overwhelmed, injury to pulmonary cells, including epithelial, endothelial 
and immune cells ensues following pollutant exposure. Additionally, the epithelial lining 
fluid (ELF), which serves as a protective barrier at the air-liquid interphase, can also undergo 
chemical modifications and injure respiratory cells. Air pollution-associated transition metals 
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present on the surface of inhaled particles can participate in generation of free radicals 
though their interaction with macromolecules in the ELF and cellular components, leading to 
increased oxidative stress and initiating inflammation (Rahman, 2007). 
  Lipid peroxidation is considered the primary consequence of pollutant-induced 
damage, especially following ozone exposure.  In humans and rodents, ozone has been 
shown to increase the reactive lipid byproduct 4-hydroxy-2-nonenal (Hamilton et al., 1996;  
Kirichenko et al., 1996) in the lung, likely involving lipid-rich airway lining fluid and 
epithelial cells, which has been implicated in airway injury, inflammation and remodeling 
(Keller et al., 1997; Suc et al., 1998;  Tsukagoshi et al., 2002) ). Ozone has also been shown 
to modify protein structure and stability through its interaction with terminal amino side 
chains and formation of protein cross-links and cleavage, which can result in perturbation of 
protein structures (Ciencewicki, et al., 2008). Thus, ozone and PM exposures have been 
implicated in protein, lipid and DNA damage (Prahalad et al., 2001;  Cheng et al., 2003).  
 Upon encounter of oxidatively-modified lung lining components or other particulate 
pollutants, activated macrophages and lung epithelial cells can express proinflammatory 
cytokines, which are involved in the recruitment of immune cells — neutrophils, eosinophils, 
macrophages — at the site of injury in the lung (Ciencewicki, et al., 2008). Air pollutants, 
including ozone, are thought to activate alveolar macrophages by directly interacting with 
cells or through secondary reactive intermediates. The inflammatory mechanisms involve 
activation of Toll-like receptors (TLR) and nucleotide-binding oligomerization domain 
(NOD)-like receptors (NLR) on monocytes (Becker et al., 2002;  Bauer et al., 2012). TLR 
and NLR receptors are a subset of pattern recognition proteins that are essential for the 
activation of defense mechanisms against foreign materials and the activation of the innate 
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immune response (Bauer, et al., 2012). Activation of TLR and NLR pathways are known to 
trigger the activation of c-Jun-NH2-terminal kinase (JNK) and degradation of IKK-β 
allowing translocation of nuclear factors such as the nuclear factor kappa-light-chain-
enhancer of activated  cells (NFB ) that leads to the upregulation of many pro-
inflammatory genes and cytokines (tumor necrosis factor tumor necrosis factor(TNF)-α, 
Interleukin (IL)-1β, IL-6,  resistin, and more) (Huang et al., 2009). These pro-inflammatory 
mediators can activate other local macrophages and secrete chemokines that initiate the 
recruitment of additional monocytes and neutrophils to the site, leading to an innate immune 
response. Persistence of exposure could lead to chronic inflammatory conditions that are 
implicated in many pulmonary diseases. Although local oxidative stress leading to 
inflammation is noted as the main contributor to pollutant-induced pulmonary effects, 
relatively less is known about potential endogenous contributors (hormones, metabolites) in 
pollutant-mediated respiratory effects.  
The pulmonary airways are densely innervated with sensory afferent vagus fibers that 
carry signals through nodose and jugular ganglion, which send second-order neurons to the 
other areas of the brain through the brainstem.  This provides a communication route 
between the bronchopulmonary system and the central nervous system. The neuronal 
circuitry regulates respiratory function and its synchronization/coordination with the 
cardiovascular system. There are three types of sensory neurons: C-fibers, neurons with 
rapidly adapting stretch receptors (RAR), and neurons with slowly adapting stretch receptors 
(SAR) (Carr and Undem, 2003).  RAR and SAR fibres are classified as bronchopulmonary 
mechanosensory receptors, while chemo- and thermo-sensory C-fibers densely innervate 
upper and deep lung airways (Carr and Undem, 2003). These fibers extend to the brain stem 
 7 
 
and the nucleus of solitarius tract (NTS) of the central nervous system (CNS), and stimulate 
vagal-mediated pulmonary refluxes and cardiopulmonary tone that control breathing and 
cardiac rhythms. Dysfunction of these neurons has been linked to lung function decrements 
including excessive coughing, bronchospasm, mucus secretion, and altered airway muscle 
tone (Lee and Pisarri, 2001;  Canning, 2010). A number of neuroactive substances are also 
released at the nerve terminals in the lung and in the brain, such as substance P and 
neurokines, which can act in an autocrine or paracrine manner to produce local or distant 
effects in the brain. Transient receptor ankyrin (TRPA1) and transient receptor vanilloid 
(TRPV1), located in the vicinity of each other on C-fibers, detect noxious stimuli such as 
chemical, pH changes, osmolarity changes and heat.  It is hypothesized that components of 
pollutants, including ozone, may interact with these receptors on pulmonary C-fibers to 
stimulate the central nervous system (CNS) and mediate lung refluxes; however, the specific 
mechanisms are not clearly understood (Taylor-Clark and Undem, 2010). Ozone has also 
been shown to stimulate RARs but is considered to be an indirect effector (Taylor-Clark and 
Undem, 2010). Thus, it is likely that pollutants may utilize C-fibers to alter pulmonary and 
cardiac function as well as to induce other neuronal pathways, but the mechanisms remain 
unclear.  
1.6 Air pollution and cardiovascular effects  
 Prior to the 1990s, air pollution studies primarily focused on the respiratory system. 
High level occupational exposures such as asbestos, agricultural dusts, metal fumes, and 
silica were shown to cause pulmonary diseases such as asbestosis, metal fume fever, silicosis, 
and pneumoconiosis. It was not until the late 20th century when ambient levels of pollution 
were linked to adverse cardiovascular health effects. The cardiovascular system and the lung 
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are hemodynamically and neurohumorally-linked, and therefore, any effect on one is likely to 
impact the other organ. For example, changes in heart rate and heart rate variability (HRV) 
have been implicated in altered alveolar-arterial oxygen transfer (Sin et al., 2010). Ozone 
exposure was demonstrated to increase heart rate and blood pressure along with inefficient 
pulmonary-gas exchange in healthy human subjects (Gong et al., 1998). Many 
epidemiological, clinical and experimental studies have emerged which show that PM and 
ozone can induce alterations in HRV, conductance abnormalities, vasoconstriction, 
endothelial dysfunction and thrombosis (Delfino et al., 2008;  Pope, 2009;  Brook et al., 
2010b;  Farraj et al., 2011), which are implicated in the rise of cardiac-related hospital 
admissions due to hypertension, myocardial infarctions, arrhythmias, congestive heart failure 
and vascular diseases such as atherosclerosis (Poloniecki et al., 1997;  Pope et al., 2004;  
Pope et al., 2009).  
1.7 Cardiac effects 
 A number of cardiac effects have been linked to air pollution exposure in 
epidemiological and clinical studies including changes in HRV, hypertension, arrhythmia, 
myocardial infarction and ischemia.  HRV is a clinical measure of variation in time interval 
between heartbeats and signifies changes in the autonomic nervous system (deBoer et al., 
1987;  Kaushal and Taylor, 2002). Changes in HRV are indicative of perturbed 
depolarization and repolarization synchrony of the myocardium, involving autonomic 
dysregulation. A reduction in HRV suggest a poor prognosis for future adverse cardiac 
events, such as impairment in cardiac conductance, myocardial infarctions and sudden death 
(Bigger et al., 1992;  Dekker et al., 2000).  Exposure to PM has been linked to reduction in 
HRV in several studies (Chan et al., 2004;  Liao et al., 2004;  Chow et al., 2006;  Lipsett et 
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al., 2006;  Adar et al., 2007).  However, other studies shown increases in HRV(Salvi et al., 
1999;  Ruckerl et al., 2007;  Devlin et al., 2012).   
Air pollutants have been postulated to increase ventricular arrhythmias and atrial 
fibrillation (Brook et al., 2010a).  Specifically, a case-crossover study that followed 203 
subjects given implantable cardioverter defibrillators over an average of 3.1 years reported 
that ozone and PM concentrations were associated with 798 ventricular arrhythmias in 84 of 
the subjects (Rich et al., 2005). Another study demonstrated that increases in ozone 
concentrations were associated with increased risk for supraventricular arrhythmias in the 
elderly (Sarnat et al., 2006). Rodent studies generally done at high concentration of ultrafine 
carbon black  or ozone  have demonstrated decreases in heart rate (Watkinson et al., 2003;  
Ghelfi et al., 2008), while other studies, conducted at relatively lower concentrations of PM, 
have shown increases in heart rate following exposure (Upadhyay et al., 2008). Farraj et al. 
(2012) demonstrated that high levels of ozone caused alterations in repolarization, 
atrioventricular conduction block, atrial premature beats, supraventricular beats, and second 
degrees morbitz type I atrioventricular block in hypertensive rats (Farraj et al., 2012). This 
study further showed that ozone exposure increased risk for ventricular tachycardia, 
ventricular fibrillation and cardiac arrest in rats during an aconitine challenge in a 
concentration-dependent manner. Overall these studies support the notion that pollutants can 
alter cardiac function.  
 In animal studies, myocardial dysfunction and cardiac ischemic injury were 
associated with increased inflammatory mediators, oxidative stress byproducts, and 
decreased antioxidant reserves following PM exposure (Kodavanti et al., 2000;  Liu and 
Meng, 2005). It has been postulated that circulating inflammatory mediators and ROS may 
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locally impact cardiac function by inducing myocardial contractile dysfunction through 
decreased systolic intracellular Ca2+ and activation of calmodulin kinase II (Erickson et al., 
2008), resulting in prolongation of action potential duration) and arrhythmogenesis (Ito et al., 
2008; Xie et al., 2009). Subchronic episodic exposures of combustion-derived PM exposures 
in rats have also been link to increased inflammation, myocardial cytotoxicity, fibrosis, and 
changes in gene expression pattern in the heart (Kodavanti et al., 2003).  
1.8 Vascular effects 
Several epidemiology and clinical studies have shown an association between air 
pollution and vascular dysfunction. An earlier study demonstrated impairment in 
endothelium dependent and independent vasodilation that were associated with higher 
concentrations of sulfate and black carbon in the air (O'Neill et al., 2005). Interestingly, these 
effects were noted among diabetes patients. Healthy humans exposed to traffic-related PM 
have also displayed impairment in endothelium-dependent vasodilation (Dales et al., 2007;  
Rundell et al., 2007). Brook et al. (2002) demonstrated brachial artery narrowing after ozone 
and PM exposure in healthy volunteers (Brook et al., 2002). More studies, focused primarily 
on diesel exhaust, have shown endothelial dysfunction and impaired vasodilation in 
conducting and resistant arteries in humans (Nurkiewicz et al., 2004;  Urch et al., 2004;  
Mills et al., 2005).  
 It is speculated that circulating mediators such as reactive oxidation byproducts, pro-
inflammatory cytokines, and vasoactive substances may be involved in pollutant-induced 
vasoconstriction and endothelial dysfunction. Rats receiving antioxidant treatment were 
protected from ozone-induced impairment of nitric oxide (NO)-mediated coronary artery 
dilation (Paffett et al., 2015), which suggests that increased oxidant production might be 
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involved in vascular effects. Similarly, reduced levels and functionality of NO are associated 
with increased  systemic oxidative stress (Tzeng et al., 2003;  Li et al., 2006) and 
inflammatory mediators (IL-6, TNF-) within the systemic circulation after PM exposure 
(Ruckerl, et al., 2007). PM has also been shown to increase endothelins (Thomson et al., 
2004) and angiotensin II (Li et al., 2005) in rats, contributing further to vasoconstrictive 
effects (Tzeng, et al., 2003;  Sun et al., 2005). Overall, pollutant-induced changes in systemic 
mediators have been postulated to impair peripheral physiological responses.  
1.9 Proposed mechanisms of air pollutant-induced systemic and cardiovascular effects 
 Three mechanisms have been proposed to explain how pollutant-induced pulmonary 
injury/inflammation may lead to systemic inflammation and cardiovascular effects: (1) 
translocation of pollutant components reaching peripheral tissues and causing direct extra-
pulmonary effects, (2) local lung injury causing release of vasoactive substances and 
spillover of pro-inflammatory cytokines from damaged lungs and affecting distant organs, 
and/or (3) activation of the autonomic nervous system (ANS) that perturbs function of the 
cardiovascular system (Figure 1.2). Each of these proposed mechanisms might be involved 
but is likely to be influenced by the chemical composition, size, pollutant concentration, and 
the nature of exposure, the physical integrity of the lung and the species sensitivity. 
1.9.1 Evidence for systemic translocation of air pollution components 
 Coarse and fine particles, due to their large size, are not systemically translocated but 
are phagocytosed by alveolar macrophages. The migration of these phagocytes to the lymph 
nodes and particle translocation have been reported in some cases. Due to their nanometer 
size range, UFP have the potential for systemic translocation. Although the postulate that 
these particles can translocate to the periphery without cells remains controversial, some 
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studies have demonstrated the translocation of UFPs to the circulation and various organs, 
but the level of translocation is generally low and is dependent upon the nature of UFPs 
(Nemmar et al., 2001;  Nemmar et al., 2002).  Particle-associated metals that are soluble and 
thus, bioavailable have been shown to translocate to the heart and extra-pulmonary organs 
(Wallenborn et al., 2007).   UFPs or soluble metals, if translocated, can induce extra-
pulmonary effects by directly interacting with tissues they encounter (Wallenborn et al., 
2009). It is noteworthy that pollutants which do not translocate systemically can also induce 
extra-pulmonary effects. For example, systemic effects can be induced by reactive gaseous 
pollutants such as ozone, which is unlikely to translocate from the lung.  Thus, it is difficult 
to delineate a specific mechanism for systemic effects induced by inhaled pollutant mixtures 
1.9.2 The evidence for systemic inflammation induced by inhaled pollutants 
During pollutant exposure, the lung was postulated to be the main source of 
circulating vasoactive and inflammatory mediators that can perturb cardiac and vascular 
function. It has been proposed that activated macrophages in the lung can, through the release 
of pro-inflammatory mediators, activate the bone marrow. Exposure to cigarette smoke has 
been shown to increase polymorphonuclear leukocytes production in the bone marrow of 
rabbits, which suggests that the bone marrow may be involved in pollutant-induced systemic 
inflammation (Terashima et al., 1999). However, the precise mechanisms by which lung 
macrophages upon activation may signal bone marrow to release progenitor leukocytes or 
increase circulating cytokines is not well understood.   
A number of rodent studies have shown that circulating pro-inflammatory cytokines 
are increased after pollution exposure and may be involved in peripheral effects of air 
pollutants (Nurkiewicz, et al., 2004;  Finnerty et al., 2007;  Mutlu et al., 2007;  Niwa et al., 
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2008), while many other rodent studies have demonstrated no change in circulating cytokine 
levels (Campen et al., 2006;  Kooter et al., 2006;  Gottipolu et al., 2009). Inhalation studies 
showing increased circulating cytokines have generally involved long-term (subchronic) 
exposures in mouse models. Therefore, it remains to be determined if increased systemic 
inflammation will be present during acute pollutant exposure and if cytokines are the 
initiating factor for extra-pulmonary effects as many studies have suggested.   
1.9.3 Autonomic involvement in regulation of cardiac physiological changes 
  Air pollutant-induced cardiac physiological changes, especially changes in HRV, are 
governed by autonomic regulation of sympathetic and parasympathetic tone. Ozone-induced 
bradycardia, along with decreased core temperature, suggests alterations in the ANS (Gordon 
et al., 2014). Likewise, changes in HRV following ozone and diesel exposure in rats and 
humans can also be mediated though autonomic imbalance. The ANS, which is divided into 
the sympathetic and the parasympathetic axes, regulates cardiac rhythmicity and blood 
supply to the periphery. Dysfunction of the ANS could result in perturbation of electrical 
conduction and propagation of cardiac arrhythmias.  Increased HRV is associated with 
parasympathetic nervous system (PSNS) activation, while decreased HRV indicates the 
predominance of the SNS activation.  Reduced HRV is considered detrimental and represents 
an ANS imbalance and increased risk for cardiovascular morbidity and mortality. The 
activation of the SNS will result in increased heart rate, while the predominance of the PSNS 
will result in bradycardia. Many human and animal studies have examined the effects of air 
pollution on cardiac physiology. Arito et al. revealed that  ozone-induced bradycardia was 
attenuated in rats, treated with a parasympathetic blocker, atropine(Arito et al., 1992), while 
another study displayed similar reversal of ozone-induced bradycardia in vagatomized dogs 
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(Vaughan et al., 1971), suggesting the involvement of sensory neurons. Although the 
involvement of autonomic regulation in air pollutant-induced cardiovascular effects has been 
identified, it is not clearly understood how pollutant exposure might alter autonomic 
regulation.   
1.10 Air pollution and neuronal effects 
 More recently, the CNS has been reported as another target of air pollutant effects. 
Exposure to air pollutants have been linked to neuroinflammation, neurodegeneration, 
learning and psychological impairment, and decrement in cognitive function in a number of 
epidemiological and animals studies (Block and Calderon-Garciduenas, 2009;  Costa et al., 
2014;  Calderon-Garciduenas et al., 2015;  Calderon-Garciduenas and Torres-Jardon, 2015). 
Exposure to diesel exhaust in rats has been shown to cause microglial activation and 
neuroinflammation in a number of brain regions (Levesque et al., 2011). Ozone exposure has 
been shown to cause oxidative and inflammatory changes in various areas of the brain in 
animals (Rivas-Arancibia et al., 1998; Rivas-Arancibia et al., 2010;  Mokoena et al., 2015). 
Three mechanisms have been proposed to explain how air pollutants impact the CNS. It has 
been thought that, depending on the physicochemical property, inhaled pollutants can induce 
neuronal effects (as indicated for systemic effects) through: 1) direct translocation of 
components, especially soluble materials and nanoparticles, through the olfactory bulb or 
systemic circulation, across the blood-brain barrier into the brain, 2) circulating inflammatory 
mediators that activate brain regions and induce local inflammation, and 3) activation of 
sensory neurons in the lung. Regardless of the initiating event, it has been shown that 
pollutant exposure is associated with oxidative stress and inflammatory responses in resident 
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endothelial glial cells such as astrocytes, and neurons, which may result in damage and loss 
of signal integration in various regions of the brain and alter behavioral outcomes. 
 PM and its constituents have been reported to translocate from the lung and into the 
brain of rodents (Oberdorster et al., 2004) and humans (Calderon-Garciduenas et al., 2008), 
which could initiate local oxidative, inflammation, and innate responses (Wang et al., 2008;  
Block and Calderon-Garciduenas, 2009). Specifically, UFP particulate have been shown to 
translocate through the olfactory nerves and reach the olfactory bulb, hippocampus, and other 
brain areas (Wang et al., 2008). These direct neuronal effects of particulates will depend 
upon the presence of pollutant components that are able to translocate to the brain upon 
inhalation. 
 Pollutants which do not translocate, such as ozone, have also been shown to cause a 
number of effects in different brain regions; however, the mechanisms still remain unclear.   
The activation of C-fibers on afferent sensory vagus nerves within the lung has been 
proposed to be involved in activation of the CNS. Acute ozone exposure has been shown to 
increase cFos staining, an indicator of neuronal activation, in the NTS, and in stress-
responsive regions including the caudal ventrolateral medulla, parabrachial nucleus, central 
nucleus of the amygdala, bed nucleus of the stria terminalis and the paraventricular 
hypothalamic nucleus (Gackiere et al., 2011).  The NTS receives vagal sensory information 
from the cardiac and pulmonary systems, and from subdiaphragmatic organs of the 
gastrointestinal tract (Travagli, 2007).  Ozone has been shown to activate specifically the 
caudal and subpostremal NTS, which overlaps with regions that receive input from the 
pulmonary C-fibers and RAR receptors (Gackiere, et al., 2011). Once the NTS is activated, it 
can relay the information to the aforementioned stress-responsive regions, specifically the 
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hypothalamus. These stress-responsive regions are known to stimulate the ANS to respond 
effectively to afferent input and lead to a plethora of responses in the body. Thus, it is likely 
that air pollutant exposure might induce peripheral effects through activation of central ANS 
mechanisms; however, the involvement of the nervous system in mediating peripheral air 
pollution systemic effects has not been well established. 
 1.11 Air pollution and metabolic effects: diabetes 
 In 2014, the American Diabetes Association estimated that 29.1 million people were 
diagnosed with diabetes (blood sugar  126 mg/dL), while 86 million were diagnosed with 
pre-diabetes (blood sugar levels between 100-125 mg/dL) in the United States. That same 
year, it was reported that 245 billion dollars were spent in medical bills associated with 
diabetes in America. Further, the diabetes epidemic goes beyond the United States. In 2013, 
the WHO estimated that 382 million people had diabetes worldwide, with 90% of the cases 
consisting of type II diabetes (TIID) and the remaining 10% being type I. TIID is 
characterized by the diminished ability of insulin to regulate glucose uptake by cells (insulin 
resistance), leading to increased blood glucose levels and the inability of cells to use glucose 
as a source of energy, resulting in a variety of other complications. Insulin resistance can 
begin to develop years before clinical signs of diabetes are observed (Froncesa, 2009) . It is 
believed that overcompensation of the pancreatic islets to produce insulin during insulin 
resistance will eventually result in β-cell dysfunction and often a reduction in circulating 
insulin, which is associated with the manifestation of TIID (Kasuga, 2006). Virtually all 
organ systems can be affected by diabetes as cells are not able to use glucose for energy 
production despite high circulating levels. Non-treatment of TIID can have an array of 
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consequences on the respiratory, urinary, reproductive, cardiovascular, CNS and endocrine 
systems.  
1.12 Systemic inflammation in insulin resistance  
 Many studies have suggested that systemic inflammation is central to the 
pathogenesis of insulin resistance (Schmidt et al., 1999;  Barzilay et al., 2001;  Pradhan et 
al., 2001;  Festa et al., 2002;  Duncan et al., 2003;  Spranger et al., 2003). High levels of  
specific pro-inflammatory markers and chemokines have been observed in diabetes patients, 
including TNF-, IL-6, IL-1β, and C-reactive protein (Shoelson et al., 2006). It is 
hypothesized that the chronic pro-inflammatory state observed in TIID patients originates in 
adipose tissue (Shoelson, et al., 2006). Obesity and high caloric diets are thought to initiate 
expansion and remodeling of adipose tissue, the activation of inflammatory mechanisms, and 
the systemic release of pro-inflammatory cytokines and chemokines. More specifically, 
recent animal studies suggest that over-nutrition and obesity can cause accumulation of free 
fatty acids (FFA) in adipocytes, leading to the activation of the inflammatory pathways c-
Jun-NH2-terminal kinase (JNK) and IKK-β pathway. The JNK and IKK-β pathways initiate 
serine phosphorylation of the insulin receptor substrate (IRS)-1/2, resulting in inhibition of 
the insulin signaling pathway and activation of transcription factors that upregulate 
inflammatory mediators (Shoelson, et al., 2006). Moreover, genetic and pharmaceutical 
intervention of JNK and IKK-B axes have ablated obesity-induced insulin resistance in mice 
(Shoelson, et al., 2006). Pro-inflammatory mediators secreted from adipose tissue can also 
activate local macrophages that initiate the recruitment of additional monocytes to the site, 
leading to chronic immune activation. These activated adipose-derived monocytes are 
observed to transition from an M2 (suppressive) to an M1 (pro-inflammatory) phenotype 
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(Shoelson, et al., 2006). Increased circulating adipose-derived FFA can also negatively 
regulate insulin signaling in other insulin-sensitive tissues like the liver and the muscle, 
contributing to global progression of insulin resistance. However, it should be noted that non-
obese individuals are also known to develop insulin resistance and diabetes. Thus, a variety 
of risk factors likely play a role in development of TIID, including calorie rich diets, 
sedentary lifestyle, genetic predisposition and chronic stress. The interactive contribution of 
these risk factors still remains unclear and thus, are under intense investigation (Finucane et 
al., 2011).  
1.13 Air pollutants and diabetes  
 More recently, air pollution has been postulated to be a contributing risk factor for 
diabetes. Epidemiological studies have shown a positive association between the incidence of 
TID and TIID and air pollution exposure (Liu et al., 2013;  Thiering and Heinrich, 2015). 
Pearson et al. in a cross-sectional study demonstrated that high levels of PM coincided with 
prevalence of diabetes in the United States (Pearson et al., 2010).  Specifically, increased 
levels of ambient PM have been associated with increases in HbA1c (a marker of  chronic 
high levels of  blood  glucose) (Chuang et al., 2011;  Tamayo et al., 2014),  impairment in 
glucose metabolism (Teichert et al., 2013), elevated homeostatic model assessment of insulin 
resistance (HOMA-IR), and decreased insulin sensitivity in humans (Kim and Y.C., 2012;  
Brook et al., 2013;  Thiering and Heinrich, 2015). However, the mechanisms by which air 
pollutants might cause metabolic effects or insulin resistance are not well understood. 
 Experimental studies have shown that long-term PM exposure results in liver 
endoplasmic reticular (ER) stress, adipose mitochondrial dysfunction,  adipose inflammation, 
and liver insulin insensitivity (Rajagopalan and Brook, 2012a), all of which have been 
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implicated in TIID. PM-induced liver ER stress, also referred to as unfolded protein response 
(UPR), has also been implicated in the onset of insulin resistance and glucose metabolic 
impairment (Rajagopalan and Brook, 2012b). ER stress is induced when protein misfolding 
occurs due to their oxidative modifications or other conformational changes  and 
impaired/decreased protein folding capacity in the ER (Lai et al., 2007).  PM exposure has 
been reported to elevate UPR-associated proteins, protein kinase RNA-like ER kinase, 
inositol-requiring enzyme-1, activating transcription factor-4, heat shock protien70, heat 
shock protein 90, and binding immunoglobulin protein in the liver and white adipose tissue 
(Rao et al., 2015). The UPR can activate inflammatory and stress signaling systems, 
including the NF-κB and JNK pathways, which may influence cellular glucose uptake 
(Rajagopalan and Brook, 2012a). However, it is not known if liver ER stress is an initiating 
event in pollutant-induced metabolic effects or a consequence of PM-induced systemic 
changes. Long-term PM exposure-induced systemic increases in pro-inflammatory cytokines 
has been postulated to contribute to insulin resistance (Xu et al., 2011). PM exposure has 
specifically been shown to increase inflammatory cytokines IL-6, TNF-, IL-1β in adipose 
tissues (Sun et al., 2009;  Sun et al., 2013). PM exposure was also associated with increases 
in systemic levels of IL-6, and reduced tyrosine phosphorylation of insulin signaling 
mediators: IRS-1/2, Protein Kinase B (PKB/AKT), and phosphatidylinositol-4,5-
bisphosphate 3-kinase in the liver, resulting in decreased insulin-mediated glucose uptake 
(O'Neill et al., 2007;  Sun, et al., 2013). Further, long-term PM exposure has been shown to 
perturb mitochondrial function in adipose tissue, leading to the accumulation of different 
metabolites, such as diacylglycerol, that could perturb insulin signaling (Xu, et al., 2011). 
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The initiating events that are involved in inducing systemic inflammation or insulin 
resistance after air pollution exposure are still under investigation. 
1.14 Neuronal involvement in air pollution-induced systemic effects 
A number of studies provide clues to the initiating events that might alter immune 
mechanisms and induce metabolic alterations. As discussed above, air pollutants alter 
autonomic function and can induce brain inflammation. It has been proposed that pollutant-
induced systemic effects may be mediated through the activation of key hypothalamic 
regions involved in the regulation of metabolic homeostasis and maintenance of energy 
requirements. A few studies have proposed that hypothalamic ER stress, and increased 
expression of pro-inflammatory cytokines such as IL-6 and transcription factors such as NF-
B  in the brain may be linked to neuronal damage, hypertension, and metabolic disturbances 
(Purkayastha, et al., 2011). Given the evidence that air pollutants can cause cardiovascular 
effects through ANS involvement and also induce neuronal inflammation in various areas of 
the brain, we postulate that systemic inflammatory and metabolic effects are mediated 
through neural pathways.   
 Ozone is a well-studied, chemically simple prototypic pollutant, which has gained 
significant interest recently for its extra-pulmonary and neuronal effects. Interestingly, 
epidemiological studies have shown a positive association between ozone and fasting 
hyperglycemia, insulin resistance and exacerbation of diabetes symptoms (Stafoggia et al., 
2010;  Zanobetti and Schwartz, 2011;  Kim and Y.C., 2012), although the mechanistic link is 
not established.  In one of our earlier studies, we showed that aged (2 year old)  rats exposed 
to ozone episodically for a period of 4 months had increased circulating insulin levels 
(Gordon et al., 2013).  This finding prompted us to examine the link between metabolic 
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alterations and ozone. We subsequently reported that acute and long-term ozone exposure in 
Brown Norway (BN) rats were associated with hyperglycemia and impaired glucose 
tolerance, but these ozone-induced metabolic effects were transient (Bass et al., 2013). 
Although inflammatory cytokines have been considered to be the main contributor to 
pollutant-induced systemic effects, our studies using rat models failed to demonstrate any 
increases in circulating cytokines with ozone or other pollutants (Gordon et al., 2013, Bass et 
al., 2013). No changes were noted in the inflammatory cytokines IL-6, IL-1β, C-reactive 
protein or TNF- in rats following an acute or subchronic ozone exposure despite impaired 
glucose tolerance; however, acute phase proteins, such as acid glycoprotein and alpha-2 
macroglobulin, were increased after an acute ozone exposure (Bass et al., 2013). Importantly, 
the metabolic effects in the Bass et al., (2013) study were evident prior to pulmonary 
inflammation or increases in circulating acute phase proteins following ozone exposure, 
suggesting that pulmonary inflammatory spillover into the systemic circulation may not be 
the main mechanism of hyperglycemia or glucose intolerance.  
 This study showed an elevation in the stress hormone, epinephrine, which suggested 
that the SNS may be activated during exposure. Epinephrine has been shown to exert insulin 
antagonistic effects by mediating increased glycogen breakdown and enhanced adipose 
lipolysis (Nonogaki, 2000). Sympathetic nerves can directly target the adipose tissue and 
stimulate lipolysis, leading to the release of non-esterified fatty acids (NEFA), which can 
potentially contribute to insulin resistance (Arner and Langin, 2014). Acute ozone exposure 
was also associated with elevated circulating corticosterone in rats, which suggests the 
activation of the hypothalamus pituitary adrenal (HPA) axis (Thomson et al., 2013). 
Corticosterone, another insulin counter-regulatory hormone like epinephrine, is known to 
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alter glucose and lipid metabolism through decreased glucose uptake and protein synthesis, 
increased hepatic glucose output, stimulated adipose lipolysis and increased amino acid 
release (Olefsky and Kimmerling, 1976). It is hypothesized that chronically elevated 
circulating corticosterone or other stress hormones may result in glucotoxicity and/or 
lipotoxicity, which may contribute to insulin resistance and the loss of glycemic control long-
term. Corticosterone has also been implicated in decreased -cell insulin secretion (Delaunay 
et al., 1997). Epinephrine and corticosterone are produced and secreted from the adrenal 
medulla and cortex, respectively, and their increases in the circulation suggests the 
stimulation of the hormones release from the adrenal gland through a stress response 
pathway. No prior air pollution studies have examined the contribution of stress hormone-
mediated systemic metabolic impairment and inflammation as a mechanism that potentially 
can impact a number of peripheral metabolic activities and insulin sensitivity or produce 
other peripheral air pollution effects including systemic inflammation. 
 Stress hormones have a major regulatory role in mediating redistribution of immune 
cells and initiating an inflammatory response after stress. Specifically, stress hormones have 
been shown to systematically shift the pro-inflammatory state characterized by increased 
production of the cytokines IL-12, TNF-, and interferon (IFN)- to an anti-inflammatory 
state, in which Il-10 and Il-4 are produced (Elenkov and Chrousos, 2002).  These stress 
hormones can influence inflammatory responses in a tissue-specific manner based on 
differential distribution of adrenergic and glucocorticoid receptors. For example, in lung-
derived monocytes and epithelial cells, catecholamines, such as epinephrine, enhance IL-8 
production, leading to further recruitment of neutrophils to the airways (Linden, 1996;  
Kavelaars et al., 1997).  Stress hormones, especially catecholamines, to initiate mononuclear 
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cell activation through the induction of the NF-B pathway (Bierhaus et al., 2003), 
subsequently increasing expression of pro-inflammatory cytokines.  
  HPA axis activation leads to stimulation of the release of stress hormones from 
adrenal glands, which regulate peripheral metabolic homeostasis under stress. These 
hormones also have potent feedback inhibitory effects at the hypothalamus and pituitary 
levels since this homeostatic response is a transient mechanism to counter stress situations. 
The activation of the hypothalamus and secretion of corticotrophin releasing hormone (CRH) 
stimulates the anterior pituitary gland to release adrenocorticotropic hormone (ACTH) in the 
circulation that directly stimulates the adrenal cortex to secrete glucocorticoids (cortisol in 
humans and corticosterone in rats) and other hormones, such as mineralocorticoids (Ulrich-
Lai and Herman, 2009). In contrast, the adrenal medulla can be directly stimulated by the 
sympathetic efferent nerves, resulting in the secretion of epinephrine and norepinephrine.  
Although stress-induced peripheral metabolic impairment is well characterized, air 
pollutants have not been linked to mediate their effects through this pathway. It has been 
proposed that circulating factors are responsible for air pollutant-induced peripheral effects, 
but no prior studies have implicated changes in circulating metabolites or neurohormones in 
mediating systemic metabolic or pulmonary responses. Therefore, we postulate that ozone-
induced increases in epinephrine, observed in pre-studies, and corticosterone, as reported by 
others, may be involved in systemic metabolic impairment and pulmonary 
injury/inflammation and are mediated through the activation of the HPA axis and SNS 
(Figure 1.3). Since the long-term dysregulation of the HPA and autonomic nervous system 
has been shown to contribute to the development of insulin resistance and other cardio-
metabolic effects (Olefsky and Kimmerling, 1976;  Nosadini et al., 1983;  Bruce et al., 1992;  
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Surwit and Schneider, 1993;  Friedman et al., 1996;  Bjorntorp et al., 1999;  Laitinen et al., 
1999;  Rask et al., 2001), we postulate that subchronic episodic ozone exposure will lead to 
tissue specific insulin resistance in the liver and muscle.  
1.15 Summary and dissertation content 
 For decades, studies related to air pollutants focused primarily on the lung. Now it is 
apparent that air pollutants that encounter the lung and produce local effects can also affect 
virtually all organ systems in our body. In recent years, pollutant exposure has been 
associated with an increased incidence of diabetes; however, causality has not been 
established and the mechanisms are not understood. Although systemic inflammation was 
implicated in a number of air pollution studies that illustrate metabolic impairment, several 
other air pollution studies failed to demonstrate increases in circulating pro-inflammatory 
cytokines.  Even though a number of studies have implicated the role of the ANS in 
pollutant-induced cardiovascular effects, its contribution to systemic and metabolic 
impairment and pulmonary injury/inflammation following air pollution exposure has not 
been examined.   
 In this dissertation, we have begun to investigate whether ozone exposure produces 
systemic metabolic impairment and to determine if these metabolic effects are associated 
with the release of stress hormones in response to SNS and HPA axis activation. We 
hypothesized that acute ozone exposure will produce broad scale metabolic derangements 
through neurohormonal activation, involving stress pathways, and that longer exposures will 
result in insulin signaling impairment in the muscle and liver. In Chapters 2 and 3, we 
characterized the nature of systemic metabolic derangement and neurohormone responses to 
acute ozone exposure using a metabolomic approach, and specifically examined the 
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temporality of glucose intolerance, release of stress and metabolic hormones, and serum 
metabolite profiling in rats. In addition, we also examined the metabolomic profile of serum 
samples obtained from humans exposed to ozone, established the coherence between rats and 
humans, and identified novel metabolite biomarkers. In Chapter 4, I examined the 
contribution of stress hormones (epinephrine and corticosterone) in metabolic impairment 
and lung injury and inflammation. For this study, I examined ozone effects in rats that 
underwent total adrenal demedullation or total bilateral adrenalectomy relative to sham 
surgeries. We showed that adrenal-derived stress hormones are essential not only in systemic 
metabolic effects of ozone, but also in pulmonary injury and inflammation. In Chapter 5, I 
determined if longer (3 months, episodic) ozone exposure in rats is associated with persistent 
metabolic alterations and liver and muscle insulin resistance by examining the 
phosphorylation of critical insulin signaling mediators that promote glucose uptake and 
metabolism, such as the phosphorylation of AKT. We also determined the relation between 
insulin sensitivity and the levels of circulating cytokines, hormones, lipids and glucose. The 
data from our studies: 1) provide causal evidence for associations between ozone exposure 
and metabolic effects observed in epidemiological studies, 2) identified novel metabolite 
biomarkers of ozone effects in humans, 3) are the first to link a systemic stress response to air 
pollution exposure in rats and in humans, 4) have a potential implication in developing a new 
adverse outcome pathway that can be employed  for many environmental stressors and 
exposures, 5) provide novel insights into how stress hormones might regulate pulmonary 
injury/inflammation induced by air pollutants, 6) challenge the current paradigm of the 
mechanisms by which ozone induces lung injury, vascular leakage and inflammation, and 7) 
examine a potential link between insulin resistance/sensitivity and air pollutant exposure.  
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Figure 1.1
 
  
Figure 1.1: Ozone-induced lung effects. Upon inhalation, ozone (O3) can directly interact 
with proteins and lipids within the epithelial lining fluid (ELF) and on the surface of cells to 
form reactive oxygen species (ROS). These ozone-derived secondary and tertiary byproducts 
can injure the pulmonary endothelium and activate nerve endings, the main targets of air 
pollutants. Injured epithelium can release pro-inflammatory mediators, tachykinins 
(Substance P and neurokinins A) and enzymes that can activate local immune cells in the 
airway and recruit additional leukocytes to the respiratory tract. These epithelial-derived 
mediators or pollutant components can also lead to the activation of vagal neurons that 
terminate in the CNS and produced extra pulmonary effects. The alveolar leukocytes can 
further exacerbate the vicious cycle of ROS and inflammatory events, resulting in vascular 
leakage and increased lung injury/inflammation. 
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Figure 1.2
Figure 1.2 Pollutant-induced peripheral effects. It has been proposed that pollutants can 
elicit extra-pulmonary effects from the respiratory tract through the following mechanisms: 
1) through pulmonary vagal C-fiber activation of hypothalamic regions in the brain, 2) 
spillover of lung pro-inflammatory cytokines or activation of the bone marrow, 3) spillover 
of reactive secondary oxidized by-products, and/or 4) spillover of soluble pollutant 
components.   Air pollutants have been associated with cardiovascular and CNS adverse 
effects, but the specific pathway(s) by which systemic effects occur after exposure to air 
pollutants remain unclear.  
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Figure 1.3 
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Figure 1.3 The Proposed Mechanism of Stress Mediated Metabolic Effects of Ozone. 
Physiological and psychological stress are known to increase the levels of stress hormones in 
the circulation through activation  HPA and SNS. These neuronal stress pathways are used to 
mobilize energy substrates to the appropriate tissues to combat stress. Specifically, the HPA 
leads to the activation of the adrenal cortex, which releases glucocorticoids, while 
sympathetic nerve terminals activate the adrenal medulla, which release catecholamines. 
These stress hormones are known to interact with their respective receptors on multiple 
organs and elicit responses: tachycardia, hyperglycemia, gluconeogenesis, glycogenolysis, 
adipose lipolysis, protein catabolism, etc, Chronic elevation of these stress hormones have 
been associated with metabolic dysfunction and insulin resistance. Ozone has been shown to 
activate hypothalamic neuro-stress responsive regions, potentially through stimulation of 
lung C-fibers (TRPA1).  
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CHAPTER 2 
 
INHALED OZONE INDUCES CHANGES IN SERUM METABOLOMIC 
AND LIVER TRANSCRIPTOMIC PROFILES IN RATS 
2.1 Introduction 
 The incidence of metabolic syndrome is steadily increasing worldwide, 
resulting in higher prevalence of diabetes mellitus and cardiovascular morbidity and 
mortality (Ford et al., 2002).  The common clinical components that comprise metabolic 
syndrome include, but are not limited to, abdominal obesity, hypertriglyceridemia, 
hypertension, low levels of high-density lipoprotein cholesterol (HDL-C), prothrombotic 
state, glucose intolerance, and insulin resistance (Ford et al., 2002; Grundy et al., 2004).  
Conventional etiologies, including sedentary lifestyle, diet-related obesity and genetics have 
been implicated as the major contributors to insulin resistance and the development of 
metabolic syndrome (Grundy et al., 2004).  Most recently, air pollution, such as PM, has also 
been linked to the development of metabolic syndrome, and may serve as an effect modifier 
for the epidemiological associations between environmental factors and increased rate of 
cardiovascular diseases (Chen and Schwartz, 2008). A number of recent epidemiological and 
experimental studies have shown that chronic inhalation of airborne PM may increase an 
individual’s risk for acquiring type 2 diabetes by creating a pro-inflammatory state, insulin 
resistance, and/or obesity (Brook et al., 2008, Rajagopalan and Brook, 2012; Liu et al., 2013)
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A number of mechanistic pathways have been proposed where lung 
injury/inflammation initiates systemic inflammation, which is postulated to play a central 
role in inhaled pollutant-induced insulin resistance, but the evidence remains insufficient 
(Shoelson et al., 2006, O’Neill et al., 2007, Xu et al., 2011, Yan et al., 2011; Rajagopalan and 
Brook, 2012).  Similar to PM, the ubiquitous air pollutant ozone has been associated with 
adverse pulmonary and cardiovascular health effects, such as lung injury/inflammation, 
decreased lung function and heart rate variability in animals and humans (Watkinson et al., 
2001;  Hollingsworth et al., 2007; Ciencewicki et al., 2008;  Liu et al., 2009; Farraj et al., 
2012; Wagner et al., 2014). However, the likely contribution of ozone to metabolic disorder 
and extra-pulmonary effects has yet to be systematically investigated.  
Exposure to ozone has also been shown to induce cardiovascular functional changes 
through modulation of the autonomic nervous system, which regulates sympathetic and 
parasympathetic balance (Farraj et al., 2012; Gordon et al., 2014). More specifically, acute 
ozone exposure has been shown to stimulate lung vagal C-fibers through transient receptor 
potential member A1 (TRPA-1) receptors that lead to activation of neural stress-responsive 
regions in the central nervous system where lung afferents of vagus nerves terminate (Taylor-
Clark and Undem, 2010 and Gackiere et al., 2011).  Stress-mediated hypothalamus pituitary 
adrenal (HPA) axis activation is well known to modulate a variety of physiological processes 
including thermoregulation, immune elicitation, hormonal disposition, and systemic 
metabolic alterations (Ulrich-Lai and Herman, 2009). One study has recently shown that 
acute ozone exposure increased serum corticosterone in rats (Thomson et al., 2013), which is 
a marker of HPA axis activation. Recently, we have shown that ozone induces glucose 
intolerance and increased serum leptin and epinephrine in Brown Norway (BN) rats, in 
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addition to inducing hypothermia and bradycardia during exposure (Bass et al., 2013 and 
Gordon et al., 2014). Observed increases in serum epinephrine and corticosterone during 
acute pollutant exposure suggest a potential involvement of sympathetic and/or HPA-
associated neurohumoral factors. However, a detailed characterization of ozone-induced 
metabolic impairment and involvement of neurohumoral intermediates has not been reported. 
This could aid in identifying potential mechanisms of ozone–induced systemic metabolic 
effects.  
The objective of this study was to utilize serum metabolomic and liver transcriptomic 
techniques together with metabolic hormonal assessment to gain insight into the 
characteristics and potential mechanisms of metabolic alterations during ozone-induced 
hyperglycemia and glucose intolerance. The serum metabolomic approach used in this study 
is able to detect quantifiable metabolites in the serum released from biochemical processes in 
various tissues critical for metabolic homeostasis (Barnes et al., 2014). The detection of 
metabolites can provide insight regarding organs being affected by ozone exposure. Liver 
being the major organ for control and maintenance of metabolic processes, the assessment of 
liver transcriptional changes could provide mechanistic insights into its role in ozone 
systemic metabolic response. We hypothesized that ozone-induced hyperglycemia and 
glucose intolerance will be associated with broad scale systemic metabolic impairment, and 
that the use of serum metabolomic together with liver transcriptomic approaches will provide 
insights into 1) the mechanisms by which ozone perturbs metabolic processes, and 2) the 
potential contribution of ozone to long-term metabolic alterations.  
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2.2 Materials and Methods 
2.2.1 Animals 
 Male, 10 week old, healthy Wistar Kyoto (WKY) rats (250-300g) were purchased 
from Charles River Laboratories Inc. (Raleigh, NC). Rats were housed (2/cage) in 
polycarbonate cages containing beta chip bedding in an isolated animal room in an animal 
facility maintained at 21 ± 1ºC, 50 ± 5% relative humidity and held to a 12hr light/dark cycle. 
The animal facility is approved by the Association for Assessment and Accreditation of 
Laboratory Animal Care (AAALAC). All animals received standard (5001) Purina pellet rat 
chow (Brentwood, MO) and water ad libitum unless otherwise stated. Animal procedures 
were approved by the U.S. EPA NHEERL Animal Care and Use Committee (IACUC; Permit 
Number: 13-02-003 and 16-03-003). Animals were treated humanely and all efforts were 
made for alleviation of suffering. 
2.2.2  Ozone generation and animal exposures 
 Ozone was produced from oxygen by a silent arc discharge generator (OREC, 
Phoenix, AZ), and its entry into the Rochester style “Hinners” chambers was controlled by 
mass flow controllers. The ozone concentrations in the chambers were recorded continuously 
by photometric ozone analyzers (API Model 400).  Chamber temperature and relative 
humidity were measured continuously. Mean chamber air temperature and relative humidity 
were 23.3 °C (74 ⁰F) and 46%, respectively. In the concentration-response study, rats were 
randomized by body weight into four exposure groups (n=6/group) to make sure each 
exposure group had the same overall average body weight. Similarly, in the time-course 
study, rats were randomized by body weight into six groups (n = 8/group) for two exposure 
conditions and each time point. In the concentration-response study, WKY rats were exposed 
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to either filtered air (FA) or ozone (0.25, 0.50, or 1.0 ppm), 6hr/day for two consecutive days 
and sacrificed 18hr after day 2.  In the subsequent time-course experiment, three groups of 
WKY rats were used. 1) The first group was either exposed to FA or 1.0 ppm of ozone for 
6hr/day for one day (1d-0hr), 2) a second group was exposed 6hr/day for two consecutive 
days (2d-0hr), and 3) a third group was allowed an 18hr recovery, following two consecutive 
days of ozone exposure (2d-18hr).  
2.2.3  Glucose tolerance testing (GTT) 
All rats that underwent GTT were fasted for 8-10hr in cage or during exposure prior 
to the assessment of blood glucose concentrations. For rats that were allowed an 18hr 
recovery period, food was removed for 10hr (overnight; 10pm to 8 am) before GTT.  
Baseline blood glucose concentrations were measured by pricking the distal surface of rats’ 
tails using a sterile needle to obtain ~1 μl of blood.  A Bayer Contour glucometer was used to 
determine blood glucose levels using test strips, which require 0.6 L whole blood.  After the 
first measurement, rats were given an intraperitoneal (I.P.) injection of glucose, 2g/kg/10 mL 
(20% D-glucose; 10ml/kg). Measurement with the glucometer was repeated every 30 min 
over the course of 2hr. In the concentration-response study, all animals underwent GTT 4 
days prior to ozone exposure, immediately following ozone on day 1 and immediately 
following ozone on day 2. For the time-course study, rats assigned to the 18hr recovery 
group were used for GTT. These rats underwent GTT one day before ozone exposure, 
immediately following ozone exposure on day 1, immediately following ozone exposure on 
day 2, and also after an 18hr recovery period following two days of ozone exposure. In 
addition, rats assigned to the 2d-0hr time point underwent GTT immediately following one 
day of FA or ozone exposure. No GTT was performed on the 1d-0hr group where tissue and 
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serum collection were performed immediately after exposure.  The 2d-0hr exposure group 
for tissue and serum collection did not undergo GTT on the 2nd day of ozone exposure.  
2.2.4  Necropsy and sample collection 
For the concentration-response study, all rats were necropsied 18hr after two 
consecutive days of FA or ozone exposure. For the time-course experiment, one group of rats 
(n=16), which did not undergo GTT, were necropsied immediately after the first day of 
exposure (1d-0hr). The 2nd group of rats (n=16) was necropsied immediately after the 
second day of ozone exposure (2d-0hr). The recovery group (n=16) was necropsied 18hr 
after the second day of exposure (2d-18hr).  In each study, rats were fasted for 8-10hr before 
necropsy regardless of fasting associated with GTT. Rats were weighed and anesthetized 
with an overdose of sodium pentobarbital (Virbac AH, Inc., Fort Worth, TX; 50-100 mg/kg, 
i.p.). Blood samples were collected through an abdominal aortic puncture directly into serum 
separator vaccutainers without coagulant for serum preparation.  Tubes were centrifuged at 
3500 x g for 10 min and aliquots of serum were stored at -80°C until analysis.  In the 
concentration-response study, bronchoalveolar lavage (BAL) was performed through tracheal 
tubing using Ca2+ and Mg2+ free phosphate buffer saline, 37°C at 28mL total lung capacity/kg 
rat weight.  Aliquots of BAL fluid were used to determine total cell counts with a Z1 Coulter 
Counter (Coulter, Inc., Miami, FL) and cell differentials were performed on cytospin slides 
stained with Diff-quick as previously described (Bass et al., 2013). The cell-free BAL fluid 
was used to analyze albumin, as previously described (Bass et al., 2013). In the time-course 
experiment, in addition to collecting serum at each time point, liver tissues were collected 
and frozen in liquid nitrogen for RNA analysis.   
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2.2.5  Serum analysis 
 Serum samples collected from rats were analyzed for insulin and leptin using rat-
specific electrochemiluminescence assays (Meso Scale Discovery, Gaithersburg, MD) via 
manufacturer’s instructions. Total cholesterol was measured in serum samples using kits 
from TECO Diagnostics (Anaheim, CA), while HDL-C and low-density lipoprotein 
cholesterol (LDL-C) were measured with kits from Thermo Fisher Scientific, Inc. 
(Middletown, VA). Both types of kits were modified for use on the Konelab Arena 30 system 
(Thermo LabSystems, Espoo, Finland). Epinephrine circulating levels was determined by 
ELISA kit (Cusabio, Wuhan, China)  
2.2.6 1 Metabolomic analysis   
 Serum global metabolomic profiling was performed by Metabolon Inc. (Durham, 
NC). Detailed methods are described in previous publications (Evans et al., 2009, Dehaven et 
al., 2010 and Reitman et al., 2011). Frozen serum samples from time-course study for 1 d–
0 h and 2d–0h time points (n = 7–8/group) were used for this analysis.  
2.2.6.2 Sample accessioning 
 Each sample received was accessioned into the Metabolon laboratory information 
management system (LIMS) and was assigned a unique identifier that was associated with 
the original source identifier only.  This identifier was used to track all sample handling, 
tasks, results, etc.  All aliquots of any sample were automatically assigned their own unique 
identifiers by the LIMS when a new task was created; the relationship of these samples is 
also tracked.  All samples were maintained at -80ºC until processed. 
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2.2.6.3 UPLC/MS/MS 
 The LC/MS portion of the platform was based on a Waters ACQUITY ultra-
performance liquid chromatography (UPLC) and a Thermo-Finnigan linear trap quadrupole 
(LTQ) mass spectrometer, which consisted of an electrospray ionization (ESI) source and 
linear ion-trap (LIT) mass analyzer.  The sample extract was dried then reconstituted in 
acidic or basic LC-compatible solvents, each of which contained 8 or more injection 
standards at fixed concentrations to ensure injection and chromatographic consistency.  One 
aliquot was analyzed using acidic positive ion optimized conditions and the other using basic 
negative ion optimized conditions in two independent injections using separate dedicated 
columns.  Extracts reconstituted in acidic conditions were gradient eluted using water and 
methanol containing 0.1% formic acid, while the basic extracts, which also used 
water/methanol, contained 6.5mM ammonium bicarbonate.  The MS analysis alternated 
between MS and data-dependent MS2 scans using dynamic exclusion.  Raw data files are 
archived and extracted as described below. 
2.2.6.4 GC/MS 
 The samples destined for GC/MS analysis were re-dried under vacuum desiccation 
for a minimum of 24hr prior to being derivatized under dried nitrogen using bistrimethyl-
silyl-trifluoroacetamide (BSTFA).  The GC column was 5% phenyl and the temperature 
ramp was from 40°C to 300°C in a 16 min period.  Samples were analyzed on a Thermo-
Finnigan Trace DSQ fast-scanning single-quadrupole mass spectrometer using electron 
impact ionization.  The instrument was tuned and calibrated for mass resolution and mass 
accuracy on a daily basis.  The information output from the raw data files was automatically 
extracted as discussed below. 
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2.2.6.5 Quality assurance (QA)/quality control (QC) 
 For QA/QC purposes, additional samples were included with each day's analysis. 
These samples included extracts of a pool of well-characterized human plasma, extracts of a 
pool created from a small aliquot of the experimental samples, and process blanks. QC 
samples were spaced evenly among the injections and all experimental samples were 
randomly distributed throughout the run. A selection of QC compounds was added to every 
sample for chromatographic alignment, including those under test. These compounds were 
carefully chosen so as not to interfere with the measurement of the endogenous compounds. 
 
2.2.6.6 Metabolomic data extraction and compound identification 
 Raw data was extracted, peak-identified and QC processed using Metabolon’s 
hardware and software. Metabolite quantification was based on area under the curve.  These 
systems are built on a web-service platform utilizing Microsoft’s .NET technologies, which 
run on high-performance application servers and fiber-channel storage arrays in clusters to 
provide active failover and load-balancing.  Compounds were identified by comparison to 
library entries of purified standards or recurrent unknown entities.  Metabolon maintains a 
library based on authenticated standards that contains the retention time/index (RI), mass to 
charge ratio (m/z), and chromatographic data (including MS/MS spectral data) on all 
molecules present in the library.  Furthermore, biochemical identifications are based on three 
criteria: retention index within a narrow RI window of the proposed identification, nominal 
mass match to the library +/- 0.2 amu, and the MS/MS forward and reverse scores between 
the experimental data and authentic standards.  The MS/MS scores are based on a 
comparison of the ions present in the experimental spectrum to the ions present in the library 
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spectrum.  While there may be similarities between these molecules based on one of these 
factors, the use of all three data points can be utilized to distinguish and differentiate 
biochemicals.  More than 2400 commercially available purified standard compounds have 
been acquired and registered into LIMS for distribution to both the LC and GC platforms for 
determination of their analytical characteristics.   
2.2.6.7 Statistical analysis of metabolomic data 
 Missing values (if any) are assumed to be below the level of detection. However, 
biochemicals that were detected in all samples from one or more groups but not in samples 
from other groups were assumed to be near the lower limit of detection in the groups in 
which they were not detected. In this case, the lowest detected level of these biochemicals 
was imputed for samples in which that biochemical was not detected. Following log 
transformation and imputation with minimum observed values for each compound, Welch’s 
two-sample t-test was used to identify biochemicals that differed significantly between 
experimental groups. Pathways were assigned for each metabolite, allowing examination of 
overrepresented pathways.  Significant (p<0.05) pathway enrichment output (cumulative 
hypergeometric distribution) was assessed for each of the selected contrasts (1d-0hr; 2d-0hr 
and 2d-18hr) using MetaboSync, version 1.0 (Metabolon, Inc. RTP, NC) to determine the 
metabolic processes impacted by ozone.  
2.2.7.1 Gene Array 
 Liver tissue samples from FA or 1 ppm ozone-exposed rats (n=5-6/group) for all 
three time points from the time-course study were used for this analysis. Total liver RNA was 
isolated from ~20 mg tissue with a commercially available RNeasy mini kit (Qiagen, 
Valencia, CA) using silica gel membrane purification.  Liver RNA was resuspended in 30µl 
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of RNAse-free water.  RNAse inhibitor was added and RNA yield was determined 
spectrophotometrically on a NanoDrop 1000 (Thermo Scientific, Wilmington, DE). RNA 
integrity was assessed by the RNA 6000 LabChip® kit using a 2100 Bioanalyzer (Agilent 
Technologies, Palo Alto, CA).  We examined global gene expression changes using the 
Affymetrix platform (RG-230 PM Array strip). Biotin-labeled cRNA was produced from 
total RNA using an Affymetrix IVT-express labeling kit (cat# 901229).  Total cRNA was 
then quantified using a Nano-Drop ND-1000 spectrophotometer (NanoDrop Technologies, 
Wilmington, DE) and evaluated for quality on a 2100 Bioanalyzer. Fragmented cRNA were 
also evaluated for quality using 2100 Bioanalyzer. Following overnight hybridization at 45ºC 
to Affymetrix RG-230 PM array strip in AccuBlock Digital Dry Baths (Labnet International 
Inc.), the arrays were washed and stained using an Affymetrix GeneAtlas fluidics station as 
recommended by the manufacturer. Arrays were scanned on an Affymetrix Model GeneAtlas 
scanner.  After scanning, raw data (Affymetrix.cel files) were obtained using Affymetrix 
Command Console Operating Software.  This software also provided summary reports by 
which array QA metrics were evaluated including average background, average signal, and 
3’/5’ expression ratios for spike-in control GAPDH.   
2.2.7.2 Normalization and determination of differentially expressed genes 
 The Affymetrix GeneAtlas array data for each sample was normalized by Affymetrix 
Expression Console software using the plier algorithm with perfect match only probes.  The 
resulting expression table was downloaded from Affymetrix Expression Console software 
into a text file.  Statistical contrasts were calculated at each time point for ozone versus the 
FA control.  Each contrast was computed on a text file containing all assayed genes as rows 
and only the contrast samples as columns by a Bayes t-test using R.  Subsequently, a multiple 
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test correction using the Benjamin-Hochberg method with an alpha of 0.05 was applied to the 
Bayes t-test output in Excel.  To support subsequent analysis, the differentially expressed 
genes (DEGs) from the three time-point contrasts were consolidated into an ozone DEG 
expression table. 
2.2.7.3 Functional gene list preparation 
 The DEG list for each time point was also submitted to the Database for Annotation, 
Visualization and Integrated Discovery (DAVID) v6.7 for determination of significant Kyoto 
Encyclopedia of Genes and Genomes (KEGG) pathways using a modified Fisher Exact test 
with a p-value cutoff of 0.05. Functional gene lists were generated by NetAffx queries at the 
Affymetrix website (www.affymetrix.com). The query terms were “apoptosis”, “diabetes”, 
“gluconeogenesis”, “glycolysis”, “mitochondria”, “steroid metabolism”, “tricarboxylic acid 
cycle”, “unfolded protein response” and “cytokines”. The eight lists were exported separately 
from NetAffx as text files. For each gene list, Affymetrix probeset IDs were used to select 
the corresponding gene from the ozone DEG expression table to build an expression table 
that only contains the genes for a given function that were also ozone DEGs. Hierarchical 
clustering was computed for each functional gene list using Cluster 3.0 (de Hoon et al., 2004) 
and the clusters were displayed using Java Treeview (Saldanha, 2004). Three functional 
probeset lists based on queries of “steroid receptor”, “insulin receptor” or “fatty acid” were 
obtained from NetAffx. Each of these lists was compared to the list of DEGs for the 1d–0hr 
time point to identify DEGs in each of the three functional categories. Each functional list 
was processed separately by Ingenuity Pathway Analysis (IPA) to produce a direct 
relationship graph. The graph constructed from the Ingenuity knowledgebase depicts some of 
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the biological relationships among the probe sets on the list. The microarray data are 
publically available through Gene Expression Omnibus (accession # GSE59329). 
2.2.7.4 Real time PCR confirmation of gene array findings 
 We selected 4 genes increased in expression from the gene array (insulin receptor 
substrate-2, IRS-2; 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1, PFKFB1; 
aconitase-2, Aco-2; and peroxisome proliferator activated receptor gamma c1a, Ppargc1a) 
and a control transcript (β-actin) to determine the validity of gene array findings. RT-PCR for 
RNA from FA or ozone-exposed rat livers at 1d-0hr time point was conducted on an ABI 
Prism 7900 HT sequence detection system (Applied Biosystems, Foster City, CA) as 
described previously (Bass et al., 2013). Primers were purchased from ABI as inventoried 
TaqMan Gene Expression Assays, each containing a 6-carboxy-fluorescein (FAM dye) label 
at the 5’ end.  Data were analyzed using ABI sequence detection software (SDS version 2.2).  
For each PCR plate, cycle threshold (cT) was set to an order of magnitude above 
background.  For each individual sample, target gene cT was normalized to a control gene cT 
(β-actin) to account for variability in the starting RNA amount.  Expression of exposure 
group was quantified as fold difference over FA control.   
2.2.8.1 General statistical analysis 
 Graphpad prism 4.03 software was used for statistical analysis of GTT and biomarker 
data. Dose response study GTT was analyzed using a two-way analysis of variance 
(ANOVA) where each time blood glucose measurement was independently assessed.  The 
two independent variables were day and dose.  One-way ANOVA was used for data analysis 
of neutrophils and albumin in the BAL fluid. The time-course study GTT was analyzed by 
two-way repeated measures MANOVA (multivariate ANOVA).  The two independent 
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variables were day and dose.  The time course study biomarker measurements were analyzed 
using a two-way ANOVA followed by Duncan’s multiple range test.  Pair-wise comparisons 
were performed as subtests of the overall ANOVA.  The nominal Type I error rate (α) was 
set at 0.05.  No adjustments were made for multiple comparisons.   
 
2.3 Results 
2.3.1 Ozone induces pulmonary injury and inflammation in a concentration-dependent 
manner 
 Although ozone is well studied for its potential to induce lung injury in many 
experimental settings, we wanted to determine the concentration-dependent cellular 
responses and inflammation in our experimental model to better correlate these changes with 
systemic metabolic alterations. Therefore, we first confirmed whether ozone-induced 
pulmonary cellular responses in WKY rats by examining the BAL fluid for increases in the 
lung vascular leakage of albumin and neutrophilic inflammation at 18hr post two consecutive 
days of ozone exposure.  Inflammation and cellular responses have been shown to peak on 
the second day of ozone exposure (van Bree et al., 2001). The concentration response 
analysis showed that 1.0 ppm ozone increased the number of neutrophils in the BAL fluid 
(Fig. 2.1A). Albumin, a lung protein leakage marker that exists at lower levels in the normal 
lung, was also elevated at 1.0 ppm ozone (Fig. 2.1B).  These changes were not evident in rats 
exposed to 0.5 or 0.25 ppm ozone. 
2.3.2 Ozone exposure induces concentration-and time-dependent hyperglycemia and glucose 
intolerance 
GTT in the concentration-response study was conducted to determine whether ozone-
induced cellular and inflammatory lung responses were associated with prior changes in 
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blood glucose regulation. In comparison to the FA group, ozone-exposed rats at 0.5 and 1.0 
ppm on day 1 displayed marked fasting hyperglycemia (0 min time point; Fig. 2.1C).  By 
contrast, the 2d-0hr ozone exposure group illustrated diminished fasting hyperglycemia (Fig. 
2.1D).  Both the 0.5 and 1.0 ppm experimental groups exhibited glucose intolerance when 
examined immediately after ozone exposure on day 1 (Fig. 2.1C) and day 2 (Fig. 2.1D).  
Ozone at 0.25 ppm caused neither hyperglycemia nor glucose intolerance (Fig. 2.1C and D).  
GTT was also performed in the time-course study where exposure was to FA or 1.0 ppm 
ozone.  As noted in the concentration-response study (Fig. 2.1C), ozone at 1.0 ppm induced 
hyperglycemia and glucose intolerance when examined immediately after a 6hr exposure 
(1d-0hr; Fig. 2.2A). Like ozone exposure on day 1, hyperglycemia and glucose intolerance 
persisted on day 2 of exposure (Fig. 2.2B).  Ozone-induced hyperglycemia and glucose 
intolerance were largely reversed after 18hr in the recovery group (Fig. 2.2C).          
2.3.3 Ozone exposure alters the serum metabolic hormones and lipids 
To determine the potential cause of hyperglycemia and glucose intolerance, we 
assessed the serum levels of metabolic hormones and cytokines through 
electroimmunochemiluminescence and colorimetric ELISA techniques. Variability was noted 
in baseline (FA control) levels of insulin between three time points, where FA-exposed rats 
after 2d-0hr had high levels of insulin relative to the other two groups. This increase in 
insulin could relate to the sustained stimulation of its release in response to the injection of a 
high dose of glucose immediately following the day 1 of FA or ozone exposure for 
performing GTT. When compared to time-matched FA group, serum insulin levels were 
lower in ozone-exposed rats at 2d-0hr time point (Fig. 2.3A). Serum leptin, a satiety 
hormone, increased after day 1 (1d-0hr) of ozone exposure, but not on day 2 (2d-0hr) or 
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following an 18hr of recovery (2d-18hr) (Fig. 2.3B). Circulating epinephrine levels were 
increased after 1d-0hr and 2d-0hr but was reversible in rats allowed an 18 hour recovery after 
two consecutive days of ozone exposure (Fig. 2.3C). There was a significant diurnal variation 
in cholesterol levels of FA-exposed rats such that rats necropsied in the afternoon times for 
1d-0hr and 2d-0hr had higher levels than rats necropsied in the morning at 2d-18hr time 
point. Ozone exposure resulted in elevated serum total cholesterol and HDL-C at 2d-18hr 
time point (Fig. 2.3D and F). The levels of LDL-C were increased on day 2 (2d-0hr and 2d-
18hr) after ozone exposure (Fig. 2.3E).   
2.3.4 Metabolomic analysis 
 We conducted metabolomic analysis of serum samples from FA or 1.0 ppm ozone-
exposed rats at 1d-0hr and 2d-0hr to gain understanding of the nature of metabolic changes 
and potential involvement of multiple organs in homeostatic control of metabolic processes.   
Comparison of global biochemical profiles for rat serum revealed several key metabolic 
differences between ozone-exposed rats vs. FA control. The metabolomic analysis identified 
strong effects of ozone exposure on metabolites that reflect changes in central energy 
metabolism. Of 313 named biochemicals identified in the serum, 81 metabolites were 
significantly increased in ozone-exposed rats and 48 decreased at 1d-0hr, while 71 
metabolites were increased and 80 were decreased at 2d-0hr. Pathway analysis identified a 
number of pathways that were significantly altered after ozone exposure. Those included 
lysine catabolism, branch chain amino acids (BCAA) metabolism, protein degradation, urea 
cycle, sphingolipids metabolism, fatty acid synthesis, primary and secondary bile acid 
metabolism and glutathione metabolism at 1d-0hr. Many of these pathways also remained 
changed at 2d-0hr, in addition to alteration in β-oxidation pathway. A detailed analysis of 
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metabolic processes affected based on individual metabolites impacted by ozone is given 
below. 
2.3.5 Metabolomic analysis: Ozone impairs glucose homeostasis through perturbation of 
glycolytic pathways 
 The metabolomic analysis confirmed hyperglycemia at 1d-0hr following ozone 
exposure (Table 2.1), as evident during GTT. In addition, the metabolite 1,5-anhydroglucitol, 
a biomarker inversely related to long-term glycemic control, was markedly decreased in 
ozone-exposed animals at both time points (Table 2.1). Fructose levels were also increased at 
1d-0hr but not at 2d-0hr. The glycolysis end-product pyruvate was increased on day 1 of 
ozone exposure while the anaerobic glycolytic metabolite, lactate, was significantly 
decreased at day 2 in ozone-exposed animals (Table 2.1).  Several tricarboxylic acid (TCA) 
cycle intermediates (citrate, α-ketoglutarate, fumarate and malate) were less abundant in the 
serum samples of ozone-exposed rats especially on day 2 (Table 2.1). 
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2.3.6 Metabolomic analysis: Ozone exposure increases serum amino acids 
 A number of BCAA and their metabolites were increased in the serum following 
ozone exposure (Table 2.1). The data showed several signatures of altered protein and amino 
acid catabolism.  Urea, generated to eliminate nitrogenous waste made from amino acid 
catabolism, was more abundant with ozone exposure. One muscle-specific protein catabolite 
(3-methylhistidine) and one possible muscle protein catabolite (N-acetyl-1-methylhistidine) 
were more abundant after 2 days of ozone exposure, suggesting their release from muscle 
(Table 2.1).  Increases were observed in the BCAA themselves (leucine, valine and 
isoleucine) as well as several metabolites generated when BCAA are catabolized to enter the 
TCA cycle.  Some of these metabolites (alpha-hydroxyisocaproate, alpha-hydroxyisovalerate 
and 2-hydroxy-3-methylvalerate) are typically present at low abundance unless 
dehydrogenase reactions are defective, or with mitochondrial dysfunction.  Combined with 
the observed decrease in TCA cycle intermediates, these metabolite changes may reflect 
mitochondrial dysfunction. 
2.3.7 Metabolomic analysis: Ozone exposure increases serum free fatty acids (FAA) and 
cholesterol while decreasing bile acids 
 All detectable short- and long-chain FFA were noticeably more abundant in ozone-
exposed rats at both time points. These increases included essential, non-essential, saturated, 
polyunsaturated and hydroxy fatty acids ranging in length from C12 to C22, as well as, 
palmitoyl and stearoyl sphingomyelin (Table 2.2).  Additionally, ozone exposure reduced 
mitochondrial -oxidation metabolites (beta-hydroxybutyric acid, propionylcarnitine and 
butyrylcarnitine) (Table 2.2).   
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 Bile acids are synthesized in the liver from cholesterol, further metabolized by the gut 
microbiome, and released into the intestine to facilitate dietary fat absorption.  In this study, 
several cholesterol and bile acid metabolites were changed by ozone exposure. Serum 
cholesterol was elevated, while virtually all serum bile acid metabolites were decreased in 
ozone-exposed rats at both time points (Table 2.3). The observed increase in diet-derived 
phytosterols (fucosterol, beta-sitosterol and campesterol) suggests increased dietary 
absorption of cholesterols or decreased metabolism/excretion of cholesterol.  While rats were 
not provided food during ozone exposure, the changes in circulating cholesterol and bile 
acids might be due to decreased metabolism and/or release in the circulation. The observed 
decreases in several bile acids and an intermediate in bile acid synthesis from cholesterol (7-
hoca) suggest decreased bile acid production may contribute to elevated serum cholesterol 
(Table 3).   
2.3.8 Liver transcriptomic profiling reveals its role in homeostatic control of ozone-induced 
systemic metabolic alterations 
 Because the liver is the primary organ that regulates glucose, amino acid, cholesterol 
and fatty acid metabolism, we conducted a global gene expression profiling of liver to 
determine its role in systemic metabolic impairment induced by ozone exposure. Overall, the 
effect of ozone on the liver transcriptome was greatest at 1d-0hr with reduction in number of 
genes affected at 2d-0hr and 2d-18hr. At 1d-0hr, 2335 genes were found to be significantly 
different in ozone-exposed rats compared to FA controls, while on 2d-0hr there were only 72 
genes and 2d-18hr there were 247 genes differentially expressed.  KEGG pathway analysis of 
liver DEGs at day 1 indicated that steroid biosynthesis, TCA cycle, and glyoxylate and 
decarboxylate metabolism pathways were significantly altered by ozone.  When genes 
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associated with various metabolic processes, apoptosis, mitochondria, unfolded protein 
response and diabetes were separated from master DEGs list, probe sets assigned to each of 
this process represented 11-34% of the total probes on the array, suggesting widespread liver 
gene expression impact of ozone exposure implicating metabolic processes (Appendix A. 
Table 2.1). The heatmaps of cytokine network showed inhibition of many genes with 
induction of some genes (Appendix A. Fig. 2.1A-C). Many genes belonging to apoptosis 
pathway were impacted by ozone exposure (Appendix A. Fig. 2.2A-F). Genes involved in 
steroid and fatty acid metabolism and insulin signaling were of interest and showed that 
ozone impacted key regulatory genes involved in these processes (Appendix A. Fig. 3 and  
Fig. 4A-C).  
 Ozone increased hepatic expression of numerous glycolytic genes including insulin 
receptor kinase-2, lactate dehydrogense A, aldolase A, phosphoglycerate mutase-1, enolase 
1-alpha, pyruvate kinase, 6-phosphofructo-2-kinase-fuctose-2,6 bisphosphatase, and 
glycerol-3-phosphate dehydrogenase-2 at 1d-0hr and 2d-0hr (Fig. 2.4), suggesting a central 
stimulation to increase glycolysis. However, the expression of glucokinase, an important 
enzyme for conversion of circulating glucose to glucose-6-phosphate, was decreased in 
ozone-exposed rats. Interestingly, ozone exposure also increased the expression of some of 
the gluconeogenic genes, such as the phosphoenolpyruvate carboxykinase 1-soluble, glucose-
6-phosphatase, and phosphofructo-2-kinase-fuctose-2,6 bisphosphatase, which is a multi-
functional protein that plays a role in gluconeogenesis, as well as, glycolysis.  In addition, 
ozone increased expression of genes involved in amino acid metabolism that feed into 
gluconeogenesis. Those included glutamate-ammonia ligase, tyrosine aminotransferase, 
serine dehydratase, and glycine- N-methyltransferase (Fig. 2.4).  Ozone also elevated 
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expression of genes encoding the TCA cycle enzymes such as fumarate hydratase, 
acontinase-2, and isocitrate dehydrogenase 3 NAD-alpha and gamma suggestive of enhanced 
energy expenditure in the liver. 
 Because many genes involved in glycolysis and TCA cycle were induced, we 
presumed that liver mitochondrial function might also be affected by ozone exposure. Many 
of the observed glycolysis, gluconeogenesis, and TCA genes modified by acute ozone 
exposure were seen in heat maps generated for mitochondria gene cluster (Fig. 2.5A and B). 
These also included genes involved in steroid metabolism. Mitochondrial heat maps (Fig. 
2.5A and B) showed that ozone decreased the expression of genes involved in cholesterol 
and steroid metabolism. These genes included farnesyl diphosphate synthase, ATP citrate 
lyases, and MLX interacting protein. Meanwhile, ozone  increased the expression of genes 
involved in glycolytic and fatty acid catabolic processes, such as acyl CoA thioesterase 1, 
acyl CoA thioesterase 2, acyl CoA thioesterase 7, 3-hydroxybutarte dehydrogense type 1, and 
pyruvate dehydrogenase phosphatase catalytic subunit 2 (Fig. 2.5B). Interestingly, ozone 
increased expression of genes encoding enzymes involved in mitochondria biogenesis and 
homeostasis in the liver, such as the peroxisome-proliferator-activated receptor gamma, 
involved in liver homeostatic control. Ozone-exposed rats also showed increases in 
mitochondria apoptotic genes such as the Bcl-2 interacting protein containing the BH3 
subunit and other genes involved in apoptotic pathways (Fig. 2.5B; Appendix A. Fig. 2).   
 While metabolomics data indicated marked changes in FFA and steroid metabolism, 
DEGs belonging to these processes were separated from a master DEGs list of liver genes. 
Since these metabolic pathways operate in mitochondria, some of these genes were readily 
seen in the heat maps for mitochondrial genes. A heat map of steroid metabolism genes 
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further confirmed that ozone exposure decreased expression of genes that encode enzymes 
necessary for cholesterol synthesis in the liver, including but not limited to, lanosterol 
synthase, farnesyl diphosphate synthase, mevalonate diphospho-decarboxylase, isopentenyl-
diphosphate delta isomerase, sterol regulatory element binding factor 1/2, and more (Fig. 
2.6A). In contrast, ozone increased the expression of genes that encode for the proteins 
arginase, argininosuccinate lyase, and argininosuccinate synthetase, which are essential for 
liver ammonia detoxifying processes and the progression of the urea cycle (Fig. 2.6B). 
Ozone-exposed rats also demonstrated higher expression of genes that encode for nuclear 
receptors, such as, estrogen, thyroid, and RAR-related orphan receptor A (Fig. 2.6B). 
 Since increases in circulating BCAA occurred likely due to increased muscle protein 
catabolism, we wanted to determine whether genes involved in liver amino acid metabolism 
responded to this systemic response.  Some of the genes involved in the use of amino acids 
for gluconeogenesis providing precursors for TCA cycle were induced by ozone, as indicated 
earlier.  These gene included dihydrolipamide S–succinyltransferase, serine dehydratase, 
aminoadipate-semialdehyde synthase, butyrobetaine, 2 –oxoglutarate dioxygenase 1 and 
more (Fig. 2.7). 
 We confirmed the validity of the liver gene array findings using RT-PCR for four 
transcripts at 1d-0hr time point (Fig. 2.8). All four transcripts that are important in metabolic 
regulation, including IRS-2, PFKFB1, Aco-2, and Ppargc1a, were found to be increased 
when expression was analyzed using RT-PCR, confirming that the array technique provided 
satisfactory results (Fig. 2.8). 
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2.4 Discussion 
Recent epidemiological and experimental studies have shown that ozone and ambient 
PM, in addition to causing respiratory effects in humans and animals, may also contribute to 
a number of systemic health outcomes such as neuronal, reproductive, cardiovascular and 
metabolic effects, including insulin resistance (Campbell, 2004; Thomson et al., 2013; Liu et 
al., 2013; Pedersen et al., 2014). The mechanisms of these systemic effects are poorly 
understood.  We have recently shown that acute ozone exposure in BN rats induces glucose 
intolerance, leptinemia and catecholamine release generally observed during a stress 
response (Bass et al., 2013).  Ozone exposure has been shown to induce lung injury and 
inflammation (van Bree et al., 2001), activate stress responsive regions in the brain (Gackiere 
et al., 2011), and induce hypothermia and bradycardia (Gordon et al., 2014). In this study, 
our goal was to characterize the homeostatic metabolic response of the WKY rat to ozone 
exposure using serum metabolomic and liver transcriptomic approaches to better understand 
the potential mechanisms responsible for systemic metabolic alterations. 
In WKY rats, ozone-induced fasting hyperglycemia, glucose intolerance, and serum 
leptin increases that were much more pronounced than responses we recently reported in BN 
rats (Bass et al., 2013). These metabolic and hormonal changes were accompanied by rapid 
and reversible increases in serum protein degradation byproducts, FAA and cholesterol, 
depictive of a systemic metabolic response, and decreases in TCA cycle intermediates, which 
might relate to hypothermia observed in rats after an ozone exposure (Gordon et al., 2014).  
Liver gene expression changes were coherent with changes in serum metabolites and showed 
inhibition of genes involved in steroid biosynthesis but stimulation of genes involved in 
gluconeogenesis, glycolysis, -oxidation and energy expenditure.  Ozone-induced release of 
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short- and long-chain FFA into the circulation, likely involving adipose lipolysis, was 
coincided with decreased expression of hepatic lipid biosynthesis genes. The concomitant 
increase in circulating cholesterol may be a result of reduced catabolism in the liver as a 
consequence of inhibition of bile acid synthesis evidenced by the decrease in circulating bile 
acid metabolites. Further, our data show increased flux of BCAA into the circulation, which 
corroborated with increased expression of hepatic enzymes that utilize precursor amino acids 
for gluconeogenesis.  Overall, we show that these acute systemic effects of ozone exposure 
involve a broad scale derangement of glucose, lipid, and protein metabolism reflective of a 
sympathetic and HPA-mediated stress response. If and how this reversible derangement 
might relate to chronic development of metabolic disorders will require studies involving 
long-term exposures.   
As observed in our study, ozone-induced lung injury and inflammation peaks one day 
after an acute exposure (van Bree et al., 2001).  We have shown that ozone initially induces 
acute hypothermia during exposure but this is followed by hyperthermia and lung 
inflammation the following day. The temporal pattern of metabolic changes seen in the 
present study suggests that neuronal response might be stimulated prior to inflammation. A 
number of animal studies have shown that ozone can induce neuroinflammation and activate 
catecholeminergic neurons likely through lung vagus afferents (Gackiere et al., 2011; 
Martinez-Lazcano et al., 2013). Activation of these central nervous system locations can 
stimulate sympathetic and HPA-mediated release of adrenal stress hormones in the systemic 
circulation, which can perturb metabolic functions involving glucose, lipids, and amino acids 
(Seematter et al., 2004).  We have also observed an increase of epinephrine after an acute 
ozone exposure in BN rats (Bass et al., 2013). In addition, ozone has been shown to increase 
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corticosteroidal activities in multiple tissues likely through activation of HPA axis (Thomson 
et al., 2013). The systemic metabolic changes such as hyperglycemia, glucose-intolerance, 
lipidemia, and amino acid influx induced by ozone are similar to those induced during a 
neuronally-mediated stress response following an organ injury (Molina, 2005; Wang et al., 
2007). Although stress-mediated metabolic disorder has been very well established, no prior 
air pollution studies have examined a stress response and subsequent systemic metabolic 
impairment.  
Temporal differences were noted in ozone-mediated hyperglycemia, leptinemia and 
glucose intolerance. Leptinemia was observed only on day 1, which coincided with fasting 
hyperglycemia, increased circulating pyruvate and 2-hydroxybutarate on day 1 and decreased 
lactate on day 2, while glucose intolerance persisted over both days. This may relate to a 
number of potential interactive mechanisms governing glucose intolerance and could explain 
the reversible nature of metabolic effects upon termination of ozone exposure.   It is not clear 
what stimulates leptin release immediately after ozone exposure, which coincides with 
release of FFA on day 1 but not on day 2. The stimulation of sympathetic nerves is known to 
result in inhibition of leptin secretion (Sandoval and Davis, 2003), but the activation of HPA 
has been associated with its increase (Roubos et al., 2012). Leptin is made primarily in 
adipocytes and has major impact on metabolic and immune processes (Mainardi et al., 2013).  
Since adipose lipolysis is likely stimulated after ozone exposure, it is possible that the release 
of FFA into the circulation stimulates concomitant leptin release.   However, leptin increase 
was not sustained on day 2 while FFA continued to be increased. Acute release of leptin from 
adipose tissue can directly signal the hypothalamus to mediate peripheral fat oxidation and 
suppress food intake (Roubos et al., 2012). It has been shown that increased leptin can inhibit 
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the neurons co-expressing neuropeptide Y (NPY) and Agouti-related peptide (AgRP) in the 
arcuate nucleus in the medio-basal hypothalamus (Morton, 2007). Thus, leptin can contribute 
to the reduction of acute fasting hyperglycemia observed on day 2 of ozone exposure.   
Enhanced expressions of some of the genes involved in glycogenolysis, 
gluconeogenesis, and glycolysis after ozone exposure are suggestive of the changes induced 
following a stress response (Raz et al., 1991; Dufour et al., 2009). The ozone-induced 
increases in corticosterone (Thomson et al., 2013) may augment hepatic glucose production 
by stimulating glycogenolysis and gluconeogenesis. However, the increase in blood glucose 
is accompanied by increases in 2-hydroxybutarate on day 1 and decreases in 1,5 –
anhydroglucitol in serum at both time points, suggesting compromised glycemic control 
(Buse et al., 2003).  Concomitantly, the glycolytic metabolite pyruvate accumulated only on 
day 1 with a slight reduction on day 2, suggesting that glycolysis does not progress into the 
TCA cycle at least in the early phase of ozone exposure in the tissues. In contrast, lactate 
decrease in the ozone-exposed group on day 2 may indicate subsequent reduction of 
anaerobic glycolysis in the peripheral tissues that may coincide with the rebound effect on 
body temperature in rats following termination of exposure as previously noted (Gordon et 
al., 2014). Ozone exposed rats showed reduced serum levels of TCA cycle and β-oxidation 
intermediates despite stimulation of genes in the liver. These changes suggest that the ozone-
induced metabolic response likely involves reduced energy expenditure by peripheral tissues, 
such as the muscle, while maintaining homeostatic activities in the liver.   
Ozone exposure decreased serum insulin levels despite glucose intolerance, 
particularly on day 2, suggesting that ß-cells in the pancreas may be impacted. It has been 
shown that the autonomic nervous system can have inhibitory effects on insulin production 
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and secretion into systemic circulation by islet ß-cells (Bloom et al., 1978; Buijs et al., 2001; 
Kiba, 2004). Additionally, short-term leptin increases have also been observed to suppress ß-
cells’ insulin production through sympathetic activation in rodents (Park et al., 2010). It is 
possible that this is an adaptive mechanism involving short-term insulin resistance in the 
peripheral tissues in the midst of ozone-induced stress to ensure adequate glucose supply to 
the brain and other organs actively involved in maintenance of homeostasis, such as the liver.   
  The release of FFA into the circulation from adipose lipolysis is one of the 
hallmark features of stress-induced metabolic alterations. Ozone-induced increases in 
circulating FFA could be due to sympathetic action on white adipocytes (Nonogaki, 2000). It 
is has been shown that catecholamines during a stress response stimulate lipolysis and the 
mobilization of FFA in adipose tissue through activation of the ß-adrenergic receptors 
(Carey, 1998). ß-adrenergic receptor activation results in stimulation of adenylyl cyclase, 
followed by increases in intracellular cAMP, leading to the degradation of triglycerides and 
shuttling of FFA into the systemic circulation (Carey, 1998). In addition, activation of the 
HPA axis can also cause increased release of FFA from adipose tissues (Carey, 1998). 
Increased circulating FFA are known to induce insulin resistance by increasing serine 
phosphorylation of IRS-1 and halting insulin-mediated glucose uptake (Schulman and Zhou, 
2009), which may explain ozone-induced glucose intolerance.  
Ozone-induced increase in circulating cholesterol further supports the contribution of 
sympathetic or HPA axis activation (Kunihara and Oshima, 1983). Despite, rats being fasted 
during ozone exposure, the observed increases in circulating cholesterol and phytosterols 
suggest decreased catabolism of cholesterol.  Bile acid production is one important 
mechanism for eliminating cholesterol through excretion.  The observed decreases in several 
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bile acids and an intermediate of bile acid synthesis from cholesterol suggest that decreased 
bile acid production may contribute to elevated serum cholesterol.  These data are supported 
by evidence that the transcription of essential genes involved in cholesterol and steroid 
synthesis was suppressed in the liver.  
Notably, ozone-induced increases in several circulating BCAA including muscle-
specific protein catabolites, combined with the observed decrease in TCA cycle 
intermediates, may reflect increased protein catabolism and mitochondrial dysfunction.  
Given the fact that BCAA are known to regulate insulin production (Lu et al., 2013), their 
increases in the circulation after ozone exposure might influence insulin action in peripheral 
tissues. Stress has been shown to augment the catabolic state and therefore increases the 
utilization of BCAA for energy production in organs such as liver (Biolo et al., 1997; Porter 
et al., 2013).  It has been shown that muscle protein catabolism is stimulated under stress to 
provide necessary precursor amino acids for the liver to synthesize large amounts of acute 
phase proteins (Biolo et al., 1997). In addition, the increases in the expression of 
gluconeogenic enzymes involving BCAA suggests their use in energy production by the 
liver.  
Changes in liver gene expression were not restricted to metabolic processes, rather 
genes involved in apoptosis and mitochondrial function were remarkably impacted by ozone. 
Ozone exposure also changed the expression of several genes involved in inflammatory 
processes that tended to be inhibited rather than induced. Air pollution has been recently 
linked to non-alcoholic liver disease, also known as liver steatohepatitis (Zheng et al., 2013; 
Lin et al., 2014). One experimental study involving long-term exposure to concentrated 
ambient PM has shown liver inflammation, fibrosis and changes in markers of insulin 
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signaling (Zheng et al., 2013). Marked acute effects of ozone on liver gene expression 
reflecting apoptosis, alteration of mitochondrial function and metabolic processes in the 
present study support the hypothesis that air pollutants could, over a long period of time, 
induce liver disease. The mechanisms by which ozone may lead to acute changes in liver 
gene expression and contribute to long-term disease will need to be examined further.  
Although a number of studies have shown an increased release of inflammatory 
mediators from the lung into the circulation following exposure to air pollutants, specifically 
PM (Finnerty, et al., 2007; Mutlu et al., 2007; Delfino et al., 2008), ozone did not 
significantly increase serum IL-6 levels in this study. We and others have previously shown 
that acute ozone alone did not influence other serum inflammatory biomarkers such as TNF-
 (Urch et al., 2010; Bass et al., 2013).  Additionally, metabolic impairment was noted at 0.5 
ppm without changes in indicators of lung injury or inflammation, suggesting that the 
immediate metabolic response likely resulted from neurohumoral activation and not from 
cytokines released systematically. 
Some of the metabolic effects of ozone observed immediately following day 1 were 
reduced upon the second day of exposure, and most were reversed upon an 18 hour recovery 
period. This is critical in considering the relevance of these observations to humans who are 
exposed episodically over their lifetime.  The reduction of ozone effects upon subsequent 
exposure might relate to the adaptation that has been widely reported in pulmonary injury 
and inflammation (Brink et al., 2008; Hamade and Tankersley, 2009); however, the 
mechanisms are poorly understood. We observed that the adaptation response to ozone might 
also involve reduced metabolic impairments upon subsequent exposure. It is likely that the 
degree of adaptation responses vary between animal species and strain (Hamade and 
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Tankersley, 2009). In our prior study, we observed that episodic subchronic ozone exposure 
might reduce some of the acute metabolic effects in BN rats; however, glucose intolerance 
was still apparent after a 13 week episodic exposure (Bass et al., 2013). Thus, the metabolic 
consequences of low-level episodic ozone exposure are likely dependent upon the nature of 
that episodic exposure, the underlying genetic susceptibility and the biomarker of interest. 
Chronic stress has been linked to a rise in circulating lipids, insulin resistance and increased 
incidence of diabetes (Kelly and Ismail, 2015).  Thus, it remains to be established if long-
term ozone exposure might be linked to insulin resistance and diabetes predisposition 
through chronic stress and persistent metabolic alterations. The EPA.gov site states that the 
average ozone concentration that humans are exposed to across the United States is at or 
below the National Ambient Air Quality Standard of 0.075 ppm, with higher levels (0.2 to 
0.3 ppm) seen frequently in regions with hot climates (Calderón-Gacidueňas et al., 2000). 
The 1.0 ppm ozone concentration used in this study for most analysis is considered high 
compared to human relevant doses.  However, it has been shown that rats require three to 
four times the concentration of ozone to acquire an equivalent dose to humans (Hatch et al., 
1994). Thus, the concentrations of ozone used in our study, although higher than ambient 
levels, are appropriate for rodent exposures.  
 In conclusion, we show that the inhaled pulmonary irritant ozone is able to induce 
systemic metabolic changes, as seen by hyperglycemia, glucose intolerance, leptinemia, 
increased serum FFA, cholesterol, and BCAA together with varied changes in liver 
transcriptome expression involving the processes of apoptosis, mitochondrial dysfunction 
and the alterations of glucose, protein and lipid metabolism. The known increases in 
epinephrine (Bass et al., 2013) and corticosterone (Thomson et al. 2013), together with the 
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nature of systemic metabolic changes involving multiple central and peripheral tissues, 
provides supportive evidence for the involvement of a stress response in ozone-induced 
systemic metabolic impairment. Further studies will be required to determine the likely long-
term consequences of these metabolic alterations on insulin resistance. Although the 
immediate metabolic responses are not associated with the systemic increases in 
inflammatory cytokines, the contribution of chronic systemic inflammation might be 
important in the development of metabolic disorders. 
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Table 2.1. Metabolomic analysis: ozone-induced changes in serum metabolites for glucose 
and amino acid metabolism. 
 
Table depicting ozone-induced changes in circulating metabolites reflecting changes in 
glucose metabolism following 1d or 2d of FA or ozone exposure. Values indicate relative 
fold differences for each biochemical between ozone and FA samples at each time point 
(n=6-7/group).  Fold change >1 indicates increase, while fold change <1 indicates decrease.  
When p-value is <.05, the change is considered significant. 
  Fold Change 
Biological 
Processes 
Metabolite Ozone 
FA 1d 
p-Value Ozone 
FA 2d 
p-Value 
Glycolysis, 
Gluconeogenesis, 
Pyruvate 
Metabolism 
Glucose 1.47 0.0000 1.07 0.2801 
Fructose 1.64 0.0168 1.16 0.5933 
1,5 androhydroglucitol 0.77 0.0073 0.75 0.004 
Pyruvate  1.87 0.0011 0.86 0.2283 
Lactate 1.10 0.3613 0.72 0.0029 
Kreb Cycle 
citrate 1.07 0.5455 0.83 0.0778 
alpha-ketoglutarate 0.70 0.0067 0.67 0.0048 
succinate 0.88 0.4810 0.91 0.3771 
fumarate 1.08 0.9269 0.66 0.0177 
malate 0.78 0.1529 0.73 0.0414 
Tryptophan 
Metabolism 
Kinurenate 3.13 0.0004 2.11 0.0137 
Kinurenine 1.63 0.0001 1.23 0.0468 
Amino Acid 
Metabolism 
3-Methylhistidine 1.03 0.7168 1.22 0.0117 
N-acetyl-1-methylhistidine 0.85 0.1509 1.60 0.0008 
3-methyl-2-oxobutyrate 1.62 0.0001 1.46 0.0009 
3-methyl-2-oxovalerate 1.84 0.0000 1.60 0.0001 
isoleucine 1.47 0.0000 1.47 0.0000 
leucine 1.57 0.0000 1.39 0.0001 
valine 1.69 0.0000 1.49 0.0000 
4-methyl-2-oxopentanoate 1.89 0.0000 1.59 0.0000 
beta-hydroxyisovalerate 1.85 0.0005 1.78 0.0006 
beta-hydroxyisovalerate 2.03 0.0000 1.53 0.0001 
N-acetylleucine 5.72 0.0000 1.36 0.1878 
N-acetylvaline 2.16 0.0000 1.00 1.0000 
N-acetylisoleucine 5.79 0.0000 1.81 0.0180 
3-hydroxyisobutyrate 1.91 0.0000 1.40 0.0038 
4-methyl-2-oxopentanoate 1.89 0.0000 1.59 0.0000 
alpha-hydroxyisovalerate 2.06 0.0000 1.47 0.0071 
isobutyrylcarnitine 1.20 0.1633 0.61 0.0011 
2-hydroxy-3-methylvalerate 1.87 0.0000 1.34 0.0041 
2-methylbutyrylcarnitine (C5) 1.31 0.0891 1.06 0.6531 
isovalerylcarnitine 1.63 0.0029 1.26 0.0973 
Urea 1.24 0.0143 1.18 0.0398 
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Table 2.2 Metabolomic analysis: ozone exposure increases circulating FFA. 
Biological 
Processes 
Metabolite Fold Change 
 Ozone  p-Value Ozone p-Value 
 FA 1d  FA 2d  
Essential fatty 
acid 
linoleate (18:2n6) 1.57 0.0034 2.14 0.0000 
linolenate [alpha or gamma; (18:3n3 or 6)] 1.63 0.0107 2.17 0.0001 
dihomo-linolenate (20:3n3 or n6) 1.67 0.0014 1.13 0.296 
eicosapentaenoate (EPA; 20:5n3) 2.12 0.0000 1.29 0.0426 
docosapentaenoate (n3 DPA; 22:5n3) 2.02 0.0000 1.3 0.0268 
docosapentaenoate (n6 DPA; 22:5n6) 2.22 0.0000 1.7 0.0001 
docosahexaenoate (DHA; 22:6n3) 1.93 0.0000 1.59 0.0001 
Long chain 
fatty acid 
myristate (14:0) 1.31 0.0087 1.49 0.0001 
myristoleate (14:1n5) 1.33 0.0358 1.84 0.0001 
pentadecanoate (15:0) 1.37 0.0048 1.39 0.0018 
palmitate (16:0) 1.59 0.0009 1.8 0.0000 
palmitoleate (16:1n7) 1.51 0.0417 2.47 0.0001 
margarate (17:0) 1.51 0.0016 1.68 0.0001 
10-heptadecenoate (17:1n7) 1.31 0.0119 1.47 0.0003 
stearate (18:0) 1.33 0.0034 1.36 0.001 
oleate (18:1n9) 1.61 0.0069 2.38 0.0000 
cis-vaccenate (18:1n7) 1.65 0.0091 1.46 0.027 
nonadecanoate (19:0) 1.27 0.1076 1.38 0.0156 
10-nonadecenoate (19:1n9) 1.4 0.1337 1.63 0.0077 
eicosenoate (20:1n9 or 11) 1.29 0.0804 1.39 0.0227 
dihomo-linoleate (20:2n6) 1.6 0.0021 1.45 0.0057 
mead acid (20:3n9) 1.77 0.0003 1.51 0.0032 
arachidonate (20:4n6) 1.22 0.0819 1.23 0.0474 
docosadienoate (22:2n6) 1.42 0.0077 1.07 0.5246 
adrenate (22:4n6) 1.88 0.0001 1.26 0.0814 
Fatty acid, 
monohydroxy 
3-hydroxypropanoate 0.99 0.9762 0.73 0.0091 
3-hydroxyoctanoate 0.93 0.7825 0.99 0.8814 
2-hydroxystearate 1.3 0.0029 1.26 0.0066 
2-hydroxypalmitate 1.34 0.0007 1.31 0.0007 
Fatty acid  
and  BCAA 
metabolism 
propionylcarnitine 0.82 0.1495 0.64 0.008 
butyrylcarnitine 0.72 0.0168 0.54 0.0001 
butyrylglycine 0.87 0.168 0.94 0.4452 
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Table depicting ozone-induced changes in circulating FFA following 1d or 2d of FA or 
ozone exposure. Values indicate relative fold differences for each biochemical between 
ozone and FA samples at each time point (n=6-7/group).  Fold change >1 indicates increase, 
while fold change <1 indicates decrease.  When p-value is <.05, the change is considered 
significant. 
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Table 2.3 Metabolomic analysis: ozone exposure alters circulating metabolites indicative of 
impairment in cholesterol and bile acid metabolism. 
Biological 
Processes 
Metabolite Fold Change 
 Ozone p-Value Ozone p-Value 
 FA 1d  FA 2d  
Bile acid 
metabolism 
cholate 0.22 0.0100 0.24 0.0019 
glycocholate 0.21 0.0061 0.18 0.001 
chenodeoxycholate 0.27 0.0401 0.16 0.0062 
hyodeoxycholate 0.32 0.0030 0.62 0.1782 
taurodeoxycholate 0.5 0.0279 1.81 0.1032 
glycodeoxycholate 0.07 0.0042 0.16 0.0671 
glycochenodeoxycholate 0.15 0.0219 0.08 0.0041 
6-beta-hydroxylithocholate 0.17 0.0005 0.45 0.1509 
beta-muricholate 0.33 0.0251 0.30 0.0011 
hyocholate 0.38 0.0974 0.33 0.011 
alpha-muricholate 0.19 0.0130 0.12 0.0006 
tauroursodeoxycholate 0.46 0.0058 1.09 0.8176 
tauro-alpha-muricholate 0.54 0.0222 0.89 0.6976 
taurohyodeoxycholic acid 0.25 0.0011 1.14 0.5012 
Monoacyl-
glycerol 
1-linoleoylglycerol (1-
monolinolein) 
0.64 0.0009 0.54 0.0000 
2-linoleoylglycerol (2-
monolinolein) 
0.64 0.0004 0.52 0.0000 
1-arachidonylglycerol 0.64 0.0065 0.79 0.0689 
2-arachidonoyl glycerol 0.67 0.0172 0.75 0.0496 
Sphingolipid 
palmitoyl sphingomyelin 1.57 0.0004 1.75 0.0000 
stearoyl sphingomyelin 2.73 0.0018 2.66 0.0002 
Sterol/Steroid 
cholesterol 1.33 0.0003 1.27 0.0008 
beta-sitosterol 1.44 0.0003 1.10 0.2589 
campesterol 1.31 0.0047 1.07 0.5349 
fucosterol 1.43 0.0101 1.25 0.0895 
 
Table depicting ozone-induced changes in circulating cholesterol and bile acid metabolites 
following 1d or 2d of FA or ozone exposure. Values indicate relative fold differences for 
each biochemical between ozone and FA samples at each time point (n=6-7/group).  Fold 
change >1 indicates increase, while fold change <1 indicates decrease.  When p-value is 
<.05, the change is considered significant. 
 81 
 
Figure 2.1.  
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Figure 2.1 Ozone-induced cellular and inflammatory responses in the lung are 
associated with hyperglycemia and glucose intolerance in WKY rats. 
Rats were exposed to FA or ozone (0.25, 0.5 or 1.0 ppm O3) for 6h/day for two consecutive 
days.  Immediately after day 1 (1d-0hr) and day 2 (2d-0hr) of exposure GTT was performed.   
Rats were necropsied 18hr after day 2 exposure (2d-18hr) and BAL fluid was analyzed for 
lung toxicity markers. (A) Neutrophils, as a marker of inflammation. (B) Albumin, as an 
indicator of vascular protein leakage. (C) Blood glucose at baseline and during GTT in rats 
exposed to FA or ozone (1d-0hr). (D) Blood glucose at baseline and during GTT in rats 
exposed to FA or ozone (2d-0hr). The values in the bar graphs are displayed as mean ± SE of 
n=6/exposure group. The GTT curve shows mean value ± SE of n=6/ group with repeated 
measures over two hours. The 0 min time point shows fasting glucose levels in each group. * 
Indicates significant difference from respective FA-exposed groups at a given time (*=p<.05, 
**=p<.01, ***=p<.001). 
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Figure 2.2.  
   
 
 
 
 
 
 
 
 
 
 
Figure 2.2 Acute ozone exposure induces reversible hyperglycemia and glucose 
intolerance. 
GTT was performed in rats exposed to FA or 1.0 ppm of ozone immediately after first day of 
6h ozone (1d-0hr) (A); immediately after second day of 6h ozone (2d-0hr) (B); and at 18h 
after second day of 6h ozone exposure (2d-18hr) (C; recovery group). Each value represents 
mean ± SE of n=8/group. *Indicates significant difference from FA exposed rats for a given 
time point (**=p<.01, ***=p<.001). 
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Figure 2.3 
 
Figure 2.3 Acute ozone exposure alters circulating mediators, metabolic hormones and 
lipids in rats.  
Metabolic hormones and cholesterols were measured in the serum of FA and ozone (1.00 
ppm) exposed rats at various time points (1d-0hr, 2d-0hr, 2d-18hr). Each value indicated in 
the bar graphs represents mean ± SE (n=6-8/group).  *Indicates significant difference from 
time-matched FA exposed rats (*=p<.05, **=p<.01, ***=p<.001). 
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Figure 2.4 
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Figure 2.4 Altered transcription levels of genes involved in glucose metabolism in the 
livers of ozone-exposed rats.  
Functional gene lists were generated by NetAffx queries at the Affymetrix website 
(www.affymetrix.com) and identified from DEGs list based on the query terms, “glycolysis”, 
“tricarboxylic acid” cycle and “gluconeogenesis”. These genes were selected to prepare 
expression value tables for each sample. Genes were then median centered with average 
linkage, hierarchically clustered using Cluster 3.0 and displayed through Java Treeview. Red 
indicates genes that have high expression values across all groups, green indicates genes that 
have low expression values across all groups, and black indicates median expression. Note 
that this heat map is truncated to show important clusters affected by ozone exposure (n=5-
6/group). 
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Figure 2.5 
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Figure 2.5 Acute ozone exposure modulates the expression of genes involved in liver 
mitochondrial function.  
Functional gene lists were generated by NetAffx queries at the Affymetrix website 
(www.affymetrix.com) and identified from DEGs list based on the query term, 
“mitochondrial genes”. Genes were then median centered with average linkage, 
hierarchically clustered using Cluster 3.0 and displayed through Java Treeview. (A) A cluster 
of mitochondria genes showing lower expression after ozone exposure relative to FA. (B) A 
cluster of genes showing higher expression in rats exposed to ozone relative to FA-exposed 
rats. Red indicates genes that have high expression values across all groups, green indicates 
genes that have low expression values across all groups, and black indicates median 
expression (n=5-6/group). 
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Figure 2.6.1 
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Figure 2.6.2. 
 
 
Figure 2.6 Modification of steroid metabolism genes in the livers of rats after ozone 
exposure.  
Functional gene lists were generated by NetAffx queries at the Affymetrix website 
(www.affymetrix.com) and identified from DEGs list based on the query term, “steroid metabolism 
genes”. Genes were then median centered with average linkage, hierarchically clustered using Cluster 
3.0 and displayed through Java Treeview. (A) A cluster of steroid metabolism genes showing lower 
expression after ozone exposure relative to FA. (B) A cluster of steroid metabolism genes showing 
higher expression in rats exposed to ozone relative to FA.  Red indicates genes that have high 
expression values across all groups, green indicates genes that have low expression values across all 
groups, and black indicates median expression (n=5-6/group). 
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Figure 2.7 
 
Figure 2.7 Ozone exposure alters expression of genes involved in amino acid 
metabolism in the liver. 
Functional gene lists were generated by NetAffx queries at the Affymetrix website 
(www.affymetrix.com) and identified from DEGs list based on the query term, “amino acid 
metabolism”. Genes were then median centered with average linkage, hierarchically 
clustered using Cluster 3.0 and displayed through Java Treeview.  Heat map of DEGs with 
significant ozone effect. Red indicates genes that have high expression values across all 
groups, green indicates genes that have low expression values across all groups, and black 
indicates median expression (n=5-6/group). 
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Figure 2.8 
 
Figure 2.8 Ozone-induced increases in expression of selected genes confirmed using RT-
PCR. 
Total liver RNA from FA and ozone (O3)-exposed rats (1d-0hr) was used for RT-PCR 
-actin as 
a control transcript and then relative fold change from ozone was calculated using FA values. 
*Indicates significant difference from FA-exposed rats for a given time point (**=p<.01, 
***=p<.001). 
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CHAPTER 3 
 
OZONE EXPOSURE INCREASES CIRCULATING STRESS 
HORMONES AND LIPID METABLITES IN HUMANS 
3.1 Introduction 
 Several epidemiological studies nationally and internationally have predicted a link 
between air pollution and prevalence of diabetes (Pearson et al., 2010; Zanobetti et al., 2014; 
Eze et al., 2015; Nicole, 2015; Thiering and Heinrich, 2015). It is apparent that the 
conventional risk factors such as sedentary lifestyle, obesogenic high caloric diets, and/or 
genetics alone do not fully explain the causal relationship.  The contribution of stress and 
environmental factors has been postulated. Near road air pollution exposure has also been 
linked to diabetes (Brook et al., 2008; Brook et al., 2013; Weinmayr et al., 2015) and a recent 
study has associated roadway proximity with hyperglycemia in women (Ward et al., 2015). 
Although both particulate matter (PM) and gaseous pollutants have been associated with 
diabetes, in one study this association was presumed to be stronger with gaseous pollutants 
than PM (Janghorbani et al., 2014).  
 Subchronic ambient PM exposure studies using rodent models have shown increased 
adipose and brain inflammation, and liver insulin resistance (Rajagopalan and Brook, 
2012;Liu et al., 2014). It has been postulated that pulmonary injury/inflammation, following 
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inhalation of air pollutants, leads to increased release of cytokines and biologically active 
mediators causing systemic inflammation and metabolic effects. 
 However, most air pollution studies examining circulating cytokines fail to 
demonstrate their increases in the blood. More recently, epidemiological and experimental 
studies have associated inhaled pollutants with a variety of neural outcomes (Allen et al., 
2014; Costa et al., 2014; Calderon-Garciduenas and Torres-Jardon, 2015; Wilker et al., 
2015). Specifically, exposure to ozone activates the nucleus tractus solitarius (NTS) and 
stress responsive regions of the hypothalamus through stimulation of pulmonary vagal C-
fibers (Gackiere et al., 2011). Acute ozone exposure can increase levels of circulating stress 
hormones such as epinephrine and corticosterone in rats (Bass et al., 2013; Thomson et al., 
2013; Miller et al., 2015a). Ozone exposure also induces cardiac autonomic effects in 
humans (Arjomandi et al., 2015), hypothermia and bradycardia in rats (Gordon et al., 2014), 
and leptinemia, hyperglycemia, glucose intolerance, and global changes in circulating 
metabolites involved in peripheral glucose, lipid, and amino acid metabolism in rats (Miller 
et al., 2015b). These changes are reflective of classical stress response-mediated homeostatic 
alterations involving activation of sympathetic neurons and hypothalamus pituitary adrenal 
(HPA) axis (Miller et al., 2015a).  
 We have previously performed global metabolomic assessment of serum to 
characterize the metabolic response to ozone and gain mechanistic insights in rats (Miller et 
al., 2015a). The goal of this exploratory study was to perform a global metabolomic 
assessment of archived human serum samples from a prior clinical study involving ozone 
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exposure, and determine ozone-induced metabolic changes in humans, establish rodent to 
human coherence, and identify novel non-protein biomarkers of ozone exposure. We 
hypothesized that global metabolomic assessment of serum samples collected after air or 
ozone exposure in humans will reveal metabolic derangements through a neurohormonally-
mediated stress response, comparable to rats. Since most human ozone exposures are 
performed during intermittent exercise and day-light cycle, we predicted that there would be 
some discrepancies in the metabolite profile of the serum between non-exercising rats 
(nocturnal) exposed during their non-active circadian cycle and exercising humans. Some of 
the results of this study have been previously reported in the form of an abstract (Miller et al., 
2015b). 
3.2 Materials and Methods  
3.2.1  Original study design: study population and ozone exposure 
 Serum samples for this exploratory study were obtained from Clinical Trial 
NCT01492517. In this trial, subjects were recruited under an EPA contract with Westat 
Corporation (Rockville, MD). Cardiac and pulmonary function, and systemic effects of 
ozone on coagulation and inflammatory markers have been previously reported from this 
study (Devlin et al., 2012).  A total of 24 volunteers were involved in the study. The protocol 
and consent forms were approved by the University of North Carolina, School of Medicine 
Committee on the Protection of the Rights of Human Subjects and the US Environmental 
Protection Agency’s Institutional Review Board. The exposure was conducted in a 
randomized crossover design where two clinical visits of each individual were separated by 
at least two weeks. During each visit, the subjects were exposed to either 0.3 ppm ozone or 
clean air for 2 hrs in the morning time in a blinded manner. During the exposure, subjects 
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alternated between 15 minutes of rest and 15 minutes of exercise on a cycle ergometer 
(Devlin et al., 2012). Exposures were conducted at the US Environmental Protection Agency, 
Human Studies Facility on the campus of the University of North Carolina, Chapel Hill. 
Ozone was generated by a silent electric discharge method (model 502; Meckenheim, Bonn, 
Germany). The exposure chambers were maintained at 40% relative humidity for all 
exposures. For more details of the exposure system, see the Appendix B and Devlin et al., 
2012 publication.  
3.2.2  Serum samples and metabolomic analysis 
 Serum samples collected prior to the start of exposure, immediately post exposure 
(within 1 hr) and during the next day morning follow up visit were assessed for glucose, 
triglycerides and cholesterols (LabCorp Inc, Durham, NC) when the clinical study was 
performed. In the present study, archived serum samples collected immediately post (within 
1 hr) after air or ozone exposure were used for exploratory metabolomic assessment. These 
samples were sent to Metabolon, Inc. (Durham, NC) for global metabolomic analysis (see 
Appendix B, methods for details). Briefly, each sample was accessioned into the Metabolon 
Laboratory Information Management System (LIMS) system and assigned a unique 
identifier. Samples were prepared using the automated MicroLab STAR® system from 
Hamilton Company (Appendix B, methods). The LC-MS portion of the platform was based 
on a Waters ACQUITY ultra-performance liquid chromatography (UPLC) and a Thermo 
Scientific Q-Exactive high resolution/accurate mass spectrometer interfaced with a heated 
electrospray ionization (HESI-II) source and Orbitrap mass analyzer operated at 35,000 mass 
resolution (Evans et al., 2014). The GC-MS portion of the platform utilized a Thermo-
Finnigan Trace DSQ fast-scanning single-quadrupole mass spectrometer using electron 
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impact ionization (EI).  The informatics system consisted of four major components: the 
LIMS, the data extraction and peak-identification software, data processing tools, and data 
interpretation and visualization tools (see methods, and Figures E1 and E2 in the Appendix 
B).  The hardware and software foundations for these informatics components were the LAN 
backbone and a database server running Oracle 10.2.0.1 Enterprise Edition. Compounds were 
identified by comparison to library entries of purified standards or recurrent unknown 
entities. Peaks were quantified using area-under-the-curve.  Statistical analysis included log 
transformation and imputation followed by one way analysis of variance with repeated 
measures. An estimate of the false discovery rate (q-value) was calculated to take into 
account the multiple comparisons that normally occur in metabolomic-based studies.  
Significant (p<0.05) pathway enrichment output (cumulative hypergeometric distribution) 
was assessed for each of the selected contrasts using MetaboLync, version 1.1.2 (Shannon et 
al., 2003) to determine the metabolic processes impacted by ozone.  
 Serum samples collected immediately post air or ozone exposure were also analyzed 
for insulin, leptin, interleukin-6 (IL-6), and tumor necrosis factor (TNF)- -
specific antibody-based electrochemiluminescence assays (Meso Scale Discovery, 
Gaithersburg, MD) according to manufacturer’s instructions.  
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3.3 Results 
3.3.1  Demographics of human subjects 
 The clinical study from which serum samples were obtained included 24 healthy, 
young adult participants; 20 males and 4 females (Table 3.1). The average age of the subjects 
was 25.6 with a range of 22–30 years. Weights averaged 78.5 kg with a range from 50.7 to 
97.3 kg.  Eleven subjects had a body mass index between 18.5 and 24.9, and 13 subjects were 
between 25 and 29.9 (see online data supplement #2 for details on individual subjects). Most 
of the subjects never smoked. Only three subjects were previous smokers, all before the year 
2006. All subjects participated in weekly exercise: 2 mild level (90 to 180 min/week), 9 
moderate level (180 to 360 min per week) and 13 high level (over 360 min per week). 
Participants did not have a recent history of prescription medication use, cardiopulmonary 
disease, or allergies as determined by a detailed medical history and physical examination. 
Their specific characteristics are summarized in Table 3.1 and detailed in the Appendix B 
and online supplement #2. 
 Heart rate, blood pressure, and serum glucose, triglycerides, and cholesterols 
measured prior to, immediately post air or ozone exposure, and after one day follow up visit 
for each subject are provided as line graphs in Appendix B (Figures E3-E4) and individual 
subject’s data in the online supplement #2. There were no marked pre or post air or ozone 
exposure differences noted in heart rate and blood pressure; however, between subject 
variability was noted in the levels of triglycerides and cholesterols. Between subject glucose 
levels varied slightly at pre exposure time but not after post exposure or next day follow up 
visit.    
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3.3.2  Ozone exposure increases circulating cortisol but does not change cytokines or 
HOMA-IR 
 Cortisol and corticosterone were significantly increased in the serum samples 
collected after ozone exposure when compared to air (Figure 3.1). In addition, a 1.62-fold 
increase in corticosterone metabolite 11-dehydrocorticosterone, but not cortisone (see data in 
the online supplement #2) suggests HPA axis involvement in acute ozone-induced extra 
pulmonary effects. Serum levels of TNF- and IL-6 as reported earlier (25) showed no 
significant difference between air and ozone immediately post exposure (data not shown). 
Serum leptin and insulin (see Figure E5 in the Appendix B and data in the online supplement 
#2) were not significantly different between air and ozone samples immediately post 
exposure. High individual sample variability was noted for 3-4 individuals in the levels of 
insulin and leptin. Homeostatic model assessment for insulin resistance (HOMA-IR) 
provided no significant differences between air and ozone exposure (see Figure E5 in the 
Appendix B for line graph and online supplement #2 for data).  
3.3.3 Correlations of subject characteristics with individual metabolites and ozone-induced 
changes 
 We attempted to correlate ozone-induced changes (fold-increase) in selected 
metabolites, including steroid hormones with individual subject’s BMI, but no significant 
relationships appeared to occur (see Figure E6 in the Appendix B.). Although the number of 
subjects included in the study were small, especially when stratified for their prior exercise 
habit (as mild, moderate or heavy) or sex, we have provided the correlation plots and results 
in Figures E7-E8 and results section of the Appendix B. Likewise, circulating levels of 
metabolites (glucose, triglycerides and cholesterols) post air or post ozone exposure were 
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analyzed for correlations with BMI, prior exercise habit and sex, and these plots are provided 
in Figures E9-E11 in the Appendix B. No significant differences were noted between air and 
ozone exposure for pre exposure normalized glucose, triglycerides and lipids levels (see 
online data supplement #2 for all individual subject’s clinical data).  
3.3.4 Ozone exposure changes the profile of circulating metabolites 
 There were 663 compounds of known identity that were detected in human serum 
samples (see online data supplement #2 for all original data, normalized data, heat maps and 
scatter plots). Of those, statistically significant differences were found for 121 biochemicals 
(p<0.05) between air and ozone exposure as determined by ANOVA. Specifically, 85 were 
increased and 36 were decreased after ozone exposure compared to air. There were also a 
number of biochemicals for which the difference between the air and ozone exposures 
approached significance (0.05<p<0.10;23 increased and 29 decreased). A pathway 
enrichment analysis using MetaboLync (27) indicated seven biochemical pathways 
(sphingolipid metabolism, endocannabinoid synthesis, fatty acid metabolism, β-oxidation, 
dicarboxylic acid metabolism, steroid hormone biosynthesis and phospholipid metabolism) to 
be significantly altered by ozone exposure (Figure 3.2). All of these pathways are associated 
with lipid metabolism.  
3.3.5 Ozone exposure increases circulating free fatty acids and lysolipids in humans 
 One of the most consistent and strongest effects associated with ozone exposure in 
this study was the pronounced increases in serum free fatty acids (Table 3.2A). There were 
significant (p<0.05) increases in medium- and long-chain free fatty acids in the serum 
samples collected after ozone exposure relative to air, along with a significant increase in 
serum glycerol, a marker of lipolysis (Table 3.2A). Additionally, higher levels of a variety of 
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lysolipids were found in the serum samples collected after ozone exposure relative to air 
(Table 3.2B), which may be indicative of membrane phospholipid hydrolysis contributing to 
fatty acid generation.  Finally, increasing trends were also noted in sphinganine (P=0.0511) 
and sphingosine 1-phosphate (P<0.00005) in combination with elevated long-chain fatty 
acids in the serum samples obtained after ozone exposure relative to the clean air.   
3.3.6 Ozone exposure during intermittent exercise increases fatty acid oxidation in human.
 There were significant changes in biochemicals associated with fatty acid β-oxidation 
(Table 3.3). These changes included significantly higher levels of ocanoylcarnitine, 
decanoylcarnitine and cis-4-decanoylcarnitine together with a trend of an increase in 
acetylcarnitine (p=0.079; a surrogate for the fatty acid oxidation end product acetyl-CoA) in 
the serum samples collected after ozone relative to air exposure. Ozone exposure was also 
associated with increases in serum laurylcarnitine, myristoylcarnitine, palmitoylcarnitine, 
oleoylcarnitine, linoleoylcarnitine and myristoleoylcarnitine. Long-chain fatty acids (>12 
carbons) are conjugated with carnitine to facilitate transport into the mitochondrial matrix 
where they may undergo fatty acid β-oxidation for energy. These changes were also 
accompanied by lower levels of carnitine in the serum samples collected after ozone 
exposure, which may be a marker of increased utilization for acylcarnitine conjugation. 
Moreover, the dicarboxylates, azelate and 2-hydroxyglutarate were significantly (p<0.05) 
increased in the serum after ozone exposure when compared to air (Table 3.3), and may 
suggest that the β-oxidation process was saturated, thereby shifting to fatty acid ω-oxidation. 
Taken together, these findings support increased fatty acid β-oxidation for energy generation 
following the 2 hr ozone exposure during intermittent exercise.  Further indication of 
increased fatty acid β-oxidation was revealed by the elevation in the ketone body, 3-
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hydroxybutyrate (BHBA; Table 3.3), a marker of hepatic fatty acid β-oxidation which can 
accumulate in cases where the capacity of the TCA cycle is overwhelmed by the availability 
of substrate. 
3.3.7 Ozone exposure increased polyunsaturated fatty acids in the serum. 
 In addition to the observed increases in free fatty acids and fatty acid oxidation 
byproducts, n3 and n6 polyunsaturated fatty acids were also significantly (p<0.05) increased 
in the serum from ozone-exposed subjects relative to air and may contribute to production of 
inflammatory mediators (Figure 3). These included linolenate alpha or gamma (18:3n3 or n6; 
Figure 3.3A), eicosapentaenoate (EPA 20:5n3; Figure 3.3B), docosapentaenoate (n3 DPA 
22:5n3; Figure 3C), docosahexaeonate (DHA 22:6n3; Figure 3.3D), linoleate (18:2n6; Figure 
3.3E), dihomo-linolenate (20:3n3 or n6 (DHGLA); Figure 3.3F), and arachidonate (AA) 
(20:4:6; Figure 3.3G). 
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3.4 Discussion 
 Epidemiological studies have associated air pollutants with increased prevalence of 
type-2 diabetes and changes in markers of insulin resistance (Brook et al., 2008; Pearson et 
al., 2010; Kim  and Hong, 2012; Brook et al., 2013; Fleisch et al., 2014; Zanobetti et al., 
2014; Eze et al., 2015; Nicole, 2015; Thiering and Heinrich, 2015; Weinmayr et al., 2015). 
However, controlled human studies examining systemic metabolic effects and potential 
mechanisms have not been performed. A number of environmental stressors are postulated to 
be interactively involved in the development of insulin resistance over a long period of time 
and linked to lipidemia and high blood glucose. We have recently reported that acute ozone 
exposure in rodents produces systemic homeostatic changes in circulating metabolites 
reflective of activation of neuronal stress response pathways (Bass et al., 2013; Miller et al., 
2015a). The goal of the current study was to determine if metabolomic assessment of serum 
samples obtained from a prior clinical study where humans acutely exposed to ozone show 
similar systemic metabolic alterations as rodents. Serum metabolomic analysis revealed 
increases in circulating cortisol and corticosterone, but not cortisone, in samples collected 
after ozone exposure, reflective of an activation of a neurohormonally-mediated stress 
response in humans.  Pathway analysis of metabolites significantly (p<0.05) changed in 
serum after ozone exposure implicated altered lipid metabolic processes. As observed in 
rodents, increased levels of a number of circulating free fatty acids and glycerols in the serum 
from ozone-exposed individuals suggested stimulation of adipose lipolysis of triglyceride 
stores and their liberation into the circulation. Increased lysolipids, likely released from 
hydrolysis of cellular and membrane phospholipids, and serum polyunsaturated fatty acids in 
ozone-exposed humans may be linked to proinflammatory mechanisms. Unlike rodents, 
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samples obtained from humans who exercised intermittently during ozone exposure showed 
elevated circulating metabolites of β-oxidation, such as ketone bodies, dicarboxylates, and 
metabolites of –oxidation. No ozone effects were noted in HOMA-IR. Overall, this study 
demonstrates that ozone exposure in humans is associated with increased release of stress 
hormones causing lipolysis as in rodents, likely through activation of HPA axis. Chronic 
elevations of these metabolites in the circulation might contribute to insulin resistance and 
systemic inflammation (Kelly and Ismail, 2015; Magomedova et al., 2015).  
  In non-exercising rats, acute ozone exposure induces glucose intolerance and 
increases circulating leptin and epinephrine (Bass et al., 2013; Miller et al., 2015a). Both 
leptin and epinephrine changes are associated with a reversible decrease in body temperature 
(Gordon et al., 2014), suggesting involvement of the sympathetic axis and changes in 
hypothalamic thermoregulation. Increased ACTH and cortisol levels after ozone exposure 
have also been noted in other rodent studies (Soulage et al., 2004; Thomson et al., 2013).  In 
this study, humans exposed to ozone also presented elevated circulating cortisol and 
corticosterone, suggesting the activation of the HPA axis, similar to rats. However, unlike 
rats (Bass et al., 2013; Miller et al., 2015a), no differences were noted in leptin levels in 
serum samples obtained after ozone exposure in humans (see Figure E5 in the Appendix B). 
This might be due to the differences in the study design and exposure protocol. The present 
human study did not involve ozone exposure during resting and exposure occurred only for 2 
hrs. Acute ozone exposure has been shown to activate neuro-stress responsive regions and 
the NTS where pulmonary vagal nerves terminate in the brain (Soulage et al., 2004; Gackiere 
et al., 2011). Thus, pulmonary C-fibers, likely through regional neurotransmission in the 
brain, can stimulate sympathetic and/or the HPA axis, leading to the release of stress 
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hormones from sympathetic nerve endings and also from the adrenal gland (Patterson et al., 
2014; Nicolaides et al., 2015).  As a result, these stress hormones can target metabolic organs 
in a tissue specific manner and alter glucose and lipid metabolism through activation of 
cellular glucocorticoids and adrenergic receptors.  
 Acute ozone exposure in humans increased circulating long- and medium-chain fatty 
acids as observed in rats (Miller et al., 2015a). This is likely induced through stress hormone-
mediated adipose lipolysis.  Endogenous and ingested free fatty acids are re-esterified in 
adipose tissue as triacylglycerides for storage (Papakova and Cahova, 2015).  During a stress 
response, circulating epinephrine and cortisol through β-adrenergic and glucocorticoid 
receptors, respectively, can increase hormone-sensitive lipase-mediated lipolysis of adipose 
triglycerides into free fatty acids and glycerol (Papakova and Cahova, 2015). Ozone-induced 
elevation of free fatty acids in the serum could lead to uptake of these lipid metabolites by 
the peripheral tissues, including liver and muscle, for oxidation. In a previous study, we 
noted that genes involved in mitochondrial metabolism and biogenesis were markedly altered 
in the livers of ozone-exposed rats (Miller et al., 2015a). Since the metabolic changes 
occurring immediately following an ozone exposure in humans are likely reversible after 
termination of exposure, as noted in rats after a single exposure (Miller et al., 2015a), there is 
likely to be minimal long-term impact on healthy individuals. However, in those with 
underlying metabolic impairment or those with defects in homeostatic mechanisms, exposure 
to ozone might be more impactful and may contribute to metabolic imbalance. 
 Lysolipids, also known as lysophospholipids, were elevated in serum samples 
obtained after ozone exposure, indicating likely increased phospholipid turnover and plasma 
membrane remodeling by phospholipases. Although specific tissue sources cannot be 
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ascertained through serum metabolomic assessment, these lipids through their action on G-
protein-coupled lysophospholipid membrane receptors (LPL-R) have been shown to impact a 
variety of cellular responses, such as cytoskeletal integrity/stability, mitogenesis, 
inflammation, energy production and lipid metabolism (Gijon and Leslie, 1999). Ozone 
exposure also increased circulating polyunsaturated fatty acids (Figure 3). In the lung, ozone 
exposure has been shown to increase polyunsaturated fatty acids, which are formed by a 
combination of activation of phospholipases and inhibition of free fatty acid esterification 
pathways (Wright et al., 1994; Madden et al., 1998). The resulting increases in arachidonic 
acid metabolites can be involved in homeostatic and acute inflammatory responses. For 
example, arachidonic acid released by phospholipase A2 is metabolized through the 
lipoxygenase or cyclooxygenase pathways to form eicosanoids, including leukotrienes, 
prostaglandins, and thromboxanes (Serhan et al., 1996). Ozone exposure was associated with 
significant increases in plasma thromboxane B2, 6-keto prostaglandin F1 alpha and 
prostaglandin E1 in guinea pigs (Miller et al., 1987). It is unclear whether the identified 
mediators shown in Figure 3 of ozone induced phospholipase activation (Kafoury et al., 
1998) can exert extra-pulmonary effects. Enzymes involved in lipid metabolism were shown 
to be altered in a primate model after subchronic exposure to 0.3 ppm ozone (Rao et al., 
1985). Interestingly, it has also been demonstrated that cortisol inhibits phospholipase 
activity and prostaglandin production (Thompson, 2003). Since these lipids were increased in 
the serum samples obtained after ozone exposure done with intermittent exercise in humans, 
but not in rats which were exposed during inactivity, the potential mechanism and 
implication of these findings will require further studies. 
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 Acute ozone exposure might alter mitochondrial β-oxidation involved in catabolism 
of free fatty acids. Decreases in carnitine and increases in acylcarnitines together with 
elevated 3-hydroxybutyrate (BHBA), a marker of hepatic β-oxidation, in serum after ozone 
exposure relative to air suggests changes in fatty acid oxidation that may be attributed to 
mitochondrial involvement (Aon, Bhatt and Cortassa, 2014). Additionally, increases in 
dicarboxylic acids (DCAs) in serum after ozone exposure may relate to increased ω-
oxidation, a NADPH- and cytochrome P450-dependent process where the omega carbon of a 
fatty acid is oxidized to an alcohol and then to a carboxylic acid, thereby generating DCA. 
DCAs are produced by peroxisomes when the supply of fatty acids to the liver exceeds the 
capacity for β-oxidation and re-esterification. Because subjects during air and ozone 
exposure underwent an exercise regimen, and exercise can influence the metabolic status, it 
is likely that the ozone response was influenced by exercise. Exercise-induced oxidative 
stress (Holland et al., 2015) was postulated to contribute to ozone-induced cytogenetic 
damage to human lymphocytes after ozone exposure (Powers, Nelson and Hudson, 2011). 
Interestingly, these changes were not observed in rats exposed to ozone (Costa et al., 2014)) 
during inactivity. It is noteworthy that the ozone-induced hypothermia in non-exercising 
rodents exposed during their inactive (daytime) cycle (Gordon et al., 2014) may lead to 
diminution of peripheral metabolic processes (muscle), while this response may not be 
apparent in humans exposed during their active cycle (daytime).  
 There are several limitations of our study. We only performed metabolomic analysis 
post air or ozone exposure during two clinical visits thus, this study is not a complete 
crossover design except for clinical measures. Ozone effects were not determined in humans 
during inactivity/resting and thus, the contribution of exercise and interaction with ozone 
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can’t be assessed directly. Since we are attempting to compare the ozone effects in exercising 
humans to non-exercising rats, only some speculation of the role of exercise can be made. 
Moreover, human exposures occurred over 2 hrs, whereas rats were exposed for 6 hrs. The 
discrepancies in effective lung ozone dose could be partially explained by the evidence that 
exercising humans will inhale a larger ozone dose relative to non-exercising rats (Hatch et 
al., 2013). We have demonstrated that acute ozone-induced metabolic changes are reversible 
the following day despite a continued inflammatory response in rodents (Miller et al., 2015), 
but we were neither able to analyze the reversibility of these changes in humans nor study the 
long-term ozone effects. In a previous study involving subchronic episodic exposure of 
Brown Norway rats, we noted that glucose intolerance still occurred after 12 weekly 
exposures (Bass et al., 2013). Since, humans are exposed episodically to ozone throughout 
their lifetime, it is important to determine if persistent episodic metabolic derangement 
contributes to insulin resistance.  
 This study is the first to characterize the global metabolic derangement in humans 
after ozone exposure using a metabolomic assessment. We show that ozone exposure in 
humans is associated with marked increases in a variety of fatty acids in the circulation 
together with increases in cortisol and corticosterone, suggesting activation of the 
neurohormonal stress response pathway and subsequent changes in peripheral metabolic 
homeostasis. This study establishes the coherence between humans and rodents in ozone-
induced stress hormone increase and metabolic effects. Through this approach, novel 
biomarkers such as cortisol, free fatty acids, monoacylglycerols, and lysolipids for acute 
pollutant-induced health effects are identified.  Further studies will be needed to examine if 
these responses will persist during chronic exposure and contribute to insulin resistance. 
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Table 3.1 Demographics of study participants*. 
 
Demographics Ratio 
Gender  
     Male 20/24 
     Female 4/24 
Race  
    White 22/24 
    Hispanic 2/24 
Smoking  
    Never Smoker 21/24 
    Former Smoker† 3/24 
Medication ‡ 3/24 
Exercise§  
   Mild  2/24 
   Moderate 9/24 
   Heavy  13/24 
 Mean 
Age (yr) 25.63.8 
Height (cm) 177.99.3 
Weight (kg) 78.513.9 
Body Mass Index 24.73.0 
     18.5-24.9 11/24 
     25-29.9 13/24 
Systolic 121.0 8.4 
Diastolic  73.9 6.8 
Heart Rate (bpm) 73.414.4 
 
*For details on individual subject demographics, see the Appendix B. 
†Smoking before the year 2006.  
‡Currently on medication (Multivitamins, and/or Lexapro). 
§Exercise level  
Mild                      90 to 180 minutes per week 
Moderate            180 to 360 minutes per week 
Heavy                   over 360 minutes per week 
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Table 3.2a. Acute ozone exposure increases circulating free fatty acids and 
monoacylglycerols in humans.  
 
 
 
*Values indicate relative fold differences for each biochemical between ozone and filtered air 
samples (n=24/group).  A fold change >1 indicates an increase, while fold change <1 
indicates a decrease.   
† When the p-value is <0.05, the change is considered significant. 
  
  Fold Change  
Free Fatty Acids Metabolite 
 Ozone * 
Air 
 p-Value † q-Value 
Medium-Chain Fatty 
Acid 
caproate (6:0) 1.17 0.0041 0.048 
laurate (12:0) 1.17 0.0649 0.218 
5-dodecenoate (12:1n7) 1.57 0.0058 0.053 
Long-Chain Fatty Acid 
myristate (14:0) 1.42 0.0102 0.072 
myristoleate (14:1n5) 1.80 0.0005 0.025 
palmitoleate (16:1n7) 1.72 0.0019 0.042 
margarate (17:0) 1.30 0.0097 0.070 
10-heptadecenoate (17:1n7) 1.48 0.0041 0.048 
oleate (18:1n9) 1.38 0.0014 0.034 
cis-vaccenate (18:1n7) 1.20 0.0759 0.238 
10-nonadecenoate (19:1n9) 1.54 0.0042 0.048 
eicosenoate (20:1n9 or 11) 1.44 0.0082 0.065 
Fatty Acid, Monohydroxy 
3-hydroxyoctanoate 1.48 0.0195 0.115 
3-hydroxydecanoate 1.78 0.0031 0.045 
3-hydroxylaurate 1.77 0.0021 0.043 
Glycerolipid Metabolism glycerol 1.34 0.0072 0.059 
Monoacylglycerol 
 
1-stearoylglycerol (1-monostearin) 2.32 0.0046 0.048 
2-stearoylglycerol (2-monostearin) 1.89 0.0028 0.044 
1-oleoylglycerol (1-monoolein) 1.56 0.0000 0.004 
2-oleoylglycerol (2-monoolein) 1.85 0.0047 0.048 
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Table 3.2b Ozone exposure elevates circulating lysolipid and sphingolipid metabolites in 
humans. 
 
* Values indicate relative fold differences for each biochemical between ozone and filtered 
air samples (n=24/group).  A fold change >1 indicates an increase, while fold change <1 
indicates a decrease.   
† When the p-value is <0.05, the change is considered significant. 
  
  Fold Change  
 
Metabolite 
Ozone * 
Air 
p-Value†  
q-Value 
Lysolipids 
1-pentadecanoylglycerophosphocholine (15:0) 1.10 0.0901 0.256 
1-palmitoylglycerophosphocholine (16:0) 1.08 0.0035 0.047 
2-palmitoylglycerophosphocholine (16:0) 1.06 0.0787 0.239 
1-palmitoleoylglycerophosphocholine (16:1) 1.11 0.0313 0.155 
1-margaroylglycerophosphocholine (17:0) 1.24 0.0004 0.023 
1-stearoylglycerophosphocholine (18:0) 1.16 0.0027 0.044 
2-stearoylglycerophosphocholine (18:0) 1.19 0.0108 0.075 
1-oleoylglycerophosphocholine (18:1) 1.18 0.0014 0.034 
2-oleoylglycerophosphocholine (18:1) 1.11 0.0665 0.219 
1-linoleoylglycerophosphocholine (18:2n6) 1.08 0.0614 0.218 
2-linoleoylglycerophosphocholine (18:2n6) 1.14 0.0324 0.158 
1-linolenoylglycerophosphocholine (18:3n3) 0.82 0.0856 0.250 
2-linolenoylglycerophosphocholine(18:3n3) 0.85 0.0406 0.176 
1-nonadecanoylglycerophosphocholine(19:0) 1.29 0.0046 0.048 
1-dihomo-linoleoylglycerophosphocholine (20:2n6) 1.22 0.0007 0.028 
1-arachidoylglycerophosphocholine (20:0) 1.44 0.0112 0.076 
1-eicosenoylglycerophosphocholine (20:1n9) 1.33 0.0029 0.044 
2-eicosenoylglycerophosphocholine(20:1n9) 1.48 0.0012 0.033 
1-eicosatrienoylglycerophosphocholine (20:3) 1.22 0.0023 0.044 
2-eicosatrienoylglycerophosphocholine (20:3) 1.20 0.0009 0.032 
1-arachidonoylglycerophosphocholine (20:4n6) 1.15 0.0006 0.028 
2-arachidonoylglycerophosphocholine (20:4n6) 1.16 0.0002 0.014 
1-eicosapentaenoylglycerophosphocholine (20:5n3) 1.17 0.0378 0.170 
Sphingolipid 
Metabolism 
sphingosine 1-phosphate 1.37 0.0000 0.042 
sphinganine 1.20 0.0511 0.198 
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Table 3.3 Ozone exposure during intermittent exercise increases circulating -oxidation 
metabolites in humans. 
 
 
 
* Values indicate relative fold differences for each biochemical between ozone and filtered 
air samples (n=24/group).  A fold change >1 indicates an increase, while fold change <1 
indicates a decrease.   
† When the p-value is <0.05, the change is considered significant. 
 
 
 
 
 
 
 
 
 
 
 
  Fold Change   
Pathway Metabolite 
Ozone * 
Air 
p-Value † 
q-Value  
Fatty Acid Metabolism 
(Acyl Carnitine) 
acetylcarnitine 1.09 0.0787 0.239  
hexanoylcarnitine 1.22 0.0827 0.246  
octanoylcarnitine 1.32 0.0224 0.127  
decanoylcarnitine 1.42 0.0132 0.085  
cis-4-decenoylcarnitine 1.27 0.0235 0.132  
laurylcarnitine 1.79 0.0094 0.069  
myristoylcarnitine 1.57 0.0360 0.169  
palmitoylcarnitine 1.25 0.0319 0.157  
oleoylcarnitine 1.38 0.0022 0.043  
linoleoylcarnitine 1.31 0.0130 0.085  
myristoleoylcarnitine 1.81 0.0051 0.048  
Fatty Acid, 
Dicarboxylate 
2-hydroxyglutarate 1.26 0.0320 0.187  
azelate 1.55 0.0002 0.004  
Carnitine Metabolism carnitine 0.92 0.0102 0.072  
Ketone Bodies 3-hydroxybutyrate (BHBA) 1.82 0.0451 0.187  
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Figure 3.1 
 
 
 
Figure 3.1 Acute two hour ozone exposure increases serum levels of stress hormones, 
cortisol and corticosterone, in humans. Boxplots convey the spread of the data with the 
interquartile range represented by the shaded box and the range of the data shown by the 
whiskers (n=24/group).  Outlier values are defined as those that exceed, in either direction, 
1.5 times the interquartile range (shown as “o” in each plot).  The solid bar across the box 
represents the median value while the “+” represents the mean. * indicates significantly 
different from air group (p<0.05). For each biochemical, data are median scaled with the 
median value across all samples set to 1.0.  The y-axis thus reflects scaled intensity for each 
metabolite.  
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Figure 3.2 
 
Figure 3.2 Ozone altered lipid metabolism pathways in humans. Pathway enrichment 
analysis (using MetaboSync) identified seven specific biochemical pathways - sphingolipid 
metabolism, endocannabinoid synthesis, fatty acid metabolism, β-oxidation, dicarboxylic 
acid metabolism, steroid hormone biosynthesis and phospholipid metabolism - as having a 
significant (p<0.05) fold enrichment value for ozone exposure. This analysis was based on a 
number of parameters including the total number of detected metabolites in the study and 
selected pathway, as well as the abundance of total metabolites associated with each pathway.  
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Figure 3.3 
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Figure 3.3 Acute ozone exposure increases circulating polyunsaturated lipids in 
humans. Polyunsaturated lipids, (A) Linolenate (alpha or gamma; 18:3n3 or n6), (B) 
Eicosapentaenoate (EPA, 20:5n3), (C) Docosapentaenoate (n3 DPA, 22:5n3), (D) 
Docosahexaeonate (DHA 22:6n3), (E)  Linoleate(18:2n6), (F) Dihomo-linolenate (DHGLA, 
20:3n3 or n6) and (G) Arachidonate (AA, 20:4:6) were increased significantly in the serum 
of ozone-exposed subjects. The metabolic pathways in which these metabolites were 
generated is summarized in the middle panel. Boxplots convey the spread of the data with the 
interquartile range represented by the shaded box and the range of the data shown by the 
whiskers (n=24/group).  Outlier values are defined as those that exceed, in either direction, 
1.5 times the interquartile range (shown as “o” in each plot).  The solid bar across the box 
represents the median value while “+” represents the mean. For each biochemical, data are 
median scaled with the median value across all samples set to 1.0.  The y-axis thus reflects 
scaled intensity for each metabolite. * indicates significantly different from air group 
(p<0.05).
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CHAPTER 4 
ACUTE OZONE-INDUCED PULMONARY AND SYSTEMIC 
METABOLIC EFFECTS ARE DIMINISHED IN 
ADRENALECTOMIZED RATS 
 
4.1 Introduction 
Epidemiological studies have demonstrated a positive association between air 
pollution and increases in type II diabetes, hyperglycemia, glucose intolerance and increased 
homeostasis model assessment (HOMA) index (Brook et al., 2008; 2013; Rao et al., 2015; 
Thiering and Heinrich, 2015; Hu et al., 2015).  The mechanisms by which air pollutants 
impact metabolic processes and change clinical indicators of insulin resistance are still 
largely unknown. Also not known is how air pollutants can induce changes in pathways 
involving lipid and amino acid metabolism (Miller et al., 2015), which can contribute to 
insulin resistance and steatohepatitis. It has been hypothesized that systemic inflammation, 
endoplasmic reticulum stress, and/or autonomic activation induced by air pollutant exposure 
are involved in insulin resistance (Rajagopalan and Brook, 2012).  
Ambient ozone has been studied for decades for its pulmonary and cardiovascular 
effects
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 Recently, the interest in ozone health effects has been rejuvenated for two reasons: 1) 
its levels are anticipated to increase as a result of climate change (Fann et al., 2015), and 2) 
its has been increasingly recognized that even though ozone is less likely to translocate 
beyond the lung, it causes a myriad of systemic effects (Miller et al., 2015). While ambient 
particulate matter (PM) exposures have been linked to the onset and/or exacerbation of 
peripheral insulin resistance (Rajagopalan and Brook, 2012), ozone has also been associated 
with the incidence of diabetes (Ren et al., 2010; Janghorbani et al., 2014).  In addition, new 
studies show that ozone exposure induces a variety of neurological effects (Akhter et al., 
2015; Chounlamountry et al., 2015 Calderón-Garcidueñas et al., 2015). Ozone exposure 
stimulates afferent vagal sensory nerves that terminate in stress-responsive hypothalamic 
regions in the central nervous system (Gackiere et al., 2011). Acute ozone exposure has been 
shown to alter neuronal catecholamine biosynthesis and increase circulating stress hormones 
(Soulage et al., 2004; Thompson et al. 2013; Bass et al., 2013; Miller et al., 2015). Our recent 
studies have demonstrated that rats exposed acutely to ozone develop lung 
injury/inflammation, hyperglycemia, glucose intolerance, and lipidemia, which are associated 
with increases in circulating epinephrine and cortisol (Bass et al. 2013; Miller et al. 2015). 
We have also shown that acute ozone produces hypothermia and bradycardia (Gordon et al., 
2014). Collectively, these data suggest that ozone peripheral metabolic effects are likely 
mediated by central sympathetic and hypothalamus-pituitary-adrenal (HPA) stress axis 
activation.  
The neuronal stress response, activated as a result of bodily injury or threat, initiates 
physiological mechanisms that provide integrated communication between all organ systems 
(Smith and Vale, 2006). The initial event includes the release of hypothalamic 
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paraventricular nucleus (PVN)-derived corticotrophin releasing hormone and the activation 
of catecholaminergic neurons within the locus coeruleus (LC), which results in the activation 
of the HPA axis and sympathetic axis, respectively (Navarro-Oliveira et al., 2000; Ulrich-Lai 
and Herman, 2009).  The priority of the neuronal stress response is to channel energy 
substrates to appropriate tissues to restore equilibrium, which is mainly achieved by elevated 
circulating stress hormones (i.e. induction of gluconeogenesis, glycogenesis, muscle 
proteolysis, and adipose lipolysis) (Smith and Vale, 2006).  Acute ozone-induced peripheral 
metabolic changes we observed in humans and rats are similar to homeostatic changes in 
response to stress (Bass et al., 2013; Miller et al., 2015, 2016). However, it is not known if 
these stress hormones can contribute to pulmonary injury and inflammation induced by 
exposure to air pollutants. 
In response to HPA activation, the adrenal cortex secretes glucocorticoids (cortisol in 
humans and corticosterone in rats). In contrast, the adrenal medulla can be directly stimulated 
by the sympathetic efferent nerves, resulting in the secretion of epinephrine and/or 
norepinephrine (Goldstein, 2010). Adrenalectomy has been used to examine the role of these 
hormones in 1) neuronal regulation of the HPA axis (Kaminski and Watts, 2012; Weidenfeld 
and Feldman, 2000; Helmreich et al., 1996), 2) regeneration of adrenals over time (Rebuffat 
et al., 2007), and 3) endogenous corticosteroid biogenesis (Freel et al., 2007; Bykowski et al., 
2007). Surgical removal of adrenal medulla can allow one to examine the role of epinephrine 
while total bilateral adrenalectomy can be used for examining the roles of epinephrine and 
cortical steroidal hormones.   
In the present study, we test the postulate that acute ozone-induced pulmonary and 
systemic metabolic effects are mediated through adrenal-derived epinephrine and 
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corticosterone. Further, that bilateral adrenal demedullation (DEMED) will selectively 
dampen some effects, while bilateral total adrenalectomy (ADREX) will have more profound 
effect on ozone-induced systemic metabolic impairment, and pulmonary injury and 
inflammation. We examined pulmonary and systemic metabolic effects of ozone exposure 
together with an assessment of adrenal-derived hormones in rats that underwent sham 
surgery, DEMED or ADREX.  
4.2 Materials and Methods 
4.2.1 Animals 
 Healthy male Wistar Kyoto (WKY) rats (250-300g) were purchased from Charles 
River Laboratory (Raleigh, NC) at 6-8 weeks of age. Rats were housed (n=2/cage or as 
indicated below) in polycarbonate cages containing beta chip bedding in an isolated room in 
an animal facility maintained at 21 ± 1ºC, 50 ± 5% relative humidity and held to a 12h 
light/dark cycle. The animal facility is approved by the Association for Assessment and 
Accreditation of Laboratory Animal Care (AAALAC). All animals received standard (5001) 
Purina pellet rat chow (Brentwood, MO) and water ad libitum unless otherwise stated. 
Animal procedures were approved by the US Environmental Protection Agency (US EPA), 
National Health and Environmental Effects Research Laboratory (NHEERL) Animal Care 
and Use Committee (IACUC; Permit Number: 16-03-003). Animals were treated humanely 
and all efforts were made for alleviation of suffering. 
4.2.2  Animal surgery and recovery protocol 
 At 12-13 weeks of age, rats underwent surgical procedures. Anesthesia was achieved 
using an intraperitoneal injection of ketamine/xylazine (25 mg/2 mg in 1mL saline/kg), 
followed by a subcutaneous injection of buprenorphine (0.02 mg/kg) for analgesia. Eye 
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ointment was applied to rats to prevent drying during surgery. Isoflurane was also used if any 
signs of movement were noticed during the procedure. Following anesthesia, rats were 
placed in sternal recumbency for Charles River Surgeons to perform SHAM, DEMED or 
ADREX) using surgical protocols established at Charles River Inc. Both (right and left) 
glands were removed for ADREX, while the DEMED involved bilateral removal of medulla 
only. The SHAM group underwent similar procedures as DEMED or ADREX rats except 
that adrenals were not removed. The muscle wall incisions were closed with absorbable 
suture. Skin incisions were then closed with stainless steel surgical wound clips. Immediately 
following surgery, animals were placed on heated pads and observed until recovery from 
anesthesia. Once recovered from anesthesia, animals were injected subcutaneously with 
Meloxicam analgesic (0.2mg/mL/kg). Additional two doses of Buprenorphine were injected 
(0.02mg/mL/kg) subcutaneously every 8-12 hours.  All drugs used in surgery were purchased 
from Henry Schein Animal Health Inc. (Dublin, OH).  Following surgery, the animals were 
single housed using Enviro Dry enrichment/nesting material and provided powdered food. 
The rats that underwent ADREX were provided with saline (0.9% NaCl) as drinking water to 
maintain water/salt balance. All animals were allowed 96 hours to recover prior to their 
exposure to air or ozone. We believe that 4 days was an appropriate time as the weight gain 
was stablized (Table 4.1), there were no clinical signs of distress noted, food and water 
consumption were normal and the recovery appeared near complete. Furthermore, a number 
of studies involving adrenalectomy previously used a 4 day recovery time (Osterlund et al., 
2013.; Sakakibara et al., 2014). We wanted to avoid the influence of secondary changes that 
might occur with a longer recovery time frame in the absence of aldosterone-
mineralocorticoids, which regulate salt-fluid balance, blood volume and cardiovascular 
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function.  The timeline of the surgery, ozone exposure, in-life testing and necropsy are shown 
in figure 4.1. 
4.2.3  Ozone generation and animal exposures 
Ozone was produced from oxygen by a silent arc discharge generator (OREC, 
Phoenix, AZ), and its entry into the Rochester style “Hinners” chambers was controlled by 
mass flow controllers (Coastal Instruments Inc., Burgaw, NC). The ozone concentrations in 
the chambers were recorded continuously by photometric ozone analyzers (API Model 400, 
Teledyne Instruments; San Diego, CA).  Mean chamber air temperature and relative humidity 
were 23.3°C (74⁰F) and 46%, respectively. Each surgery group (SHAM, DEMED, ADREX; 
n=20-24/surgery group) was randomized and subdivided into air or 1.0 ppm ozone exposure, 
4h/day for either 1 day or 2 days (n=4 for SHAM-air, n=6 for all other exposure groups). 
This ozone concentration is much higher than what one would expect environmentally. 
However, ozone concentrations as high as 0.4 ppm can be expected in tropical hot climates 
with high anthropogenic pollution (WHO, 1974). It has been shown that in rats once inhaled, 
ozone deposition in the lung is 3-4 times less than what humans will experience (Hatch et al, 
1994). We have shown that humans experience metabolic effects of ozone at 0.3 ppm (Miller 
et al., 2016).  
For the 1 day group, rats were necropsied immediately following a 1 day, 4h exposure 
(1-D group), whereas for the 2 day group, rats were necropsied immediately following the 
second day of a 4h ozone exposure (2-D group). Only the 2-D group underwent glucose 
tolerance testing (GTT) immediately following the first day of exposure. As observed in our 
prior study, the ozone effects are evident immediately following the first and also second day 
exposure. Since GTT takes ~ 3 hours and a large bolus of glucose is injected in the animals, 
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which may require several hours for blood glucose levels to return to baseline, we decided to 
do GTT immediately following first day exposure in rats assigned for 2-D exposure. Another 
group of rats, which did not undergo GTT, was necropsied immediately following first day of 
exposure (1-D) to correlate with changes in GTT. Since lung injury and inflammation 
generally takes several hours to peak after ozone exposure, and the ozone effects are 
maximum on the second day, we believed that 2-D exposure was necessary to determine the 
extent of lung damage/injury, while at the same time determining systemic responses 
immediately following the second day.  
4.2.4 Glucose tolerance test (GTT) 
Immediately following the first day of ozone exposure, rats assigned to the 2-D 
exposure group underwent GTT (rats were fasted for ~6h prior to testing).  Baseline blood 
glucose concentrations were measured by pricking the distal surface of rats’ tails using a 
sterile needle.  A Bayer Contour glucometer (Leverkusen, Germany) was used to determine 
blood glucose levels using test strips.  After the first measurement, rats were given an 
intraperitoneal injection of glucose (20% D-glucose; 10ml/kg in saline; Sigma-Aldrich, St 
Louis, MO). Measurement with the glucometer was repeated every 30 min over the course of 
2h. 
4.2.5 Whole body plethysmography 
Pulmonary ventilatory parameters were examined prior to the first day of exposure in 
the morning (6:00am), immediately following first ozone exposure (11:30am) and in the 
morning prior to second day of exposure (6:00am) in the 2-D group. A four chamber whole-
body plethysmography system using Buxco BioSystem XA software (Buxco Electronics, 
Wilmington, NC) was used to measure minute volume, tidal volume, breathing frequency, 
 134 
 
and the enhanced pause (Penh), which is presumed to provide an index of airflow limitation 
and often used as a surrogate for bronchoconstriction (Hamelmann et al. 1997). Each rat was 
placed in a plethysmograph chamber and allowed 1 min prior 5 min to adapt prior to 
assessing the respiratory parameters. Respiratory parameters were computed as described 
earlier (Kodavanti et al., 2005).   
4.2.6 Necropsy and sample collection 
 The 1-D and 2-D groups were necropsied immediately following the first and second 
4h ozone exposure, respectively. Rats were weighed and anesthetized with an overdose of 
Nembutal (Virbac AH, Inc., Fort Worth, TX; 50-100 mg/kg, i.p.). Blood samples were 
collected through an abdominal aortic puncture.  Complete blood counts were performed 
using a Beckman-Coulter AcT blood analyzer (Beckman-Coulter Inc., Fullerton, CA, USA).  
All blood samples were centrifuged and aliquots of serum and plasma stored at -80°C until 
analysis.  Bronchoalveolar lavage (BAL) was performed through tracheal tubing using 37°C 
phosphate buffer saline at a volume of 28mL/kg body weight.  Aliquots of BAL fluid were 
used to determine total cell counts with a Z1 Coulter Counter (Coulter, Inc., Miami, FL) and 
cell differentials were performed on cytospin slides stained with Diff-quick (Fischer 
Scientific, Pittsburgh, PA) as previously described (Bass et al., 2013). The cell-free BAL 
fluid (BALF) was used to analyze protein, albumin, and lactate dehydrogenase (LDH) 
activity as previously described (Bass et al., 2013). 
4.2.7 Plasma and serum snalysis 
 Adrenaline and noradrenaline plasma levels were measured using kits from Rocky 
Mountain Diagnostics (Colorado Springs, CO) per the manufacturer’s protocol. Serum 
corticosterone concentrations were analyzed employing an immunoassay kit (Arbor Assay, 
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Ann Arbor, MI) per the manufacturer’s protocol. Total cholesterol and triglycerides were 
measured in serum samples using kits from TECO Diagnostics (Anaheim, CA). Non-
esterified free fatty acids were measured in serum by a coupled enzymatic reaction and the 
resultant hydrogen peroxide detection using a colorimetric probe as per the manufacturer’s 
protocol (Cell Biolabs, Inc, San Diego, CA).  The kit protocols for measuring lipids were 
modified for use on the Konelab Arena 30 system (Thermo LabSystems, Espoo, Finland). 
Branched chain amino acids (BCAA) were measured in serum using ELISA kits and the 
protocol based on chemiluminescence detection (Abcam, Cambridge, MA).       
4.2.8 Statistics 
 GTT data were analyzed using a two-way repeated measure multivariate analysis of 
variance (MANOVA) where serial blood glucose measurements were incorporated in the 
analysis (Graphpad prism 4.03 software).  Area under the curve (AUC) for GTT was 
determined by the trapezoidal method and analyzed for statistical significance by ANOVA 
followed by a Duncan’s multiple range test. Other variables were analyzed using a two-way 
ANOVA model (independent variables being exposure and surgical manipulation). The two 
assumptions associated with ANOVA models are equality of variances and normality of 
errors (residuals). We used Levene’s test to assess the equality of variances and Shapiro 
Wilk’s test to examine the normality of errors.  The ANOVA assumptions for serum 
adrenaline, serum corticosterone, serum cholesterol, serum FFA, BALF protein, BALF 
albumin, BALF LDH, BALF neutrophils, BALF eosinophils and PenH did not satisfy 
desired equal variance and/or normality. These data were then transformed to satisfy two 
assumptions (log or square root as appropriate). Pairwise comparisons were performed as 
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subsets of the overall ANOVA. The level of significance was set at 0.05. No adjustments 
were made for multiple comparisons. 
 
4.3 Results 
4.3.1 Body weights 
 Body weights were closely examined after surgery, throughout recovery and during 
ozone exposure. The SHAM and DEMED groups did not lose body weight as a result of 
surgery as determined 4 days after surgery or during the course of air exposure over 2 days 
(Table 4.1). In general, ADREX group showed a slight but significant decrease in body 
weight gain after surgery compared to other surgery groups. Ozone exposure on the second 
day tended to reduce body weight in all rats; however, this effect was not significant relative 
to time-matched air groups. 
4.3.2 ADREX, DEMED and ozone impacted circulating adrenal-derived hormones 
 To determine ozone-induced changes in adrenal-derived hormones and the 
effectiveness of surgical intervention, we evaluated levels of circulating adrenaline, 
noradrenaline and corticosterone. Concentrations of adrenaline, derived from the medulla, 
were markedly reduced in all DEMED and ADREX rats, regardless of exposure (Fig. 4.2A). 
Ozone significantly increased adrenaline plasma levels in SHAM rats on day 1 and day 2 
compared to air exposure (Fig. 4.2A). Noradrenaline plasma levels were not altered by 
exposure or surgical interventions (Fig. 4.2B). DEMED caused a slight reduction in the 
levels of circulating corticosterone, which was significant only in 2-D air-exposed rats. 
Ozone exposure in SHAM rats tended to increase levels of serum corticosterone on day 1, 
but the difference was statistically insignificant when compared to time-matched air group 
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(Fig. 4.2C).  Corticosterone levels dropped to nearly zero in all ADREX rats. Ozone did not 
affect corticosterone levels in the DEMED and ADREX groups (Fig. 4.3C). 
4.3.3 Acute ozone-induced glucose intolerance is inhibited by ADREX 
GTT was conducted in SHAM, DEMED, and ADREX groups immediately following 
the first day of ozone exposure in the 2-D group to determine the relative contribution of 
adrenal-derived hormones to acute ozone-induced glucose metabolic effects. Glucose 
tolerance was not affected by ADREX or DEMED in air-exposed rats (Fig. 4.3). The SHAM 
group exposed to ozone demonstrated significant fasting hyperglycemia and glucose 
intolerance compared to its matching air group (Fig 4.3A) as observed in our previous study 
(Miller et al., 2015). The DEMED rats showed marked suppression of ozone–induced 
hyperglycemia and glucose intolerance throughout the testing period (Fig. 4.3A). There was 
nearly a complete reversal of ozone-induced fasting hyperglycemia and glucose intolerance 
in ADREX rats (Fig. 4.3A). AUC calculations further revealed that ozone-induced glucose 
metabolic effects were almost completely eliminated in ADREX rats (Fig. 4.3B).  
4.3.4 Acute ozone-induced increases in circulating lipids and protein metabolites are reduced 
in rats with prior ADREX 
 The activation of the stress response pathway and subsequent release of adrenal stress 
hormones are central to changes in peripheral metabolism. Our prior study demonstrated that 
exposure to ozone resulted in increased circulating FFA and BCAA in rats (Miller et al., 
2015). Although prior metabolomic assessment showed a small increase in serum cholesterol 
after a 6h ozone exposure in our previous study (Miller et al., 2015), in this study 4h ozone 
exposure for 1-D or 2-D did not affect serum cholesterol levels in any group regardless of 
prior surgical procedure (Fig. 4.4A). ADREX rats exposed to air had increased triglycerides 
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at 1-D compared to SHAM rats (Fig.  4.4B). Serum triglycerides were significantly increased 
after day 1 of ozone exposure in SHAM rats (Fig. 4.4B). Ozone-induced triglyceride increase 
was smaller in DEMED rats while ADREX was associated with nearly a complete negation 
of ozone effect in the 1-D group (Fig. 4.4B). Circulating FFA were not affected by DEMED 
or ADREX as evident in air-exposed rats. FFA tended to increase in SHAM rats (p=0.15) 
when exposed to ozone on 1-D; however, this increase was not observed in DEMED or 
ADREX rats (Fig. 4.4C). 
 Air-exposed ADREX group showed significant increases in circulating BCAA on 1-
D relative to SHAM rats. On day 1, BCAA also tended to increase (p=0.13) in the SHAM 
ozone-exposed group but the difference remained insignificant. On day 2, however, BCAA 
levels significantly increased in the SHAM rats exposed to ozone. Importantly, this ozone-
induced increase in BCAA did not occur in the ADREX group (Fig. 4.4D). 
4.3.5 Ozone-induced ventilatory changes are reduced in ADREX rats 
Whole body plethysmography was used to assess breathing parameters. DEMED or 
ADREX did not significantly affect breathing frequency, tidal volume (data not shown), 
minute volume or PenH as determined prior to exposure in all rats or in the air groups post 
exposure (Fig. 4.5). Ozone exposure did not change body weight-normalized minute volume 
in any group (Fig. 4.5A). Immediately following 1-D of ozone exposure, PenH was markedly 
increased in SHAM and DEMED rats.  This ozone-induced increase in PenH was 
significantly lower in ADREX rats compared to SHAM rats (Fig. 4.5B). The morning after 
the first ozone exposure, the ozone-induced increases in PenH were still apparent in SHAM 
and DEMED rats but the levels were much lower compared to the measurement taken 
immediately after the first ozone exposure. In the morning after the first ozone exposure, the 
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ADREX ozone-exposed group did not present significant increases in PenH compared with 
surgery-matched air control. 
4.3.6 Ozone-induced lung injury and inflammation are diminished by DEMED and ADREX 
Ozone exposure for 1-D increased markers of vascular protein leakage including 
BALF total protein and albumin in SHAM and DEMED groups compared to surgery-
matched air controls (Fig. 4.6A and B). Ozone-induced protein and albumin increases in the 
SHAM rats were more pronounced on 2-D when compared to 1-D. The ADREX group did 
not display any ozone-induced increases in protein or albumin following 1-D ozone 
exposure. Likewise, ozone exposure did not increase BALF protein or albumin in DEMED 
and ADREX rats on 2-D (Fig. 4.6A and B). Ozone exposure led to increases in BALF LDH 
activity (a marker of lung cell injury) on day 1 in SHAM rats (Fig. 4.6C). Ozone-exposed 
DEMED and ADREX rats did not show any increase in BALF LDH activity.   
Lung inflammatory responses to ozone were assessed by determining BALF cell 
differentials. The number of macrophages in BALF did not change significantly as a result of 
DEMED or ADREX in air exposed rats. Ozone exposure also did not change the number of 
BALF macrophages (data not shown). The baseline levels of neutrophils were slightly higher 
in ADREX rats exposed to air when compared to other surgery groups (Fig. 4.7A).  
Significant increases in BALF neutrophils occurred on 1-D and 2-D in SHAM rats after 
ozone exposure. This ozone-induced increase in neutrophils was much more pronounced on 
day 2 when compared to day 1 in SHAM rats (Fig. 4.7A). The increase in neutrophils 
following ozone exposure was significantly reduced in DEMED (SHAM>DEMED) rats. 
Surprisingly, the effect of ozone on neutrophils was nearly abolished in ADREX rats, 
especially on 2-D. On day 1, only the ADREX rats exposed to ozone showed increases in 
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BALF eosinophils compared to air controls (Fig. 4.7B). On day 2, eosinophil levels in 
ADREX rats exposed to ozone remained higher than the air group.  
To determine systemic inflammatory response, hematological parameters were 
assessed. The circulating white blood cells (WBC) were significantly decreased after ozone 
exposure on 1-D and 2-D in SHAM rats (Fig. 4.7C). Ozone exposure led to a small decrease 
in WBC on day 1 also in DEMED rats, but did not decrease WBC in ADREX rats at any 
time point. ADREX and DEMED caused an increase in circulating platelets (Fig. 4.7D).  
Ozone exposure led to increases in circulating platelets in SHAM and DEMED rats but not in 
ADREX rats on 1-D. 
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4.4 Discussion 
We have recently shown that acute ozone-induced peripheral metabolic alterations are 
associated with elevated adrenal-derived stress hormones in humans and animals (Bass et al., 
2013; Miller et al., 2015, 2016). The goal of the current study was to evaluate if the adrenal-
derived stress hormones are essential for mediating acute ozone-induced metabolic and 
pulmonary effects in rats. We used surgical DEMED to remove the medulla, which produces 
catecholamines in response to sympathetic stimulation, and ADREX where the medulla as 
well as the cortex are removed in rats. The cortex produces corticosteroids in response to 
pituitary-derived ACTH via the HPA axis, when exposed to ozone, SHAM-surgery rats 
produced typical systemic metabolic effects and lung injury similar to that observed in our 
previous study (Miller et al., 2015). These effects were characterized by hyperglycemia, 
glucose intolerance, increased levels of epinephrine, corticosterone, circulating FFA, BCAA 
and decreased circulating WBC, together with increased pulmonary ventilatory changes, 
vascular leakage and neutrophilic inflammation. All these ozone effects were partially or 
fully blocked in rats with bilateral DEMED or ADREX. Thus, we demonstrate that not only 
ozone-induced metabolic impairment, but also pulmonary injury and inflammation are 
largely modulated through adrenal-derived stress hormones likely through sympathetic 
stimulation and activation of the HPA axis. 
Ozone produces nociceptive stimuli and activates pulmonary vagal C-fibers that 
trigger various cardiopulmonary reflexes (Jimba et al., 1995; Schelegle et al., 1993). Ozone 
activates the nucleus tractus solitarius (NTS) and also stimulates various hypothalamic 
stress–responsive regions-including the PVN and LC (Gackiere et al., 2011).  Consequently, 
activation of these limbic regions could lead to changes in heart rate, peripheral 
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vasoconstriction, pulmonary arterial hypertension and increased capillary permeability 
(Kubin et al., 2006; Nicolaides et al., 2015). However, these neurohormonal pathways have 
not been linked to ozone-induced pulmonary injury and systemic metabolic effects. 
Diminution of circulating epinephrine and corticosterone confirmed successful 
removal of adrenals. As expected, ozone-induced increases in epinephrine and corticosterone 
in SHAM rats were not apparent in either DEMED and ADREX rats. This confirms our 
earlier findings that acute ozone increases the release of stress hormones likely through 
activation of sympathetic adrenomedullary and the HPA axis (Bass et al., 2013; Miller et al., 
2015). Since ~80% of circulating noradrenaline is released from peripheral sympathetic 
nerve terminals and only 20% produced by the adrenal medulla (Patel et al., 2000; Esler et 
al., 1990), DEMED or ADREX did not affect those levels. The lack of ozone effect on 
noradrenaline raises the question as to the role of efferent sympathetic stimulation in 
mediating systemic metabolic and pulmonary effects. Since it is technically not feasible to 
remove the cortex and leave the medulla intact, the question about the contribution of cortex-
derived hormones in response to the release of medullary epinephrine remains.  
During the stress response, epinephrine initiates a transient increase in circulating 
glucose by the stimulation of hepatic glycogenolysis and gluconeogenesis, and inhibition of 
glucose disposal by insulin-dependent tissues (Sherwin and Sacca, 1984; Sherwin et al., 
1980). Similarly, cortisol suppresses insulin-mediated glucose uptake through the 
glucocorticoid receptors (Steiner et al., 2014). The ozone-mediated increase in circulating 
epinephrine and cortisol in SHAM rats, together with the diminution of ozone-induced 
hyperglycemia and glucose intolerance in ADREX and DEMED rats, demonstrates that the 
adrenal-derived stress hormones are essential for the observed impairment in glucose 
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metabolism. This corroborates with previous findings where DEMED suppressed hypoxia-
induced hyperglycemia and insulin secretion (Shin et al., 2014). The stress hormones are 
known to prompt adipose tissue lipolysis, leading to the release of FFAs in the circulation, 
which are known to interfere with insulin signaling and contribute to insulin resistance 
(Shulman et al., 2000). We show that ozone-induced increases in FFA and triglycerides were 
diminished in ADREX and DEMED rats, further confirming the role of stress hormones in 
the observed lipidemia. Activation of glucocorticoid receptors in response to increases in 
stress hormones results in muscle protein catabolism and release of BCAA in the circulation 
(Braun and Marks, 2015). An increase in serum BCAA levels were apparent in the present 
study in SHAM rats exposed to ozone, similar to our previous study (Miller et al., 2015), but 
not in ADREX and DEMED rats.  These data provide further confirmation that ozone 
induces stress hormone-mediated muscle protein catabolism. Accumulation of BCAA have 
been implicated in initiating pancreatic β-cell dysfunction, inflammation, endoplasmic 
reticular stress and apoptosis (Lynch and Adams, 2014). Since metabolic effects of ozone 
were found to be reversible upon termination of exposure (Miller at al., 2015), the long-term 
consequences remain to be investigated.   
The contribution of pulmonary neural refluxes mediated by different areas within the 
NTS in ozone-induced ventilatory changes has been described (Schelegle et al., 1993; 
Schelegle and Walby, 2012; Taylor-Clark and Undem, 2010; Chen et al., 2003).  It has been 
shown that ozone exposure induces reflux bronchoconstriction (Schelegle and Walby, 2012). 
In our study, PenH, which is often linked to airflow limitation, was increased in SHAM rats 
exposed to ozone. This might be due to changes in airway smooth muscle contractility. β 
receptors, which are heavily distributed in large and small airways, have been shown to play 
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a major role in regulating smooth muscle tone by epinephrine and corticosterone (Bosse, 
2014). DEMED had no effect on PenH responses after ozone, whereas the reduction in 
ozone-induced increases in PenH by ADREX suggests that corticosterone, epinephrine and 
other circulating factors might be directly or indirectly playing a role in mediating the ozone-
induced ventilatory changes.   
There are likely a number of mechanisms influencing the development of pulmonary 
edema after ozone exposure in SHAM rats. First and foremost, ozone exposure can directly 
injure capillary walls, leading to leakage of protein in the alveoli (Vella et al., 2015; Banks et 
al., 1990). Pulmonary edema can also occur through acute sympathetic activation 
(neurogenic), which may lead to baroreflex-induced bradycardia. The resulting enhancement 
of venous return can cause pulmonary vascular congestion and increase hydrostatic pressure, 
which can damage the capillary wall causing fluid leakage (Šedý et al., 2015). Increased 
circulating epinephrine can also cause systemic capillary pressure increase, which may 
contribute to pulmonary edema after ozone exposure (Krishnamoorthy et al, 2012). Increases 
in circulating epinephrine and corticosterone, and ozone-induced cardiac depression together 
might affect the protein leakage. We have previously shown that ozone induces bradycardia 
and hypothermia (Gordon et al., 2014). Ozone has also been shown to decrease blood 
pressure (Uchiyama et al., 1986) and produce cardiac depression (Wagner et al., 2014) which 
may contribute to lung protein leakage. The finding that pulmonary protein leakage and lung 
cell injury are nearly abolished in ADREX and DEMED rats suggests that release of stress 
hormones, likely through sympathetic and HPA-activation, were critical in ozone-induced 
protein leakage. 
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Ozone-induced extravasation of inflammatory cells into the lung through activation of 
signaling mechanisms involving transendothelial migration has also been well characterized 
(Alexis and Carlsten, 2014; Hollingsworth et al., 2007). Consistent to these studies, ozone 
exposure in SHAM rats caused neutrophilic lung inflammation and depletion of circulating 
white blood cells, likely due to their extravasation into the lungs. It is generally believed that 
corticosteroids inhibit inflammation (Edwards, 2012); however, numerous studies have 
shown that acute stress-mediated increases in corticosterone and epinephrine can stimulate 
leukocyte trafficking and extravasation at the site of injury in an immune cell-specific 
manner (Dhabhar, 2009; Dhabhar et al., 2012). The precise mechanisms by which distinct 
types of chronic stresses modulate inflammatory processes still remain an area of intense 
research. The selective diminution of ozone-induced neutrophil influx but stimulation of 
eosinophil influx, together with the lack of an ozone-induced decrease in circulating 
lymphocytes in ADREX and DEMED rats suggests contribution of the dynamic and 
temporal changes in corticosteroids and epinephrine (Dhabhar, 2012).  Interestingly, ozone-
mediated thymus atrophy was reduced in adrenalectomized mice (Dziedzic and White, 
1986), suggesting that adrenal hormones might modulate ozone-induced inflammatory 
response through changes in thymus function. These data together provide the insights into 
the contribution of central neurohormonal mechanisms in modulating pulmonary 
inflammatory responses induced after ozone exposure.  
In this study, we show that acute ozone exposure induced a classical stress-associated 
systemic metabolic response and pulmonary injury/inflammation in SHAM rats, similar to 
what was seen in our previous studies (Bass et al., 2013; Miller et al., 2015). This response is 
characterized by increased levels of epinephrine and corticosterone, hyperglycemia, glucose 
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intolerance, increased circulating FFA, increased BCAA, and decreased circulating white 
blood cells as has been observed in our previous study (Miller et al., 2015). Surgical removal 
of the adrenal medulla or whole adrenal glands resulted in nearly complete inhibition of these 
ozone-induced metabolic and pulmonary effects. Thus, we show adrenal-derived hormones 
mediate systemic metabolic impairment and acute pulmonary injury/inflammation likely 
through sympathetic and HPA-activation. 
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Table 4.1 Effect of surgery and ozone exposure on body weights in rats. 
 
 Time Point of Body Weights (g)  
 
Prior to 
Surgery 
Day 1 exposure Day 1 exposure Day 2 exposure Day 2 exposure 
Group Air Ozone Air Ozone Air Ozone Air Ozone Air Ozone 
SHAM 321± 32 318± 18 322±39 320±13 314±31 307±15 324±30 313±25 309± 26 299±15 
DEMED 318± 16 321± 17 319±14 327±15 310±12 315±9 318±14 316±17 305±13 305±12 
ADREX 321± 15 321± 18 305±16 299±16† 292±13 292± 9 297±13 296±14 291±11 281±9† 
 
SHAM=sham surgery; DEMED=bilateral adrenal demedullation; ADREX=total bilateral 
adrenalectomy. † Significant (p≤0.05) ADREX effect relative to sham surgery. 
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Figure 4.1 
 
 
 
Figure 4.1. Experimental Timeline. Four days prior to air or ozone exposure, WKY rats 
underwent SHAM, DEMED, ADREX. After 4 days of recovery, rats were exposed to air or 
ozone for 4h/day for 1 day (A, 1-D) or 4h/day for 2 consecutive days (B, 2-D).  GTT was 
performed in the 2-D exposure group only after the first day of exposure.  Immediately 
following each exposure, rats were necropsied for analysis of lung injury and inflammation, 
neurohormones and metabolic biomarkers. WKY, Wistar Kyoto: SHAM, sham surgery; 
DEMED, bilateral adrenal demedullation; ADREX, total bilateral adrenalectomy; GTT, 
glucose tolerance test. 
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Figure 4.2 
 
Figure 4.2 Changes in the levels of circulating hormones after air or ozone exposure in 
SHAM, DEMED, or ADREX rats. Adrenal cortex and medulla-derived hormones were 
measured in the serum and plasma, respectively, from rats exposed to air or ozone at both 
time points (1-D, 2-D), A, Adrenaline (Epinephrine), B, Noradrenaline (Norepinephrine), and 
C, Corticosterone. Values indicate mean ± standard error (n=4-6/group). *Indicates ozone 
effect when compared to matching air group at a given time point (p≤0.05). †Indicates 
surgery effect within matching exposure group at a given time point (p≤0.05).  
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Figure 4.3 
 
 
Figure 4.3 Changes in glucose tolerance after air or ozone exposure in SHAM, DEMED, or 
ADREX rats. GTT was performed only after the first day of exposure in the 2-D group (A). 
The 0 min time point shows fasting glucose levels in each group post exposure.  Panel B 
shows the graph for the area under the curve (AUC) for the GTT data. Values indicate mean 
± standard error (n=4-6/group). *Indicates ozone effect when compared to matching air 
group (p≤0.05). 
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Figure 4.4 
 
 
Figure 4.4 Changes in circulating metabolites after air or ozone exposure in SHAM, 
DEMED, or ADREX rats). Serum metabolites were measured after air or ozone exposure in 
rats at each time point (1-D, 2-D): A, Total Cholesterol, B, Triglycerides, C, FFA and D, 
BCAA. Values indicate mean ± standard error (n=4-6/group). *Indicates ozone effect when 
compared to matching air group at a given time point (p≤0.05). †Indicates surgery effect 
within matching exposure group at a given time point (p≤0.05). P=0.15 for FFA air and 
ozone, 1-D and p=0.13 for BCAA air and ozone 1-D in the SHAM rats. FFA, free fatty acids; 
BCAA, branched chain amino acids. 
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Figure 4.5 
 
 
 
 
Figure 4.5 Ozone-induced changes in lung minute volume and PenH, an index of labored 
breathing, in SHAM, DEMED and ADREX rats.  The plethysmography was performed the 
morning prior to first ozone exposure (1-D Morning), immediately following first ozone 
exposure (1-D Afternoon) and prior to the start of second exposure (2-D Morning). A, 
Minute volume was calculated based on breathing frequency and tidal volume and the values 
were normalized to body weight. B, PenH values were computed from all ventilatory 
parameters measured during plethysmography. Values indicate mean ± standard error (n=4-
6/group). *Indicates ozone effect when compared to matching air group at a given time point 
P ≤ 0.05. †Indicates surgery effect within matching exposure group at a given time point P ≤ 
0.05. 
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Figure 4.6 
 
 
Figure 4.6 Lung injury in rats as determined by analysis of bronchoalveolar lavage fluid 
(BALF) after ozone exposure in SHAM, DEMED, or ADREX rats. Rats were necropsied 
immediately after each exposure time point (1-D, 2-D). BALF was analyzed for lung injury 
markers: A, Total Protein, B, Albumin, and C, LDH activity. Values indicate mean ± 
standard error (n=4-6/group). *Indicates ozone effect when compared to matching air group 
at a given time point P ≤ 0.05. †Indicates surgery effect within matching exposure group at a 
given time point P ≤ 0.05. BALF, bronchoalveolar fluid; LDH, lactate dehydrogenase.  
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Figure 4.7 
 
Figure 4.7 Lung inflammation as determined by analysis of cells in bronchoalveolar lavage 
fluid (BALF) after air or ozone exposure in SHAM, DEMED, or ADREX rats.  BALF cell 
differentials were performed to quantify macrophages, neutrophils and eosinophils at both 
time points after air or ozone exposure (1-D, 2-D). A, Neutrophils and B, Eosinophils. Data 
for macrophages are not shown. Circulating white blood cells (WBC) and platelets were also 
quantified. C, WBC and D, Platelets. Values indicate mean ± standard error (n=4-6/group). 
*Indicates ozone effect when compared to matching air group at a given time point P ≤ 0.05. 
†Indicates surgery effect within matching exposure group at a given time point P ≤ 0.05.  
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CHAPTER 5 
 
SUBCHRONIC OZONE EXPOSURE: SYSTEMIC METABOLIC 
DERANGEMENT, PULMONARY EFFECTS AND INSULIN 
INSUFFICENCY 
5.1 Introduction 
 In 2011, the International Diabetes Federation reported that the diabetes epidemic 
affected 366 million people worldwide, with 90% of the reported cases being classified as 
type 2 diabetes (TIID). Most mitigation efforts of TIID have focused on conventional risk 
factors such as sedentary lifestyle, obesity, high-fat diet, and genetic background. Recently, 
epidemiological studies have demonstrated a positive association between air pollutants and 
chronic metabolic conditions (Pearson et al., 2010;  Liu et al., 2013;  Thiering and Heinrich, 
2015). For instance, there is an overlap of diabetes cases reported by the Center of Disease 
Control and high concentrations of particulate matter in the United States (Pearson, et al., 
2010). Likewise, several studies have shown a positive association between ozone exposure, 
insulin resistance, and exacerbation of pre-existing metabolic conditions in the elderly 
(Stafoggia et al., 2010;  Zanobetti and Schwartz, 2011;  Kim and Y.C., 2012). However, the 
causality and underlying mechanisms for air pollutant-induced metabolic effects are unclear.
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 Long-term ambient particulate matter exposures are linked to the onset of metabolic 
risk factors for TIID such as adipose inflammation, mitochondrial dysfunction, liver 
endoplasmic reticulum stress and insulin resistance in mouse models of obesity (Xu et al., 
2011;  Mendez et al., 2013;  Sun et al., 2013). It has been proposed that inhaled air pollutants 
may cause systemic insulin resistance by: 1) increased circulating pro-inflammatory 
cytokines, and/or 2) neuronal activation (Rajagopalan and Brook, 2012). While some air 
pollution studies have demonstrated systemic inflammation (Nurkiewicz et al., 2004;  
Finnerty et al., 2007;  Mutlu et al., 2007;  Niwa et al., 2008), many others show no increases 
in circulating cytokines (Campen et al., 2006;  Kooter et al., 2006;  Montero et al., 2006;  
Gottipolu et al., 2009).  
 Alternatively, air pollutants have been shown to cause neuroinflammation, oxidative 
stress and endoplasmic reticulum stress in the hypothalamus and other regions that regulate 
the autonomic nervous system (ANS) and hypothalamus pituitary adrenal (HPA) axis 
(Calderon-Garciduenas et al., 2008; Block and Calderon-Garciduenas, 2009; Levesque et al., 
2011; Liu et al., 2014). Dysfunction or chronic activation of the sympathetic nervous system 
(SNS) and the HPA-axis, have been implicated in hyperglycemia, obesity, β-cell dysfunction 
and insulin resistance (Cai, 2013; Nosadini et al., 1983; Surwit and Schneider, 1993; 
Friedman et al., 1996;  Delaunay et al., 1997;  Bjorntorp et al., 1999; Rask et al., 2001). 
Likewise, persistent increases in stress hormones, such as epinephrine and corticosterone, are 
postulated to induce insulin resistance through increased circulating non-esterified free fatty 
acids (NEFAs) (Nonogaki, 2000). It is suggested that the continuous supply of NEFAs to the 
tissues could elevate intracellular ceramide and diacylglycerol levels, which can interfere 
with insulin signaling through increased IRS-1/2 serine phosphorylation and decreased AKT-
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mediated glucose uptake (Arner and Langin, 2014;  Perry et al., 2014). However, a potential 
link between neuronal stress response and insulin resistance has not been examined in air 
pollution studies. 
 We have recently reported that acute ozone exposure in rats induces a classical stress 
response characterized by increases in circulating stress hormones, glucose, long-chain free 
fatty acids, and branched chain amino acids (BCAA), suggesting the involvement of the SNS 
and activation of the HPA axis (Miller et al., 2015). The increases in circulating lipid 
metabolites and stress hormones were also noted in humans after an acute ozone exposure 
(Miller et al., 2016a). Interestingly, adrenalectomy prior to ozone exposure resulted in 
diminution of not only metabolic but also pulmonary effects in rats (Miller et al., 2016b). 
However, no insulin resistance was observed during an acute ozone exposure in our rat or 
human studies. This is in contrast to a study conducted by Vella et al. (2015), who 
demonstrated muscle insulin resistance in rats after 16 hr ozone exposure. It is not known if 
subchronic ozone exposure could lead to long-lasting elevations in circulating stress 
hormones lipids, or peripheral insulin resistance.   
 The objective of the present study is to examine if weekly episodic ozone exposure 
will lead to non-reversible metabolic alterations and insulin resistance in the liver and muscle 
tissues in rats. In this study, rats were exposed episodically to ozone 5hr/day x 3 consecutive 
days/week (wk) x 13wks. Metabolic alterations and hormone levels were assessed 
immediately after the last exposure or following a 1wk recovery. Clinical tests for glucose 
tolerance and insulin resistance were performed intermittently during exposure, together with 
assessment of stress hormones, lung injury/inflammation, and peripheral insulin signaling.  
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5.2 Materials and Methods  
5.2.1 Animals 
 Heathy male Wistar Kyoto (WKY) rats (250-300g) were obtained from Charles River 
Laboratories Inc. (Raleigh, NC) at 10 wks of age. All rats were housed 2/cage in 
polycarbonate cages in an isolated animal room maintained at 21 ± 1ºC, 50 ± 5% relative 
humidity and on a 12hr light/dark cycle. The EPA NHEERL animal facility is approved by 
the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC). 
All animals received standard (5001) Purina pellet rat chow (Brentwood, MO) and water ad 
libitum unless otherwise stated. Animals were treated humanely and all efforts were made for 
alleviation of suffering. The EPA NHEERL Animal Care and Use Committee (IACUC) 
approved the research protocol for this study. 
5.2.2 Ozone generation and animal exposures 
 Ozone was generated from oxygen by a silent arc discharge generator (OREC, 
Phoenix, AZ), and its entry into the Rochester style “Hinners” chambers was controlled by 
mass flow controllers. The chambers relative mean temperature was 23.3°C (74⁰F) and 
humidity was 46%. Ozone concentrations were recorded continuously using the photometric 
API Model 400 ozone analyzer (Teledyne Instruments, San Diego, CA). Animals were 
divided into two groups: group 1 and group 2. Each group was further seperated into three 
exposure conditions: 1) filtered air, 2) 0.25 ppm ozone, and 3) 1.0 ppm ozone (n=8-
10/exposure for each group). Both groups underwent whole body exposure to air or ozone, 
5hr/day, 3 consecutive days/wk for 13wks. For group 1, necropsies were performed 
immediately post final exposure (13wk). For group 2, necropsies were performed after 1wk 
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recovery in their home cages following the 13wk exposure (13wk + 1wk recovery) to 
determine if ozone effects were reversible (Fig. 5.1).  
5.2.3 Intraperitoneal glucose tolerance test (IPGTT) 
 IPGTT was conducted in group 1 animals during the 1st wk of exposure immediately 
following day 1 (1wk-D1) or day 3 (1wk-D3) of exposure, and during the 12th wk of 
exposure immediately following day 1 of exposure (12wk-D1). IPGTT was also performed 
in group 2 following 1wk recovery. Animals were fasted ~6hr in air or ozone exposure 
chambers and during loading/unloading, except for the recovery group where food was 
withheld for 6hr prior to IPGTT. For this test, baseline blood glucose levels were measured 
by pricking the tip of the tail using a sterile 25 gauge needle and Bayer Contour Glucometer 
(Leverkusen, Germany). Animals were then injected I.P. with pharmaceutical grade glucose 
solution (20% D-glucose; Sigma-Aldrich, St. Louis. MI)  at 2g/10 mL/kg body weight. 
Glucose levels were measured at 30, 60, 90, and 120 min post glucose injection as reported 
in our previous studies (Miller et al., 2015; 2016b). 
5.2.4 Blood collection for insulin measurement during IPGTT 
  During IPGTT at 12wk-D1, blood samples were collected from the lateral tail vein 
for insulin measurement before injecting glucose (baseline) and 30 min post glucose 
injection. Rats were placed in nose-only inhalation restraining tubes that were mounted on a 
lab bench device during blood collection. In order to reduce tube stress, rats were 
acclimatized for 5 min to restrainer tubes for three consecutive days prior to the start of the 
blood collection. The tails were warmed for 1 min using a damp warm cloth and wiped clean. 
A heparinized 20 gauge sterile needle was inserted into the tail vein, and after discarding the 
first two drops, ~200 L of blood sample was collected into serum seperator tubes. 
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Hemostasis was then achieved by pressure using clean sterile gauze. These samples were 
spun at 3500 x g for 10 min, serum aliquots were separated, and stored at -80oC until insulin 
analysis. For analysis of acute ozone exposure effects on glucose-mediated β-cell insulin 
secretion, a separate group of animals were exposed to air or 1.0 ppm ozone for 4hr. 
Immediately post exposure, ~50-100 L blood samples were collected prior to and 30 min 
post glucose injection from the tail prick. These samples were spun and serum aliquots were 
stored at -80oC for insulin measurement as stated above. 
5.2.5 Intraperitoneal insulin tolerance test (IPITT) 
Group 1 underwent IPITT at wk 1, day 2 (1wk-D2), and group 2 underwent IPITT at wk 12, 
day 1 (12wk-D1). As in the case with IPGTT, animals were fasted during air or ozone 
exposure and chamber loading/unloading for ~6hr. Immediately post air or ozone exposure in 
each group, baseline glucose levels were measured from the tail prick as in the case of 
IPGTT. HumulinR (Lilly USA, LLC, Indianapolis, IN) was injected I.P. (1.0 IU diluted in 1 
mL saline/kg body weight) and blood glucose was measured at 30, 60, 90 and 120 min post 
insulin injection.   
5.2.6 Intraperitoneal pyruvate tolerance test (IPPTT) 
 PPTT was conducted in group 2 at 1wk-D1, 13wk-D1 and at 13wk-D3. This 
procedure indirectly measures hepatic gluconeogenesis in conscious animals. As in the case 
with IPGTT and IPITT, immediately following exposure, fasting baseline glucose levels 
were measured using a glucometer through a tail prick (0 min). Pharmaceutical grade sodium 
pyruvate (Sigma-Aldrich, St. Louis. MI, diluted in saline (1g/2mL/kg body weight), was then 
injected I.P. Blood glucose levels were measured at 30, 60, 90, and 120 min following 
injection of pyruvate.   
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5.2.7 Necropsy and sample collection 
 Group 1 animals were necropsied immediately following the 13wk of exposure 
(13wk), while group 2 animals were necropsied after a 1wk recovery period (13wk + 1wk 
recovery). 10-15 min prior to necropsy, half of the animals (n=4-5) in each group were 
injected I.P. with 1.0 IU/kg body weight dose of HumulinR to accelerate insulin-mediated 
glucose uptake through AKT phosphorylation. Rats were euthanized with an I.P. injection of 
~200 mg/kg sodium pentobarbital (Fatal-Plus diluted 1:1 with saline; Vortech 
Pharmaceuticals, Ltd., Dearborn, MI). All animals in both groups were fasted 6hr prior to 
necropsy. 
5.2.8 Blood collection, complete blood count (CBC), and tissue collection 
 When animals were completely non-responsive to hind paw pinch after Fetal-Plus 
injection, blood samples were collected through the abdominal aorta. CBC was performed 
from EDTA containing blood tubes using a Beckman-Coulter AcT blood analyzer 
(Beckman-Coulter Inc., Fullerton, CA). All blood tubes were then centrifuged at 3500 rpm, 
at 4oC for 10 min. Plasma and serum samples were stored at -80°C until further analysis.  
Liver lobe and gracilis leg muscle tissues were collected and stored at -80oC for later 
assessment of markers of the insulin signaling pathway. 
5.2.9 Bronchoalveolar lavage and bronchoalveolar lavage fluid (BALF) processing for 
pulmonary injury and inflammation assessment 
 The trachea was cannulated and then a suture was used to tie the left lung. The right lung 
was lavaged using Ca2+/Mg2+ free phosphate buffered saline (pH 7.4) equal to 28 ml/kg body 
weight (total lung capacity) x 0.6 (right lung is ~60% of total lung weight). Three in-and-out 
washes were performed using the same aliquot of buffer and BALF was transfered to ice 
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until processing. Aliquots of BALF were used to determine total cell counts with a Z1 
Coulter Counter (Coulter, Inc., Miami, FL) and cell differentials as described previously 
(Bass et al., 2013).  Cell-free BALF aliquots, stored at -80oC, were used to analyze total 
protein, albumin, γ-glutamyl transpeptidase (GGT) activity, and n-acetyl glucosaminidase 
(NAG) activity as described previously (Bass et al., 2013). 
5.2.10 Serum and plasma analysis 
 The catecholamines adrenaline and noradrenaline in the EDTA plasma samples were 
measured using kits from Rocky Mountain Diagnostics (Colorado Springs, CO) per the 
manufacturer’s protocol. Serum corticosterone concentrations were analyzed employing a 
rat-specific immunoassay kit from Arbor Assays (Ann Arbor, MI) per the manufacturer’s 
protocol. Total cholesterol and triglycerides were measured in serum samples using kits from 
TECO Diagnostics (Anaheim, CA), while high density lipoprotein cholesterol (HDL-C) and 
low-density lipoprotein cholesterol (LDL-C) were measured using kits from Thermo Fisher 
Scientific, Inc (Middletown, VA). All cholesterol kit protocols were modified for use on the 
Konelab Arena 30 system (Thermo LabSystems, Espoo, Finland). Serum NEFAs were 
measured by a coupled enzymatic reaction and the resultant hydrogen peroxide detection 
using a colorimetric probe as per the manufacturer’s protocol (Cell Biolabs, Inc, San Diego, 
CA). BCAA were measured in serum using an ELISA kit and protocol based on 
chemiluminescence detection (Abcam, Cambridge, MA). Insulin serum levels were detected 
using rat-specific chemiluminescence assay kit (Millipore, Billerica, MA) via manufacturer’s 
instructions. Serum levels of inflammatory cytokines were measured in selected groups of 
animals (13wk; air and 1.00 ppm ozone groups) using rat-specific V-Plex Proinflammatory 
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Panel 2 kit based on electrochemiluminescence detection (Meso Scale Discovery, 
Gaithersburg, MD) via manufacturer’s instructions. 
5.2.11 Insulin signaling assessment in liver and muscle 
 Liver and muscle tissues from 13wk and 13wk + 1wk recovery air and ozone groups 
were homogenized in lysis buffer containing protease and phosphatase inhibitors using a 
polytrone-type homogenizer. Homogenates were centrifuged at 14,000 x g at 4oC for 10 min. 
The supernatants were analyzed for protein concentrations using Coomassie Plus protein 
assay kit (Pierce, Rockford, IL) and aliquots were stored at -80oC for total and 
phosphoprotein assessment. Phosphorylated AKT (pAKT) and non-phosphorylated AKT 
were analyzed using a rat-specific electrochemiluminescence assay (Meso Scale Discovery, 
Gaithersburg, MD) via manufacturer’s instructions. The pAKT level for each sample was 
normalized to total AKT (pAKT + non-phosphorylated AKT), and the relative fold change 
was calculated based on the air control for non-insulin injected animals for their respective 
time point. 
5.2.12 General Statistics 
 Graph Pad Prism (6.0) was used for all data analysis. IPGTT, IPITT and IPPTT data 
were analyzed using a two-way repeated measure multivariate analysis of variance 
(MANOVA). Each of these time-dependent metabolic measures were also analyzed for area 
under the curve by the trapezoidal method. All other measurements had two independent 
variables (exposure and time) and therefore, these parameters were analyzed by two way 
analysis of variance (ANOVA) followed by Duncan’s multiple range test. Pairwise 
comparisons were performed on all data and the level of significance was set at p <0.05. 
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5.3 Results 
5.3.1 Acute and subchronic episodic ozone exposure induces glucose intolerance without 
impacting insulin tolerance. 
 IPGTT was conducted immediately following exposure at 1wk-D1, 1wk-D3, 12wk-
D1 and 13wk + 1wk recovery to determine if ozone-induced glucose metabolic impairment 
would persist during subchronic exposure and if these effects were reversible following a 
recovery period. Ozone exposure at 1wk-D1 induced fasting hyperglycemia and glucose 
intolerance at the 1.00 ppm dose (Fig. 5.2A), as observed in previous studies (Miller et al., 
2015). Ozone-induced hyperglycemia and glucose intolerance appeared to be reduced at 
1wk-D3 compared to the 1wk-D1 (Fig. 5.2B). Ozone exposure led to marked increases in 
fasting glucose and glucose intolerance at 1.00 ppm at 12wk-D1 (Fig.5.2C) which appeared 
to be more pronounced relative to the 1wk-D1 time point. One week recovery resulted in a 
complete reversal of ozone-induced fasting hyperglycemia and glucose intolerance (Fig. 
5.2D).  
 IPITT was conducted to determine if subchronic ozone-induced glucose intolerance 
was accompanied with peripheral insulin resistance. Neither 1wk-D2 (Fig. 5.2E) nor 12wk-
D1 (Fig. 5.2F) assessment indicated impairment in peripheral insulin-mediated glucose 
clearance. Ozone-induced hyperglycemia and glucose intolerance were reversed after insulin 
injection suggesting effective insulin-mediated glucose uptake. 
5.3.2 Acute ozone increases hepatic gluconeogenesis 
 One of the potential contribution to hyperglycemia after ozone exposure could be 
increased hepatic gluconeogenesis. IPPTT allows one to examine the stimulation of 
gluconeogenesis since pyruvate is a gluconeogenic precursor that is converted to glucose in 
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the liver when injected. To determine if ozone-induced hyperglycemia resulted from 
stimulated gluconeogenesis, IPPTT was conducted in animals at 1wk-D1 and 13wk-D1. 
During 1wk-D1, 1.00 ppm ozone-exposed animals were already hyperglycemic and showed 
a significant increase in blood glucose levels following pyruvate injection when compared to 
air or 0.25 ppm groups (Fig. 5.3A). The AUC further confirmed the stimulation of 
gluconeogenesis at this time point. In contrast, after a 13wk subchronic ozone exposure, no 
increases in gluconeogenesis were observed (Fig. 5.3B & 3C).   
5.3.3 Acute and subchronic episodic ozone exposure attenuates glucose-activated pancreatic 
β-cell insulin secretion 
 Impairment of pancreatic β-cell insulin secretion is another potential mechanism by 
which ozone could induce glucose intolerance. We evaluated the effect of acute and 
subchronic ozone exposure on β-cell function in rats by determining baseline and glucose-
stimulated insulin release in to the circulation. No differences were observed in serum insulin 
levels between air and 1.00 ppm ozone at baseline prior to I.P. glucose injection at 1wk-D1 
(Fig. 5.4A). However, 30 min after glucose injection, insulin levels were significantly 
increased in air-exposed animals, whereas ozone-exposed rats showed no insulin increase in 
response to glucose (Fig. 5.4A). Neither baseline nor glucose-stimulated insulin release in the 
0.25 ppm ozone-exposed rats were determined during the wk 1 of exposure (Fig. 5.4A). 
Subchronic air and ozone exposures showed similar insulin responses compared to acute 
exposure responses. At 12wk-D1, baseline serum insulin levels tended to decrease with 1.00 
ppm ozone exposure relative to air group (p=0.1018; Fig. 5.4B). Bolus glucose injection led 
to marked increases in serum insulin in air and 0.25 ppm ozone-exposed rats, suggesting a 
robust response of pancreatic β-cells to release insulin when circulating glucose levels were 
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high.  This glucose-induced increase in insulin levels was completely abolished in rats 
exposed to 1.00 ppm ozone (Fig. 5.4B). Glucose-stimulated insulin secretion was not 
determined in rats after the 1wk recovery period following 13wks of ozone exposure. 
However at necropsy, we measured basal insulin levels at the 13wk and the 13wk + 1wk 
recovery to determine ozone effects. Although  the insulin levels in 1.00 ppm exposed rats 
were markedly lower relative to air or 0.25 ppm groups at 13wk, this difference did not reach 
statistical significance using a 2-way ANOVA method due to large intragroup variability and 
small group size (n=3-5; Fig 5.4C). However, when insulin mean values for the air and 1.00 
ppm ozone were compared with an unpaired t-test, there was a significant (p=.0007) 3-fold 
decrease. This ozone-induced decrease was less pronounced after a 1wk recovery period (Fig 
5.4C). 
5.3.4 Subchronic episodic ozone exposure does not produce liver or muscle insulin resistance 
 Although there was no significant change in insulin tolerance between the air- and 
ozone-exposed rats, we presumed that tissue-specific insulin sensitivity might be altered, 
specifically in the liver and muscle following subchronic ozone exposure. We measured non-
phosphorylated AKT and pAKT, which mediates insulin-induced cellular glucose uptake at 
13wk and after a 13wk + 1wk recovery in the liver and muscle from air and 1.00 ppm ozone-
exposed rats. In a selected number of rats within a given exposure condition, insulin was 
injected 10-15 min prior to necropsy to increase the sensitivity of detecting levels of pAKT 
in response to high insulin. No changes were noted in the pAKT levels in the liver (Fig. 
5.5A) nor muscle (Fig. 5.5B) following ozone exposure in rats with or without insulin 
injection, suggesting that insulin-mediated glucose uptake was not altered by ozone exposure 
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in these tissues. The validity of the pAKT measurements was confirmed by significant 
increases in the levels of pAKT in rats injected with insulin prior to necropsy. 
5.3.5 Subchronic episodic ozone exposure alters circulating stress hormone levels 
We have shown that circulating adrenaline is elevated during acute ozone exposure 
(Miller et al., 2015). We have also noted increases in circulating corticosterone following a 
2hr ozone exposure in rats (unpublished data) and humans (Miller et al., 2016a). To 
determine if these stress hormones are still elevated following a subchronic episodic 
exposure, adrenaline, noradrenaline, and corticosterone plasma levels were measured in rats 
exposed to air or ozone for 13wks and after a 1wk recovery period. Serum adrenaline levels 
were significantly increased at 13wk following 1.00 ppm ozone with levels returning to 
baseline following a recovery period (Fig. 5.6A). Noradrenaline plasma levels tended to be 
high in the 1.00 ppm ozone-exposed rats at both time points, however, these increases were 
statistically insignificant (Fig. 5.6.B). The level of corticosterone tended to be low in the 1.00 
ppm ozone-exposed rats relative to air controls at 13wk, however, this difference was not 
significant (Fig. 5.6C). No ozone effects were observed in the recovery group. 
5.3.6 The effect of subchronic ozone exposure on circulating proinflammatory cytokines and 
metabolic biomarkers 
 Although circulating cytokines are postulated to be involved in peripheral metabolic 
effects of air pollutants, our prior studies show no significant increases in IL-6 or TNF- 
after acute or subchronic ozone exposure in Brown Norway rats (Bass et al., 2013; Gordon et 
al., 2013). To determine if pro-inflammatory cytokines might be increased after subchronic 
exposure in WKY rats, we examined serum levels of cytokines at 13wks. No significant 
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increases were observed in IL-6, TNF- or IL-1β however, small increases were observed in 
serum IFN-γ, IL-4, and IL-10 after subchronic ozone exposure (Table 5.1).  
We have previously shown that acute ozone exposure elevated circulating total 
cholesterol, FFA and BCAA in rats (Miller et al., 2015). To determine if these changes 
would persist during a subchronic exposure, we evaluated the serum levels of these metabolic 
biomarkers.  At 13wk, 1.00 ppm ozone significantly increased total cholesterol (Fig. 5.7A). 
However, after a 1wk recovery, serum cholesterol levels were decreased in both ozone-
exposed groups when compared to air control (Fig. 5.7A). LDL was not significantly 
changed at the 13wk time point after ozone exposure, however, these levels were 
significantly decreased in ozone-exposed rats after the recovery period (Fig. 5.7B). HDL was 
significantly elevated in the 1.00 ppm ozone-exposed rats at 13wk (Fig. 5.7C). In the 
recovery group, HDL serum levels were significantly lower in the ozone-exposed rats 
compared to the air (Fig. 5.7C). Triglycerides were not significantly affected by ozone at 
13wk but were found to be decreased in the 1.00 ppm ozone group after recovery (Fig. 5.7D). 
Neither the levels of FFA (Fig. 5.7E) nor BCAA (Fig. 5. 7F) were not significantly changed 
by ozone at any time point.  Contrary to the marked increases in leptin following an acute 1 
day ozone exposure (Miller et al., 2015), there were no significant increases in leptin at 
13wk, with levels  decreased after recovery in rats exposed to 1.00 ppm ozone (Fig. 5.7G). 
5.3.7 Subchronic episodic ozone exposure induces lung injury and inflammation 
 Many studies have shown that acute ozone exposure causes lung injury and 
inflammation in animals and humans. To determine if subchronic episodic exposure would 
cause persistent lung changes, BALF was evaluated for injury and inflammation biomarkers. 
Both total protein and albumin, markers of lung permeability, were significantly elevated at 
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1.00 ppm ozone when compared to air at 13wk but this effect was largely reversed following 
recovery (Fig. 5.8A & 8B). Rats exposed to 1.00 ppm ozone showed significant increases in 
BALF GGT activity at 13wk, which persisted when the animals were allowed a 1wk 
recovery period (Fig. 5.8C). NAG activity was also increased in rats exposed to 1.00 ppm 
ozone at the 13wk, however, this effect was attenuated after recovery (Fig. 5.8D). 
 Lung neutrophilic inflammation was increased after 13wk of ozone exposure 
compared to air and 0.25 ppm groups. This ozone effect on neutrophils was not observed in 
recovery group (Fig. 5.9A). The number of BALF alveolar macrophages were also increased 
in rats exposed to 1.00 ppm ozone relative to air at 13wk with levels returning to baseline 
following 1wk recovery (Fig. 5.9B). Interestingly, circulating white blood cells were not 
significantly decreased by the subchronic ozone exposure as they are following an acute 
exposure (Miller et al., 2016b) (Fig. 5.9C). 1.00 ppm ozone exposure for 13wk increased 
circulating platelets, but this effect was reversed following the recovery (Fig. 5.9D).     
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5.4 Discussion 
 We have previously shown that acute ozone exposure induces a systemic stress 
response characterized by hyperglycemia, glucose intolerance, lipidemia, and elevations in 
BCAA, FFA, and circulating stress hormones (Miller et al., 2015; 2016b). Humans are 
exposed episodically to ozone throughout their lifetime, which may cause chronic stress 
response activation. Chronic elevations of stress hormones have been implicated in metabolic 
dysfunction and postulated to lead to insulin resistance. However, the persistence of these 
stress and metabolic effects, and their contribution to insulin resistance have not been 
examined after subchronic ozone exposure. The main objectives of this study were to 
determine: (1) if ozone-induced acute metabolic and stress effects would persist after 
subchronic episodic exposure, and (2) if subchronic ozone exposure will lead to liver and 
muscle insulin resistance.  
 Our data show that, as observed after an acute exposure, 3 days/wk of subchronic 
episodic ozone exposure for 13wks induced fasting hyperglycemia, glucose intolerance, and 
increases gluconeogenesis, circulating cholesterols and epinephrine levels, but these effects 
are reversible upon a 1wk recovery period. More importantly, basal circulating insulin levels 
were decreased and glucose-stimulated insulin release was abolished after subchronic ozone 
exposure. No insulin resistance was noted in liver or muscle tissues after 13 week ozone 
exposure. In addition, no ozone-induced changes were observed in serum FFA and BCAA, 
suggesting the likely contribution of adaptation. Increases in lung injury and inflammation 
were still present at 13wk but these effects were reversible after a 1wk recovery period. 
Overall, our data demonstrate that ozone-induced pulmonary, metabolic and stress effects 
persist through 13wk episodic ozone exposure however, these effects are reversible upon a 
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short recovery of 1wk. Further, subchronic ozone exposure diminishes glucose-stimulated 
insulin release, while decreasing the baseline levels over time, without the impairment of 
peripheral insulin resistance.      
 Three potential mechanisms may explain hyperglycemia and glucose intolerance after 
acute and subchronic episodic ozone exposure: 1) increased glucose release from the liver 
through gluconeogenesis, 2) decreased glucose uptake by peripheral tissues, and 3) decreased 
release of insulin from pancreatic -cells. We observed that acute ozone exposure increased 
hepatic gluconeogenesis but did not impair insulin-mediated glucose clearance from the 
circulation. In contrast, hepatic gluconeogenesis was not altered during subchronic exposure. 
More importantly, acute and subchronic ozone exposures abolished glucose-mediated -cell 
insulin secretion.  
Hepatic gluconeogenesis is activated by different physiological conditions, such as 
fasting or exercise, and is tightly regulated by the availability of gluconeogenic precursors 
and phosphorylation/expression of gluconeogenic enzymes. Moreover, gluconeogenesis is 
further regulated by the availability of insulin (Girard, 2006) and stress hormones (Altuna et 
al., 2006). It is postulated that insulin can directly or indirectly inhibit gluconeogenesis by 
specifically targeting hepatic glucose production or suppressing the release of glucagon from 
pancreatic -cells, the main stimulator of gluconeogenesis. Insulin can also suppress the 
formation of gluconeogenic precursors through the inhibition of adipose lipolysis and 
skeletal muscle proteolysis (Girard, 2006). Adrenaline, through 2-adrenergic receptors, can 
enhance hepatic glucose output by increasing endogenous cyclic AMP (cAMP), which 
subsequently activates protein kinase A that stimulates  fructose bisphosphatase 2 and cAMP 
response element binding dependent activation of  phosphoenolpyruvate 
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carboxykinase and inhibits phosphofructokinase 2 (Valera et al., 1994; Burgess et al., 2004). 
The ozone-induced increases in gluconeogenesis thus, could be explained by the increased 
levels of epinephrine together with decreased insulin levels and glucose-mediated insulin 
release.  
Pancreatic β-cell insulin secretion is regulated at many levels (central and local) by 
factors including endocannabinoids (Jourdan et al., 2016), glucocorticoids (Kuo et al., 2015), 
circulating glucose and fatty acids (Oh, 2015), micro RNAs (Esguerra et al., 2014), 
epinephrine (Iwanir and Reuveny, 2008; Gibson et al., 2006), and many more. We observed 
that acute and subchronic ozone exposure diminished glucose-mediated pancreatic -cell 
insulin secretion even though circulating glucose levels remained elevated in rats. Since this 
effect is associated with increased circulating epinephrine during acute (Miller et al., 2015) 
and chronic exposure to ozone as seen in this study, it is conceivable that diminished insulin 
secretion in the present study could be due to the effect of epinephrine on pancreatic β-cells. 
Catecholamines have been proposed to act through different members of the -adrenergic 
family of receptors and impair insulin secretion through changes in cAMP and/or Ca2+ levels, 
hyperpolarization of the pancreatic -cells or glucagon release from pancreatic -cells 
(Peterhoff et al., 2003). It has been shown that glucose-induced ERK1/2 activation and 
subsequent insulin secretion are inhibited by epinephrine through the 2-adrenergic receptors 
(Gibson et al., 2006).  However, it cannot be ascertained from our study if other factors 
played a role in inhibiting insulin secretion during ozone exposure. Since basal levels of 
insulin were not affected after acute exposure, but were decreased after subchronic ozone 
exposure, it is likely that the diminished insulin release could contribute to the observed 
persistent hyperglycemia and glucose intolerance following the 13wk subchronic exposure. 
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 We have previously shown that subchronic ozone exposure is associated with 
increased levels of insulin in 24 month but not 4 month old Brown Norway rats (Gordon et 
al., 2013), however, peripheral insulin signaling was not examined in that study. As observed 
before, in this study too, acute or subchronic ozone exposure did not elevate insulin levels in 
young WKY rats. On the contrary, serum insulin levels decreased in ozone-exposed rats 
relative to air group (Fig. 5.4), suggesting that there might be a tendency to develop insulin 
deficiency if the exposures continued in young rats. More importantly, our data show no 
peripheral insulin resistance in the muscle or liver after ozone exposure. Incidentally, 
exposure to ozone has been associated with type 1 diabetes (T1D) in pregnancy and in 
children (Hathout et al., 2002; 2006; Beyerlein et al., 2015; Malmqvist et al., 2015). Our data 
show that insulin resistance is not the cause of ozone-induced hyperglycemia, glucose 
intolerance, or the activation of gluconeogenesis observed in our study. These findings 
contradict the Vella et al. (2015) study involving a 16hr ozone inhalation, which showed 
insulin resistance in the muscle involving the c-Jun N-terminal kinase pathway. This 
discrepancy could be due to the very long single exposure in the Vella paper as opposed to 
the episodic subchronic exposure in our study. The possibility that ozone may contribute to 
the susceptibility of T1D by producing -cell dysfunction requires further investigation. 
 Since long-term particulate matter exposures have been shown to induce systemic 
inflammation and peripheral insulin resistance (Rajagopalan and Brook, 2012) , we examined 
a number of circulating cytokines after ozone exposure. No increases were observed in IL-6, 
TNF- or IL-1β. Small increases were observed in serum IFN-γ, IL-4, and IL-10 after 
subchronic ozone exposure in our study (Table 1). Our previous studies involving long-term 
ozone exposure have also failed to demonstrate increases in circulating proinflammatory 
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cytokines such as IL-6 and TNF- (Gordon et al., 2013; Bass et al., 2013). Since ozone-
exposure was not associated with insulin resistance, the contribution of systemic 
inflammation in insulin resistance after particulate matter exposure remains to be examined. 
Although we have shown that acute ozone exposure increases circulating FFA and BCAA 
(Miller, et al., 2015), elevations in these circulating metabolites were not noted after 
subchronic ozone exposure.  Total cholesterol and HDL, however, were higher in rats after 
subchronic ozone exposure. As in the case with acute exposure, increased epinephrine could 
alter cholesterol metabolism (Kunihara and Oshima, 1983) leading to increases in cholesterol 
levels. The increases and decreases noted after the 13wk ozone exposure and recovery in 
cholesterols and triglycerides may result in lipid redistribution in peripheral tissues, which 
will be important to examine in future studies.  
 Our exposure protocol differed somewhat from previous subchronic studies we have 
done using ozone (Kodavanti et al., 2011; Gordon et al., 2013; 2014; Bass et al., 2013) in that 
this study involved 3 days/wk exposure as opposed to 1 or 2 days/wk exposure. This was 
done with the understanding that while the 1st 2 days of weekly ozone could produce 
pronounced pulmonary injury and systemic response (Miller et al., 2015), 3 consecutive days 
of exposure was expected to attenuate these ozone-induced effects. Adaptation to ozone-
induced pulmonary injury, inflammation, and function after daily repeated exposure is fairly 
well demonstrated in humans (JÖRres et al., 2000; Schelegle et al., 2003) and in animals 
(Kirschvink et al., 2002; van Bree et al., 2002). The degree of adaptation depends on the 
ozone concentration and the temporality of exposure, and it has been shown that the 
adaptation to weekly 2-3 day ozone exposure is lost within 1wk upon re-exposure (Gordon et 
al., 2013; 2014). Rats exposed to ozone for 6hr/day, 2 days/wk led to partial adaptation 
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relative to acute exposure in pulmonary and systemic metabolic effects when determined 
after 13wk exposures (Bass et al., 2013), suggesting that weekly exposure for several wks 
will also dampen the degree of pulmonary and systemic effects observed after the 1st wk. In 
this study, we wanted to determine if the weekly adaptation would start following 3 
consecutive days of exposure, and if so, whether repeated induction of adaptation over 13wk 
would lead to failure in this response. We noted that IPGTT and IPPTT when performed on 
the third day in a given wk showed marked reduction in ozone-induced hyperglycemia, 
glucose intolerance as well as gluconeogenesis, however, the pulmonary injury inflammation 
determined after day 3 post 13wks exposure were nearly as robust as what is reported after 
acute exposure (Miller et al,. 2015).  This suggests an adaptation in some systemic effects 
following weekly ozone exposure with less robust adaptation in pulmonary outcomes.  
The phenomenon of adaptation might involve many factors, the degree of 
injury/inflammation at a given concentration being the most critical, and thus the 
interpretation of any findings becomes highly complex. Nevertheless, one could speculate 
that central mechanisms might be playing an important role in ozone adaptation 
phenomenon.  Since we have shown that catecholamines and glucocorticoids are potentially 
involved in these ozone-induced pulmonary and metabolic effects (Miller et al., 2016b), it is 
likely that adaptive mechanisms may involve altered stress response signaling during 
subchronic exposure. Chronic stress activation can lead to the adaptive response 
“habituation”, involving neural plasticity and downregulation of glucocorticoid and β-
adrenergic receptors in the central nervous system, and in the periphery leading to reduced 
stress-mediated responses (Herman, 2013).  
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One of the critical questions we wanted to address is the reversibility of effects upon 
discontinuation of ozone exposure. The persistence of the effects, including insulin 
insufficiency, can have implications in chronic disease outcomes. As noted, pulmonary and 
systemic effects observed immediately following the 13wk exposure were largely reversed 
following the 1wk recovery. However, the circulating lipids showed a reversed pattern of 
change, suggesting that while most effects are not persistent upon discontinuation of 
exposure, lipid redistribution might remain an important outcome of chronic episodic 
exposure and needs to be further examined in light of liver and muscle diseases and their link 
to pulmonary complications.     
 In conclusion, we demonstrate that subchronic weekly episodic ozone exposure 
induces pulmonary injury/inflammation, hyperglycemia, glucose intolerance, and increase 
cholesterols as observed after acute exposures. We further show that while peripheral insulin 
resistance did not occur by subchronic ozone, it had a major impact on -cell insulin 
secretion in response to circulating glucose, likely mediated by increased circulating 
epinephrine levels. This, together with reduced circulating insulin levels after subchronic 
ozone exposure, supports a link between chronic ozone and TID. Despite the fact that most 
subchronic ozone-induced changes are reversible upon termination exposure, the question 
remains about lipid redistribution in peripheral tissues and chronic episodic pollution effects. 
Overall, these data provide further insight into the mechanism(s) of how subchronic ozone 
exposure may contribute to insulin insufficiency and produce other systemic impairments.
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Table 5.1 Serum levels of proinflammatory cytokine biomarkers in WKY rats after subchronic 
exposure to air or 1.00 ppm ozone 
 
 Exposure 
Biomarker Air  Ozone  
IL-6 (pg/ml) 210.52 9.01 229.62 ± 4.68 
TNF- (pg/ml) 3.88 ± 0.35 4.57 ±  0.45 
IL-1β (pg/ml) 63.37 ± 4.58 70.19 ± 7.74 
IFN-γ (pg/ml) 26.99 ±0.92 29.48 ± 0.49* 
IL-10 (pg/ml) 81.00 ±2.45 88.91 ± 1.38** 
IL-4 (pg/ml) 6.85 ±0.15 7.32 ± 0.12** 
IL-5 (pg/ml) 23.96 ±5.65 16.25 ± 2.28 
KC-GRO (pg/ml) 191.21 ±23.36 195.66 ± 34.85 
 
Serum samples obtained after 13wk air and 1.00 ppm ozone (mean ± SEM; n=8) were analyzed 
using a Mesoscale Discovery Inc. cytokine multiplex panel kit. *Indicates significant ozone 
effect when compared to matching air group (*p≤0.05, **p≤0.01). Note that half of rats per 
group were injected with 1U/kg insulin, 10-15 min prior to necropsy. 
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Figure 5.1 
 
Figure 5.1 Experimental design. Two groups of animals were exposed to: 1) filtered air, 2) 
0.25 ppm or 3) 1.00 ppm ozone for 5h/d, 3d/wk for 13wks (n=8-10 rats/exposure/ group). 
Group 1 rats were necropsied immediately after the final exposure. Group 2 animals were 
necropsied after a 1wk recovery period following 13wk of episodic exposure (13wk + 1wk 
recovery). Metabolic testing time points are indicated by arrows for each test: 
intraperitoneal glucose tolerance test ( IPGTT: 1wk-D1; 1wk-D3; 12wk-D1; 13wk + 1wk 
recovery; the final test conducted six days following final exposure), intraperitoneal insulin 
tolerance test (IPITT:1wk-D2; 12wk-D1) intraperitoneal pyruvate tolerance test (IPPTT:1wk-
D1; 13wk-D1; 13wk-D3). All IPGTT, IPITT, IPPTT were conducted immediately following 
exposure time points. -cell insulin secretion test was conducted on 1wk-D1 and 12wk-D1. 
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Figure 5.2  
 
 
Figure 5.2 Acute and subchronic ozone exposures induce hyperglycemia and glucose 
intolerance without impairing insulin tolerance. IPGTT was conducted in animals at (A) 
week 1, day 1 (1wk-D1), (B) week 1, day 3 (13wk-D3), (C) week 12, day 1 (12wk-D1), and 
(D) six days after the 13wk final exposure (13wk + 1wk recovery). IPITT was conducted at 
(E) week 1, day 2 (1wk-D2) and (F) week 12, day 1 (12wk-D1).  Bar graphs show respective 
area under the curve (AUC) values for each test. Values indicate mean ± SEM (n=8-10). 
*Indicate ozone effect when compared to matching air group (*p≤0.05, **p≤0.01, 
***p≤0.001). 
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Figure 5.3 
 
 
Figure 5.3 Acute and subchronic ozone exposures induce hepatic gluconeogenesis. 
IPPTT was conducted in animals at (A) week 1, day 1 (1wk-D1), (B) week 13, day 1 (13wk-
D1) and (C) week 13, day 3 (13wk-D3). Bar graphs show respective area under the curve 
(AUC) values for each test. Values indicate mean ± SEM (n=8-10). *Indicate significant 
ozone effect when compared to matching air group (*p≤0.05, **p≤0.01, ***p≤0.001). 
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Figure 5.4 
 
Figure 5.4 Acute and subchronic ozone exposure inhibits glucose-stimulated β-cell 
insulin secretion. Serum insulin levels were measured immediately following 1 day air or 
1.00 ppm ozone exposure (A; 1wk-D1; a separate group of rats was used for this testing and 
air or ozone exposures was performed only for 4hr) and at 12wk-D1 (B).  Insulin levels were 
measured at baseline (0 min) and 30 min after I.P. injection of glucose (20% D-glucose; 
2g/kg). (C) Insulin levels were also determined immediately after necropsy at 13wk and 
13wk + 1wk recovery. Insulin levels were not determined (N.D.) in 0.25 ppm ozone group 
during acute exposure. Values for A and B indicate mean ± SEM (n=6-10) while values for C 
indicate mean ± SEM (n=3-5). *Indicate significant ozone effect when compared to matching 
air group (*p≤0.05, **p≤0.01, ***p≤0.001). † Indicate significant effect of glucose injection 
compared to baseline levels. 
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Figure 5.5 
 
Figure 5.5 The effect of subchronic ozone exposure and 1wk recovery on insulin 
signaling in liver and muscle tissue. Half of the rats from each group were I.P. injected with 
1.0 IU insulin/kg body weight 10-15 min prior to blood collection (necropsy) to enhance 
phosphorylation of AKT, which mediates glucose uptake through insulin receptors. The 
levels of non-phosphorylated and phosphorylated AKT (pAKT) were measured in the (A) 
liver and (B) muscle extracts, and the relative pAKT levels were normalized to non-insulin 
injected air control group. Values indicate mean ± SEM (n=4-5). †Indicates significance 
between insulin injected and non-insulin injected rats (p≤0.05).  
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Figure 5.6 
 
Figure 5.6 Subchronic ozone exposure changes circulating stress hormones. Stress 
hormones were measured in plasma samples collected using EDTA as an anticoagulant in 
rats exposed to air, or ozone at 0.25 ppm, or 1.00 pm immediately after final exposure at 
(13wk) and immediately after 1wk recovery. Stress hormones included (A) adrenaline, (B) 
noradrenaline and (C) corticosterone. Values indicate mean ± SEM (n=8-10). *Indicates 
significant ozone effect when compared to matching air group (*p≤0.05). 
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Figure 5.7 
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Figure 5.7 Subchronic ozone-induced changes in serum metabolic markers. Changes in 
circulating metabolites and leptin were measured in rats exposed to air, 0.25 ppm, or 1.00 pm 
ozone at 13wk and after 1wk recovery. The biomarkers included (A) total cholesterol (Chol.), 
(B) low density lipoprotein (LDL), (C) high density lipoprotein (HDL), (D) triglycerides, (E) 
free fatty acids (FFA), (F) branched chain amino acids (BCAA) and (G) leptin. Values 
indicate mean ± SEM (n=8-10). *Indicates significant ozone or recovery effects (*p≤0.05, 
**p≤0.01, ***p≤0.001). 
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Figure 5.8 
 
Figure 5.8 Subchronic ozone induced lung injury as determined by the assessment of 
bronchoalveolar lavage fluid (BALF). Lung injury markers were determined immediately 
after air, 0.25 ppm or 1.00 ppm ozone exposure for 13wks (13wk) and 1wk recovery 
following 13wk exposure. BALF was analyzed for lung injury markers: (A) total protein, (B) 
albumin, (C) γ-glutamyl transferase (GGT) activity and (D) N-acetyl glucosaminidase 
(NAG) activity. Values indicate mean ± SEM (n=8-10). *Indicates differences between 
groups (*p≤0.05, ***p≤0.001). 
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Figure 5.9 
 
Figure 5.9 Subchronic ozone induced lung inflammation as determined by the assessment 
of bronchoalveolar lavage fluid (BALF). Lung inflammation was determined by analysis of 
cells in bronchoalveolar lavage fluid (BALF) immediately after air, 0.25 ppm or 1.00 ppm 
ozone exposure for 13wks (13wk) and after 1wk recovery following 13wk exposure. BALF 
total cell count and cell differentials were performed to quantify (A) alveolar macrophages 
(AM) and (B) neutrophils. Circulating white blood cells (WBC) and platelets were also 
quantified using a Beckman-Coulter AcT blood analyzer (C, WBC; D, platelets). Values 
indicate mean ± SEM (n=8-10). *Indicates significance between groups (*p≤0.05, 
***p≤0.001).  
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CHAPTER 6 
 
OVERALL CONCLUSIONS AND SIGNIFICANCE 
 
6.1 Air pollution and metabolism/diabetes  
 Recent epidemiological studies have implicated air pollutant exposure as a risk factor 
for diabetes (Pearson et al., 2010; Liu et al., 2013; Thiering and Heinrich, 2015). 
Specifically, respirable ambient particulate matter (PM) has been associated with increases in 
HbA1c (a marker of  chronic high levels of  blood  glucose) (Chuang et al., 2011;  Tamayo et 
al., 2014),  impairment in glucose metabolism (Teichert et al., 2013), elevated homeostatic 
model assessment of insulin resistance (HOMA-IR), and decreased insulin sensitivity in 
humans (Kim and Y.C., 2012;  Brook et al., 2013;  Thiering and Heinrich, 2015). High ozone 
levels have been positively correlated with fasting hyperglycemia, insulin resistance and 
exacerbation of diabetes symptoms in humans (Stafoggia et al., 2010;  Zanobetti and 
Schwartz, 2011; Kim and Y.C., 2012). Exposure to ozone has also been associated with type 
1 diabetes in pregnancy and in children (Hathout et al., 2006; Beyerlein et al., 2015; 
Malmqvist et al., 2015).  However, the question of how pollutants, specifically ozone, might 
contribute to these metabolic effects still remains. Mechanistic understanding of the causality 
of air pollutant-induced metabolic impairment will provide insight into the actual human risk 
for metabolic disease from pollutant exposures and the implementation of effective 
preventative measures.
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 Experimental studies on pollutant-induced metabolic effects have primarily focused 
on ambient respirable PM and long-term exposures in mice. Findings from these studies 
suggest that ambient PM exposure can impair glucose metabolism, increase adipose 
inflammation and induce liver insulin resistance in healthy and obese mice (Sun et al., 2009; 
Xu et al., 2011; Yan et al., 2011; Conklin et al., 2013; Sun et al., 2013; Laing et al., 2010). 
Regarding ozone, limited experimental studies have explored its role in inducing systemic 
metabolic effects. Previous ozone studies in our lab have shown that acute exposure causes 
hypothermia and bradycardia (Gordon et al., 2014) together with hyperglycemia and glucose 
intolerance in Brown Norway (BN) rats (Bass et al., 2013), while subchronic exposure 
increased circulating insulin in aged rats with a 1 day per week exposure protocol (Gordon et 
al., 2013), suggesting that like PM, ozone can induce glucose metabolic effects. A recent 
study has demonstrated that a single 16 hour ozone exposure in rats increased oxidative stress 
biomarkers and reduced insulin sensitivity in the muscle (Vella et al., 2015). However, the 
mechanisms by which an acute ozone exposure may induce systemic metabolic effects and 
over a longer period of time lead to insulin resistance are not clearly understood. 
6.2 Proposed mechanisms of pollutant-induced metabolic dysfunction and insulin resistance 
 A number of mechanisms have been proposed on how air pollutants may trigger 
metabolic dysfunction. Based on their physicochemical properties, inhaled pollutants might 
induce systemic effects by: (1) translocation of pollutant components from the airway to the 
periphery, (2) increases in circulating secondary oxidative byproducts and pro-inflammatory 
mediators and/or (3) effects on the CNS that regulate peripheral organ functions 
(Rajagopalan and Brook, 2012). It is postulated that these mechanisms can work 
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independently or synergistically with each other and target peripheral organs in a tissue-
specific manner to perturb biochemical processes. 
 Ozone, an oxidizing agent, once inhaled immediately reacts with airway lining 
components, such as proteins and lipids, and is not likely to translocate systemically. Thus, 
ozone-mediated peripheral effects are likely to be caused by other proposed mechanisms. 
While PM exposure studies have implicated chronic systemic inflammation and oxidative 
stress in the mechanisms for metabolic dysfunction and the onset of insulin resistance, our 
data show no increases in circulating cytokines acutely or after subchronic ozone exposure, 
although acute phase proteins are increased (Bass et al., 2013; Gordon et al., 2013; Miller et 
al., 2015). Some PM exposure studies have shown increases in circulating pro-inflammatory 
mediators (Nurkiewicz et al., 2004;  Finnerty et al., 2007;  Mutlu et al., 2007;  Niwa et al., 
2008), but other inhalation studies present no increases (Campen et al., 2006;  Kooter et al., 
2006;  Montero et al., 2006;  Gottipolu et al., 2009). Thus, systemic inflammation as an 
initiating and causal factor for the inhaled pollutant-induced metabolic effects is not 
consistently supported by the published studies, especially those involving ozone. 
6.3 The potential involvement of the CNS and stress-response pathway 
 It has been shown that ozone can induce alterations in pulmonary and cardiovascular 
physiology through the autonomic nervous system, which includes sympathetic and 
parasympathetic arms. We have previously shown that acute ozone exposure causes 
hypothermia and bradycardia within 1hr, suggesting the involvement of the CNS (Gordon et 
al., 2014). Ozone is thought to initiate changes in the autonomic nervous system through the 
activation of the transient receptor potential cation channel, member A1 (TRPA1) present on 
pulmonary C-fibers that terminate in the CNS (Taylor-Clark and Undem, 2010). Ozone has 
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been shown to activate the nucleus tractus solitarius (NTS) in the brain stem and different 
hypothalamic stress-responsive regions, such as the paraventricular nucleus (PVN) and the 
locus coeruleus (LC) (Gackiere et al., 2011) that are linked to the autonomic nervous system 
and the hypothalamus pituitary adrenal (HPA) axis (Tsigos and Chrousos, 2002;  Smith, 
2006). These hypothalamic regions stimulated by ozone exposure might regulate adaptive 
stress responses, such as the regulation of thermogenesis, immune response, and peripheral 
tissue-specific metabolic alterations, and suggest a potential link between the nervous system 
and ozone-induced systemic effects. 
 Generally, when presented with a physical injury or psychological threat, alarm 
signals in the body are sent to hypothalamic stress-responsive regions that activate the 
integrated responses of the sympathetic nervous system (SNS) and HPA axis to release 
neuroendocrine hormones that initiate temporally precise peripheral metabolic and immune 
changes to counter the threat and restore homeostasis (McEwen, 2007).  This classical stress 
response involves tissue specific changes in processes to mobilize and provide energy 
substrates to affected tissues (McEwen, 2007). The stress hormones, catecholamines 
(norepinephrine or noradrenaline and epinephrine or adrenaline) and glucocorticoids 
(corticosterone) regulate biochemical processes involving glucose, fat and protein 
metabolism through their action on stress hormone receptors (adrenergic for catecholamines 
and glucocorticoid for corticosterone), which show tissue-specific distribution in peripheral 
organs and centrally. This classical neuronally-mediated hormonal stress response and its 
implications for chronic diseases has been well studied for decades and still remains an area 
of interest.  Persistent increases in these stress hormones and associated metabolic changes 
have been implicated in chronic metabolic dysfunction and insulin resistance through a 
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number of mechanisms involving the role of systemic inflammation and lipids.  However, 
this stress response has not been linked to air pollution-induced systemic effects and 
metabolic dysfunction. 
 We have shown that circulating catecholamines increased after ozone exposure in rats 
(Bass et al., 2013). Other investigators has also noted increases in circulating corticosterone 
and adrenocorticotropic hormone (ACTH) after ozone exposure (Thomson et al., 2013). The 
adrenal gland is one of the main sources of stress hormones, where catecholamines are 
released from the adrenal medulla and glucocorticoids are released from the adrenal cortex, 
and play a central role in stress-mediated changes in metabolic homeostasis. The adrenal 
cortex can be activated through the HPA axis, which involves the activation of the 
hypothalamus and the secretion of corticotrophin releasing hormone (CRH). CRH activates 
the anterior pituitary gland to release ACTH that directly stimulates the adrenal cortex to 
secrete glucocorticoids (cortisol in humans and corticosterone in rats) and other hormones 
(Smith, 2006). In contrast, the adrenal medulla can be directly stimulated by sympathetic 
efferent nerves, which results in the secretion of epinephrine and/or norepinephrine (Smith, 
2006). Therefore, based on the evidence of acute ozone-induced increases in stress hormones 
and hyperglycemia, it can be postulated that the initiating event for metabolic alterations 
might involve the activation of a neurohormonal stress response, leading to effects in 
multiple organs. No prior air pollution studies have examined the contribution of the 
neurohormonal stress response and subsequent release of epinephrine and corticosterone in 
mediating air pollution-induced systemic effects. In addition, no prior air pollution studies 
have reported in detail the types of systemic metabolic alterations or linked these effects to a 
neuronal stress response. 
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6.4 Project goals 
 The goals of this dissertation were to address the critical missing link between ozone 
exposure and peripheral metabolic alterations involving neuronal stress response 
mechanisms, and the potential of these effects to cause insulin resistance after subchronic 
exposure.  As depicted in the second chapter, we wanted to characterize the nature of extra-
pulmonary metabolic effects of acute ozone exposure in rats using a metabolomics approach 
and examine the levels of circulating cytokines and hormones. We also wanted to examine 
the peripheral metabolic changes, especially in the liver as it is the major metabolic organ, 
using global gene expression assessment to understand the mechanisms of ozone-induced 
systemic alterations. The temporal assessment of ozone-induced systemic metabolic 
derangement was important in understanding the role of the SNS and HPA axis. To assess 
the relevancy of our findings to humans, as depicted in the third chapter, we examined the 
profile of circulating metabolites using a metabolomics approach applied to serum samples 
from a clinical study involving human exposure to air or ozone. This was done to establish 
coherence between humans and rats with respect to ozone-induced systemic alterations. 
Moreover, we also presumed that using a metabolomic approach would lead to the 
identification of novel non-protein biomarkers of acute ozone exposure and inform the 
regulatory decision for ozone.  In the fourth chapter, we evaluated if adrenal-derived stress 
hormones were essential in ozone-induced systemic and pulmonary effects using the surgical 
interventions of adrenal demedullation and total bilateral adrenalectomy followed by the 
exposure of rats to ozone. We also wanted to determine if the activation of TRPA1 and 
TRPV1 receptors were essential in mediating systemic and pulmonary effects of ozone (as 
discussed in this chapter). Lastly, as described in the fifth chapter, we determined if acute 
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ozone-induced metabolic and stress effects would persist during subchronic episodic ozone 
exposure, and lead to insulin resistance in the liver and muscle. Below, I have summarized 
the major findings from the dissertation project, stated limitations and made some 
suggestions for future research.  
6.5 Acute ozone exposure induces peripheral metabolic alterations in rats 
 We show that acute ozone exposure produces fasting hyperglycemia, glucose 
intolerance and increases hepatic gluconeogenesis in Wistar Kyoto (WKY) rats in a 
concentration and time-dependent manner (Chapter 2) as observed previously in BN rats 
(Bass et al., 2013). We further sought to evaluate the mechanism of glucose intolerance to get 
a better understanding of the contributing mechanisms. Acute ozone exposure increased 
gluconeogenesis as evident by the pyruvate tolerance test. However, acute ozone exposure 
did not induce peripheral insulin resistance as determined by the insulin tolerance test. 
Instead, ozone attenuated glucose-mediated pancreatic β-cell insulin secretion (Chapter 5). 
These results indicate that ozone-induced hyperglycemia and glucose intolerance might not 
originate from peripheral tissue insulin insensitivity but might occur as a result of insulin 
insufficiency. Altogether, our ozone studies implicate the pancreas as a potential tissue target 
in ozone-induced metabolic alterations. More research evaluating the mechanism of the 
pancreatic alterations after ozone exposure would provide insight into how ozone may alter 
β-cell insulin secretion.  
  To further characterize ozone-induced global metabolic effects, we employed a 
serum metabolomics approach since this emerging technology allows for unbiased, 
comprehensive identification and relative quantification of various biochemical metabolites. 
This approach allowed us to identify systemic changes that have not been previously reported 
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in any air pollution study. Serum metabolomics analysis in rats revealed significant ozone-
induced changes in hundreds of metabolites in the circulation. These significantly-changed 
metabolites consisted of numerous long- and medium-chain FFA, carnitines, bile acids, 
cholesterols, glucose, and BCAA, and revealed alterations in metabolic processes in the liver, 
muscle and adipose tissues. We noted that the pattern of metabolite changes after ozone 
exposure reflected those that are induced in a classical flight-or-fight hormonal stress 
response, revealing adipose lipolysis, muscle protein catabolism and a number of changes in 
liver reflecting increased gluconeogenesis and major changes in lipid metabolism. These 
metabolic effects were further associated with increases in circulating catecholamines and 
glucocorticoids as observed in our prior study (Bass et al., 2013), which collectively supports 
the hypothesis that ozone induces systemic metabolic alterations through the activation of a 
classical neurohormonal stress response.  
It is important to note that this stress response is well established with other physical 
and psychological stressors (injury, surgery, infection, fear etc.) (Schneiderman et al., 2005). 
However, these systemic changes and activation of stress mechanisms have not been studied 
with air pollution. Our data demonstrate that ozone, a prototypic air pollutant, can elicit a 
stress response and produce a myriad of extra-pulmonary effects. These data also allow us to 
postulate that a variety of environmental and social stressors might involve one common 
mechanism that can be linked to chronic disease conditions. Future studies could include the 
evaluation of the metabolomic profile of the liver, adipose and muscle tissue directly to 
provide additional insight in to the mechanism and identification of biochemical pathways 
affected by ozone exposure. Since these metabolic effects may persist during longer 
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exposure, metabolic profiling could also be used to examine the temporality and long-term 
effects of ozone exposure.   
6.6 Acute ozone exposure increases circulating stress hormones and induces metabolic 
alterations in humans 
 To determine whether humans would present a similar pattern of metabolomic 
alterations and stress response as observed in rats when exposed to ozone, a metabolomics 
approach was used to assess human serum samples obtained from a clinical study involving 
air or ozone exposure. We hypothesized that since stress response-mediated mechanisms and 
metabolic processes are conserved across species, ozone exposure in humans would produce 
comparable metabolic dysfunction as in rats. In this study, serum samples from ozone-
exposed humans showed a similar pattern of change in long-chain FFA and glycerols, 
indicating adipose lipolysis as observed in rats. This study also depicted increases in 
circulating cortisol, supporting the role of a neuronally-mediated stress response in systemic 
metabolic effects of ozone.  Since humans were performing intermittent exercise during air 
or ozone exposure, more wide-spread changes in lipid metabolites were noted, such as 
increases in lysolipids a variety of phospholipid metabolites and -oxidation byproducts, 
which were not evident in rats exposed during inactivity. Exercise alone is known to increase 
metabolic responses and thus, might have influenced some of the effects of ozone in humans. 
However because our study did not include non-exercising subjects, it is not possible to 
accurately separate ozone and exercise effects. A future study where one evaluates the 
differences between resting-state versus exercise-state in ozone-induced metabolic effects 
would further enhance our understanding of whether air pollutants might have more 
detrimental effects from ozone where humans are generally exposed outdoors during high 
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level activity. Future analysis to determine coherence between animals and humans’ 
metabolic effects should repeat the current study with a higher number of subjects so that 
data can be stratified based on different characteristics, such as diet and exercise, and 
statistical power can be increased. The future studies may also include clinical assessments 
such as glucose tolerance testing for comparisons to the acute ozone-induced glucose 
intolerance observed in rodents. Additionally, metabolic profiling can be used to profile 
effects of ozone exposure with other contributing factors that may predispose humans to 
additional metabolic dysfunction (diet, pre-existing disease, BMI, etc.), however, we did not 
see any correlation with BMI and the effects induced by ozone on lipid metabolites (Chapter 
3).  
6.7 Adrenal-derived stress hormones are required for acute ozone-induced metabolic effects  
 To determine the contribution of adrenal-derived glucocorticoids and catecholamines 
in ozone-induced metabolic effects, we performed a comparative assessment of ozone 
metabolic and pulmonary effects in rats that underwent total adrenalectomy (to determine 
overall influence of sympathetic and HPA-mediated hormone release) or adrenal 
demedullation (to determine the influence of direct sympathetic stimulation on adrenal to 
release epinephrine). Moreover, the adrenalectomy and demedullation allowed for a more 
direct approach to control for circulating stress hormones levels in contrast to 
pharmacological interventions, which can have non-specific off-target effects. These surgical 
interventions have been utilized in many studies to evaluate HPA integrity and the 
assessment stress hormones effects (Kaminski and Watts, 2012; Weidenfeld and Feldman, 
2000; Helmreich et al., 1996). However, this approach is sparingly used in air pollution 
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studies, and no studies have implicated HPA axis activation in air pollutant-induced systemic 
effects.   
 Overall, we demonstrated that the surgical removal of adrenal glands eliminated both 
corticosterone and epinephrine, while adrenal demedullation led to nearly complete 
elimination of epinephrine with a small reduction in corticosterone. This allowed us to 
examine the role of these hormones in ozone-induced systemic and pulmonary effects. 
Ozone-induced hyperglycemia, glucose intolerance, and increases in circulating adrenaline, 
FFA and BCAA were completely abolished by adrenalectomy and partially diminished by 
adrenal demedullation. Thus, it was clear that ozone-induced metabolic effects were 
produced from circulating catecholamines and corticosterone. Overexpression of the 
glucocorticoid receptors or increased levels of glucocorticoids in vivo has been shown to 
induce glucose intolerance and decrease insulin secretion, which results in insulinopenia, as 
observed in Cushing’s disease patients (Delaunay et al., 1997;  Pivonello et al., 2010;  Kuo et 
al., 2015). To further support if these stress hormones are involved in ozone-induced 
metabolic effects, a future experimental design should incorporate re-supplementation of the 
stress hormones at various concentrations in adrenalectomized rats to determine if the ozone-
induced effects would resurge. 
6.8 Adrenal-derived stress hormones are required for acute ozone-induced pulmonary injury 
and inflammation 
 The mechanism of ozone-induced lung injury and inflammation has been widely 
studied for decades. Upon inhalation, it has been demonstrated that the oxidant ozone can 
injure lung epithelial cells and mediate subsequent recruitment of inflammatory cells at the 
site of injury. It is believed that ozone-induced lung injury is a local event. No prior studies 
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have implicated the role of circulating stress hormones in mediating lung effects of ozone in 
vivo or in vitro. We were intrigued with our findings that ozone-induced lung protein 
leakage, lung cell injury and neutrophilic inflammation were partially inhibited in rats 
lacking adrenal medulla and nearly completely abolished in rats lacking whole adrenal 
glands. These results suggest that adrenal-derived hormones are not only involved in ozone-
induced peripheral metabolic effects but also the inflammation and vascular leakage in the 
lung.   
 Our data show that in adrenalectomized rats, ozone-induced protein leakage was 
abolished. One potential mechanism of vascular leakage might relate to ozone-induced 
bradycardia and generalized cardiac depression (Wagner et al., 2015), which can increase 
hydrostatic pressure in respiratory capillary walls and increase the vascular leakage (Šedý et 
al., 2015). Another study showed that sympathetically-induced increased systemic blood 
pressure can also contribute to pulmonary vasculature pressure and injury (Krishnamoorthy 
et al, 2012), however, ozone exposure is known to decrease systolic blood pressure 
(Uchiyama et al., 1986; Wagner et al., 2014). β-adrenergic stimulation by epinephrine can 
increase right ventricular output and generalized vasodilation, which can increase the blood 
volume in pulmonary capillary bed and increase capillary pressure leading to edema (Rassler, 
2012). As indicated above, ozone exposure leads to decreased blood pressure and systemic 
vasodilation. The ozone-induced increase in epinephrine, but not norepinephrine, together 
with decreased blood pressure-related systemic vasodilation, supports the role of -
adrenergic mechanisms in inducing lung protein leakage after ozone exposure and the 
decrease of edema when epinephrine is removed from circulation via adrenelectomy or 
demedullation.   
 212 
 
 Ozone-induced lung neutrophilia is associated with a decrease in circulating white 
blood cells (lymphocytes) as observed in SHAM rats exposed to ozone. Supplementing 
cortisol-mimic to patients with adrenal insufficiency leads to depletion of lymphocytes in the 
circulation (Geigen et al., 2015). Generally, stress hormones, such as glucocorticoids, are 
known to produce immuno-suppression and reduce inflammatory responses in chronic 
diseases (Edwards, 2012), however, in more acute inflammatory conditions, glucocorticoids 
can initiate leukocyte trafficking and extravasation at the site of injury in an immune cell-
specific manner (Dhabhar, 2009; Dhabhar et al., 2012). For instance, circulating lymphocytes 
can decrease, as observed following ozone exposure, and neutrophils can increase in blood, 
which was not separately quantified in our study. Catecholamines initiate recruitment of 
neutrophils to the airways though initiation of IL-8 production from monocytes (Linden, 
1996;  Kavelaars et al., 1997). These findings support our results where removal of the 
adrenal medulla and the total adrenalectomy diminished ozone-induced increases in 
neutrophils in the lung while not affecting circulating lymphocytes. Instead, the removal of 
stress hormones appeared to increase eosinophils, which might suggest either the differential 
influence of catecholamines versus corticosterone in an immune cell-specific manner or the 
time-related differences in the type of cells extravasated. Identification of different types of 
immune cells and their maturation stages will need to be evaluated in a temporal manner 
using flow cytometry to understand the precise contribution of stress hormones to the 
homeostatic innate immune response after ozone exposure.  These studies should evaluate 
the role of specific stress hormones in selective recruitment of neutrophils, monocytes, and 
eosinophils to the lung from their marginated pool within bone marrow, spleen, circulation or 
other depots within the lung (i.e. lung-associated lymph nodes). 
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6.9 The role of pulmonary afferent C-fibers in mediating ozone induced activation of 
neuronal stress response through TRPA1 and TRPV1 
 It was hypothesized that ozone activation of brain stress responsive regions through 
TRPA1 and transient receptor potential-member V1 (TRPV1) receptors (Lee and Pisarri, 
2001), co-localized on pulmonary C-fibers, were involved in peripheral metabolic effects. 
These TRP receptors on C-fibers are activated in the presence of internal and/or external 
chemical and thermal stimuli and send neural impulses to the CNS regions, including the 
NTS, which regulate respiratory mechanics and its synchronization/coordination with 
cardiovascular function (Lee and Pisarri, 2001). The activation of TRPA1 on bronchial vagal 
C-fibers by ozone has been implicated in bradycardia and arrhythmias in rats (Hazari et al., 
2011), and is likely to be involved in ozone-induced metabolic effects through stress 
hormones.  To evaluate the role of TRP receptors in ozone-induced systemic and pulmonary 
effects, we pretreated rats with selective pharmacological antagonists of TRPA1 (HC030031) 
and TRPV1 (AMG 9810), separately or in combination, and then assessed ozone-induced 
metabolic impairment. The results from this study showed that antagonism of the TRPA1 and 
TRPV1 separately or in combination did not show significant protection in ozone-induced 
metabolic or pulmonary effects (Fig. 6.1.). Although the contribution of TRPA1 has been 
reported in the literature using same antagonists and similar treatment protocols, our data 
raises a concern as to the availability of the sufficient quantity of antagonists at the airway 
surface lining after intraperitoneal treatment, and potential contribution of TRPs in mediating 
neuronal activation. We did not determine the circulating levels of these pharmacological 
antagonists, therefore, it will be important to evaluate the bioavailability, efficacy, and the 
pharmacokinetics of the TRPA1 and TRPV1 receptor antagonists used in our study. Another 
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limitation is that we did not assess receptor activation to make sure the drug effectively 
inhibited the respective receptors. We presumed that the protocols reported to effectively 
antagonize TRP receptors would be adequate to modulate their effect in our experimental 
setting. It is also possible that other potential mechanisms might be involved for neuronally-
mediated stress response activation by ozone. The roles of other neurons with rapidly 
adapting receptors and slowly adapting receptors that terminate in the CNS will also need to 
be clarified since high specificity exists in which neurons are activated by distinct stimuli 
(Taylor-Clark and Undem, 2010).  
6.10 Long-term episodic subchronic ozone exposure effects on stress and metabolic 
outcomes 
 To determine if persistent stress and metabolic effects induced by long-term ozone 
exposure are linked to peripheral insulin resistance, we conducted a weekly episodic 
subchronic ozone exposure study in rats (Chapter 5). In this study, we showed that 
subchronic ozone exposure is associated with persistent pulmonary injury and inflammation, 
fasting hyperglycemia, glucose intolerance, and elevated circulating adrenaline and 
cholesterol levels when determined at the end of the last exposure, however, these responses 
are of lesser magnitude than the effects noted after 1 or 2 days of  ozone exposure. Moreover, 
the increases in FFA and BCAA that were noted after an acute ozone exposure were not 
apparent following a subchronic exposure. More importantly, if rats were allowed a one 
week recovery, these effects were largely reversed. Our data further show that subchronic 
ozone exposure did not significantly increase gluconeogenesis as determined after 13 weeks, 
but it abolished the response of -cells to increase insulin secretion in response to 
hyperglycemia. Catecholamines, such as epinephrine, decrease glucose-mediated uptake and 
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pancreatic insulin secretion through the α-adrenergic α (2A) and α (2C)-adrenoreceptors 
(Iversen, 1973;  Halter et al., 1984; Ullrich and Wollheim, 1984; Philipson, 2002; Peterhoff 
et al., 2003). Future analysis of the direct implication of ozone-mediated stress response and 
the examination of α-adrenergic and/or glucocorticoid receptors on β-cell insulin secretion 
using pharmacological means will provide valuable mechanistic information on how air 
pollutants may impair the function of the pancreatic -cells.  Our data indicating ozone-
induced impairment in insulin secretion are consistent with the finding that ozone exposure 
decreases circulating insulin after subchronic ozone exposure. More importantly, no 
peripheral insulin resistance was noted after subchronic ozone exposure, as determined by an 
insulin tolerance test and liver and muscle pAKT levels. Thus, our findings in young-adult 
rats provide insights into epidemiological studies that show a positive association between 
ozone exposures and T1D in children and pregnant women (Hathout et al., 2002; Hathout et 
al., 2006; Beyerlein et al., 2015). It is possible that ozone-induced β-cell dysfunction may 
secondarily contribute to insulin resistance and a TIID phenotype in the long term due to 
non-regulation of glucose, lipid, and protein metabolites that have been implicated in 
decreased insulin sensitivity. 
 Repeated daily ozone exposure has been shown in many studies to induce an 
adaptation response, characterized by the reduction in ozone-induced lung injury and 
inflammation. Since, our experiment included 3 days per week exposure, we expected that 
the effects seen after 3 days would be smaller magnitude than the effects seen during the 1st 
or 2nd day. Therefore, we performed IPGTT and IPPTT on the 1st and 3rd day to determine if 
the effects seen on the 1st day were diminished on the 3rd day. We noted that on the 3rd day, 
ozone-induced glucose intolerance and gluconeogenesis response was markedly reduced 
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relative to the 1st day response, suggesting an induction of adaptation upon continuous 
exposure. This adaptation response is lost if animals were allowed 4-5 days recovery prior to 
the next ozone hit. The mechanisms of ozone adaptation are unknown.  Since repeated 
stimulated stress responses have been shown to decrease c-fos staining in the medial 
parvocellular region of the PVN and glucocorticoid receptors in hypothalamic regions and in 
the periphery (Herman, 2013), we postulate that ozone adaptation is centrally regulated and 
might involve the HPA-axis. We believe that subchronic ozone-induced stress mechanisms 
are likely involved in adaptation to repeated exposure in a given week and episodic 
exposures over 13 weeks. To address the role of neuronal mechanisms in ozone-induced 
adaptation, more studies are needed with varied temporal exposure scenarios.  
 
6.11 Summary/conclusions and implications on human health 
 Neurohormonal stress response has been well characterized for decades but has not 
been linked to air pollution effects. We show that the activation of neurohormonal 
stress response pathway is involved in ozone-induced systemic metabolic and 
pulmonary effects in rats.  
 We further show that this hormonal stress response is also induced in humans after 
ozone exposure, and that rat and human metabolic responses to ozone are coherent. 
Our rat and human metabolomic data allowed us to identify novel non-protein 
biomarkers of acute ozone effects.  
 Through the use of metabolomics, we characterized “the circulating molecular 
shrapnel” referred for unknown biochemical identity by others in air pollution 
studies. This included over 100 metabolites and other biochemicals (neurohormones, 
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lipids, fatty acids, cholesterols, glucose metabolites, and acute phase proteins) – most 
are known to have varied cellular effects (Fig. 6.2).  
 Through the use of surgical intervention involving adrenalectomy that has not been 
used in prior air pollution studies, we demonstrated that not only systemic metabolic 
impairment but also pulmonary injury/inflammation are mediated through 
circulating stress hormones such as epinephrine and corticosterone after ozone 
exposure (Fig. 6.2). 
 Chronic perturbation in these homeostatic pathways can lead to disturbed metabolic 
status, immune dysfunction, disrupted neuronal regulation, and failure to repair the 
injury caused by stressors such as air pollutants. We demonstrate that ozone-induced 
pulmonary and metabolic affects still persist during subchronic exposure but are 
reversible upon termination of exposure. However, it remains to be determined how 
pre-existing conditions or longer duration may alter adaptation and reversibility of 
ozone-induced metabolic and stress effects. 
 Through the subchronic ozone inhalation study, we demonstrated that ozone, 
contrary to what was hypothesized, does not induce peripheral insulin resistance, but 
rather severely impairs the ability of the -cells to secrete insulin in response to high 
circulating glucose, and results in lower circulating insulin upon subchronic 
exposure.  
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 We believe that this neurohormonal stress response pathway induced after ozone 
exposure can also be induced by other environmental insults and thus, can be used as 
a common mechanistic pathway to stratify risk from many environmental chemicals. 
 This research emphasizes on the need to investigate the potential contribution of air 
pollution to systemic metabolic diseases, such as neuronal, developmental, liver, and 
muscular diseases, in people who have impaired stress mechanisms. 
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Figure 6.1  
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Figure 6.1 TRPA1 and TRPV1 antagonism does not inhibit acute ozone-induced 
pulmonary injury nor glucose intolerance. 
Rats were intraperitoneally injected with either DMSO (control), AMG9810 (TRPV1 
antagonist), or HC030031 (TRPA1 antagonist; 50 mg/kg) four times every 10-12 hours (the 
night before exposure, immediately before the 1st exposure, the night after the 1st exposure 
and the morning before the 2nd exposure). Rats were exposed to air or 1.00 ppm ozone for 
4h/day for two consecutive days.  Immediately after day 1, GTT was performed.  Rats were 
necropsied immediately following the 2nd day exposure and bronchoalveolar lavage fluid 
(BALF) was analyzed for lung injury markers: (A) protein and (B) albumin, as indicators of 
vascular protein leakage. (C) GTT and (D) AUC for GTT in rats exposed to air or ozone for 
4 hr, 1 day. The values in the bar graphs are displayed as mean ± SEM of n=6/exposure 
group. The GTT curve shows mean value ± SEM of n=6/group with repeated measures over 
two hours. The 0 min time point shows fasting glucose levels in each group. * Indicates 
significant difference from respective air-exposed groups at a given time (*=p<.05) 
 
 221 
 
Figure 6.2
 
 
Figure 6.2 Proposed mechanism(s) of overall ozone-induced stress mediated pulmonary, 
cardiovascular and metabolic responses. In our studies, we show that ozone induces a 
classical stress response reflected by changes observed in multiple organs, including the lung, 
liver, adipose, and muscle, that overtime may be linked to chronic diseases. Upon inhalation, 
ozone may elicit these extrapulmonary responses through activation of the CNS and 
subsequent activation of the HPA axis, and/or SNS, resulting in changes in the periphery 
through neuroendocrine hormones. NTS, nucleus tractus solarius; PVN, paraventricular 
nucleus; HPA, hypothalamus pituitary adrenal axis; CRH, corticotropin-releasing hormone; 
ACTH, adrenalcorticotrophic hormone; TRPA1, Transient receptor potential-member A1; 
TRPV1, Transient receptor potential-member V1; RAR, rapidly adapting receptor 
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APPENDIX A.  
CHAPTER TWO 
Figure 1A. 
 
 
 
 
 229 
 
Figure 1B. 
 
 
Figure 1C. 
 
Figure 1: Heatmaps of liver gene expression for cytokine network in rats exposed to ozone 
(A: immediately after 1-day 6-hr air or ozone, 0-hr time point; B. immediately after 2-day 6-
hr air or ozone, 2-day, 0-hr) and C. 18-hr after 2-day 6-hr air or ozone; 2-day, 18-hr) 
exposure. Functional gene lists were generated by NetAffx queries at the Affymetrix website 
(www.affymetrix.com) and identified from differentially expressed genes (DEGs) list for 
each time point (air vs O3) based on the query term, “cytokines”. Genes were then median 
centered with average linkage, hierarchically clustered using Cluster 3.0 and displayed 
through Java Treeview.  Heat map of DEGs with significant O3 effect were identified 
separately at each time point. Red indicates genes that have high expression values across 
both groups, green indicates genes that have low expression values across both groups, and 
black indicates median expression.  
  
 230 
 
Figure 2A. 
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Figure 2B. 
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Figure 2C. 
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Figure 2D. 
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Figure 2E. 
 
Figure 2F.
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Figure 2: Heatmaps of liver gene expression showing differentially expressed genes (air 
versus O3) for apoptosis network in rats exposed to O3 (A-D, exposed for 6hr/day; 
immediately after 1-day; E, immediately after 2-day, F, 18-hr after 2-day time point). 
Functional gene lists were generated by NetAffx queries at the Affymetrix website 
(www.affymetrix.com) and identified from differentially expressed genes (DEGs) list based 
on the query term, “apoptosis”. Genes were then median centered with average linkage, 
hierarchically clustered using Cluster 3.0 and displayed through Java Treeview.  Heat map of 
DEGs with significant O3 effect were identified separately at each time point. Red indicates 
genes that have high expression values across both groups, green indicates genes that have 
low expression values across both groups, and black indicates median expression.  
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Figure 3. 
 
 
Figure 3: Heatmap of liver gene expression showing differentially expressed genes (air 
versus O3) for Steroid, insulin and fatty acid receptor signaling network in rats exposed to O3 
for 6hr/day for 1-day (immediately after exposure). Functional gene lists were generated by 
NetAffx queries at the Affymetrix website (www.affymetrix.com) and identified from 
differentially expressed genes (DEGs) list based on the query term, “steroid, insulin and fatty 
acid signaling”. Genes were then median centered with average linkage, the normalized 
expression values for those probesets present on both lists were converted to z values and 
hierarchically clustered using Cluster 3.0 with average linkage and displayed with Treeview. 
Red indicates genes that have high expression values across both groups, green indicates 
genes that have low expression values across both groups, and black indicates median 
expression.                  
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Figure 4. Ingenuity pathway analysis showing ozone exposure-induced changes in liver 
steroid receptor (A), insulin receptor (B) and fatty acid signaling (C). 
Figure 4A 
 
  
 238 
 
Figure 4B 
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Figure 4C 
 
Three functional probeset lists based on queries of “steroid receptor”, “insulin receptor” or 
“fatty acid” were obtained from NetAffx.  Each of these lists was compared to the list of 
differentially expressed genes (DEGs) for the one day zero hour time point to identify DEGs 
in each of the three functional categories.  Each functional list was processed separately by 
Ingenuity Pathway Analysis (IPA) to produce a direct relationship graph.  The graph 
constructed from the Ingenuity knowledgebase depicts some of the biological relationships 
among the probesets on the list.  The shape of a gene-labeled object indicates its molecular 
function and its color indicates whether it is upregulated (red) or downregulated (green).  The 
features of the connecting lines convey the nature of the molecular interaction.  For a detailed 
legend of these IPA graphs see the ingenuity.com website. 
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Table 1: Effect of acute ozone exposure on the expression of probe sets belonging to 
different biological processes in the liver. 
 
 
 
 
 
 
 
 
 
 
Significantly different probes for specific biological processes were identified from a master 
differentially expressed genes list (DEGs) for air versus O3 exposure which included genes 
for all three time points (Immediately after 1-day 6-hr, immediately after 2-day, 6-hr and 18 
hours after 2-day, 6-hr).   
 
 
 
 
 
 
 
Process 
Number of 
probes on array 
Number of 
DEGS from 
Master List 
Per Cent Master 
List DEGs on 
Functional List 
Amino acid 
biosynthesis 
4650 507 11 
Apoptosis 2345 259 11 
Diabetes 743 117 16 
Gluconeogenesis 80 21 26 
Glycolysis 114 20 18 
Mitochondria 671 111 17 
Steroid Metabolism 416 77 19 
Tricarboxylic  29 10 34 
Unfolded protein 154 26 17 
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APPENDIX B.  
CHAPTER THREE 
Methods  
Details of the human clinical study where serum samples were obtained 
Study population 
Serum samples were obtained from a prior clinical study in which subjects were recruited 
under an EPA contract with Westat Corporation (Rockville, MD), Clinical Trial 
NCT01492517 (E1). A total of 24 volunteers were involved and completed the study. The 
median age was 27.9 years; there were 20 male and 4 female participants (22 whites, 2 
Hispanics).  Participants were free of cardiopulmonary diseases and allergies as determined by 
a detailed medical history questionnaire and physical examination. All subjects were 
nonsmokers and had normal spirometry. Subjects were informed of the procedures and 
potential risks and signed an informed consent. The protocol and consent forms were approved 
by the University of North Carolina School of Medicine Committee on the Protection of the 
Rights of Human Subjects and the US Environmental Protection Agency’s Institutional 
Review Board. The data for cardiovascular, systemic and pulmonary effects have been 
published by Devlin and collaborators (E1).  
The original study design and ozone exposures (E1): Selected serum samples for this 
exploratory assessment were obtained from a previously conducted clinical study (Clinical 
Trial NCT01492517). This study was conducted in a randomized crossover design where two 
clinical visits of each individual were separated by at least two weeks (E1). During each visit, 
the subjects arrived in the morning. In each case, the participant was exposed to 0.3 ppm ozone 
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or clean air in a blinded manner for 2hr. During the 2hr exposure, each subject alternated 
between 15 minutes of rest and 15 minutes of exercise on a cycle ergometer. Most subjects 
underwent moderate to intense intermittent exercise during the 2hr period. Exercise intensity 
(i.e. cycle ergometer workload) was adjusted so that subjects breathed at a ventilatory rate, 
normalized for body surface area, of 25 L/meter2/minute. In these subjects, this approximated 
to 50 L/minute (i.e. a VO2 of approximately 1.0 L/min). Exposures were performed as 
previously described (E1-E2). All exposures were conducted at the U.S. EPA Human Studies 
Facility on the campus of the University of North Carolina, Chapel Hill. The exposure 
chambers were maintained at 40% relative humidity for all exposures. Ozone was generated 
by a silent electric discharge method (model 502; Meckenheim, Bonn, Germany) and did not 
deviate beyond 0.001 ppm of the target concentration (0.3 ppm). During exposure, fine 
particulate matter (by TEOM, DataRa, and filter weight), NO2, NO, total hydrocarbon, SO2, 
and CO were measured for the air and ozone chambers.  All measurements were either zero or 
negligible except for total hydrocarbon, which was between 1 and 3 ppm (all of which is 
methane). All participants completed the entire study and no adverse events were reported. 
Ozone concentrations were maintained at 0.3 ppm during ozone exposure. All exposures began 
at the same time in the morning (~9am) to avoid having circadian fluctuations as a confounder. 
Prior to the start of exposure, during exposure and post exposure, blood pressure, heart rate 
and EKG were recorded (E1). Each individual’s systolic as well as diastolic blood pressure 
and heart rate were recorded and the data were available to us for correlation assessment in 
this study. 
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Sample collection and analysis 
Prior to the start of exposure, immediately upon completion of designated exposure (within 
1hr), and during the next day’s morning follow up visit, venous blood was drawn in serum 
separator vaccutainers.  Serum samples were aliquotted and stored at -80⁰C for further analysis. 
One aliquot of serum collected immediately following air or ozone exposure (two separate 
visits) for each individual was used for this exploratory metabolomic analysis. These serum 
samples were sent to Metabolon Inc. (Durham, NC) for global metabolomic analysis, as 
described below. Serum samples were also analyzed for insulin, leptin, interleukin-6 (IL-6), 
and tumor necrosis factor (TNF)-, using human-specific antibody-based 
electrochemiluminescence assays (Meso Scale Discovery, Gaithersburg, MD) via 
manufacturer’s instructions. In addition, during this clinical study, the clinical chemistry 
assessment along with complete blood cell counts were completed for blood samples collected 
prior to and post air or ozone exposure, and during next day follow up visit. While the data for 
total cholesterol and blood pressure are published as group means (E1), the individual data for 
all clinical measurements were available for this manuscript for supporting the metabolomic 
exploratory assessment performed in serum samples collected post air or ozone exposure. Post 
exposure glucose assessment was used to derive HOMA-IR with insulin data collected from 
the serum aliquot used for metabolomic assessment by Metabolon Inc (Durham, NC). 
 244 
 
Clinical and biomarker data assessment 
Clinical chemistry assessment completed for serum samples collected prior to, immediately 
post air or ozone exposure, and during next day follow-up visit included measurement of 
glucose, triglycerides and cholesterols (LabCorp Inc, Durham, NC).  Clinical markers data 
were first normalized to pre-exposure values and analyzed for differences following air or 
ozone exposure using a paired t test with each subject serving as their own control. HOMA-IR 
was calculated from glucose data from clinical assessment and insulin data obtained post air 
or ozone exposure, and analyzed using a paired t test for assessment of difference post air and 
ozone exposure.  Pearson’s correlation coefficient (r) was used to determine the relationship 
between ozone-induced changes (fold-increases in selected serum free fatty acids and stress 
hormones; metabolomic data) as well as serum levels of metabolites (glucose, triglycerides 
and different cholesterols) measured in clinical chemistry to each subject’s BMI, gender, and 
exercise level. GraphPad Prism (GraphPad Software version 6.04, San Diego, CA) was used 
for statistical analyses.  A p-value < 0.05 was considered statistically significant. 
Metabolomic analysis  
Sample accessioning:  Following receipt, samples were inventoried and immediately stored 
at -80oC.  Each sample received was accessioned into the Metabolon LIMS system and was 
assigned by the LIMS a unique identifier that was associated with the original source identifier 
only.  This identifier was used to track all sample handling, tasks, results, etc.  The samples 
(and all derived aliquots) were tracked by the LIMS system.  All portions of any sample were 
automatically assigned their own unique identifiers by the LIMS when a new task was created; 
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the relationship of these samples was also tracked.  All samples were maintained at -80oC until 
processed. 
Sample preparation:  Samples were prepared using the automated MicroLab STAR® system 
from Hamilton Company.  A recovery standard was added prior to the first step in the 
extraction process for QC purposes.  To remove protein, dissociate small molecules bound to 
protein or trapped in the precipitated protein matrix, and to recover chemically diverse 
metabolites, proteins were precipitated with methanol under vigorous shaking for 2 min (Glen 
Mills GenoGrinder 2000) followed by centrifugation.  The resulting extract was divided into 
five fractions: one for analysis by UPLC-MS/MS with positive ion mode electrospray 
ionization, one for analysis by UPLC-MS/MS with negative ion mode electrospray ionization, 
one for LC polar platform, one for analysis by GC-MS, and one sample was reserved for 
backup. Samples were placed briefly on a TurboVap® (Zymark) to remove the organic solvent.  
For LC, the samples were stored overnight under nitrogen before preparation for analysis.  For 
GC, each sample was dried under vacuum overnight before preparation for analysis. 
QA/QC:  Several types of controls were analyzed in concert with the experimental samples: a 
pooled matrix sample generated by taking a small volume of each experimental sample (or 
alternatively, use of a pool of well-characterized human plasma) served as a technical replicate 
throughout the data set; extracted water samples served as process blanks; and a cocktail of 
QC standards that were carefully chosen not to interfere with the measurement of endogenous 
compounds were spiked into every analyzed sample, allowed instrument performance 
monitoring and aided chromatographic alignment.  Tables E1 and E2 describe these QC 
samples and standards.  Instrument variability was determined by calculating the median 
relative standard deviation (RSD) for the standards that were added to each sample prior to 
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injection into the mass spectrometers. Overall process variability was determined by 
calculating the median RSD for all endogenous metabolites (i.e., non-instrument standards) 
present in 100% of the pooled matrix samples.  Experimental samples were randomized across 
the platform run with QC samples spaced evenly among the injections as outlined in Figure 
E1. 
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Table E1:  Description of Metabolon QC Samples 
Type Description Purpose 
MTRX 
Large pool of human plasma 
maintained by Metabolon 
that has been characterized 
extensively. 
Assure that all aspects of the 
Metabolon process are operating 
within specifications. 
CMTRX 
Pool created by taking a small 
aliquot from every customer 
sample. 
Assess the effect of a non-plasma 
matrix on the Metabolon process and 
distinguish biological variability from 
process variability. 
PRCS Aliquot of ultra-pure water 
Process Blank used to assess the 
contribution to compound signals from 
the process. 
SOLV 
Aliquot of solvents used in 
extraction. 
Solvent Blank used to segregate 
contamination sources in the 
extraction. 
Table E2:  Metabolon QC Standards 
Type Description Purpose 
RS Recovery Standard 
Assess variability and verify 
performance of extraction and 
instrumentation. 
DS Derivatization Standard 
Assess variability of derivatization for 
GC-MS samples. 
IS Internal Standard 
Assess variability and performance of 
instrument. 
 
Figure E1. 
 
Client samples
1st injection Final injection
CMTRX         Process Blank
Client samples
DAY 1
DAY 2
Study samples randomized and balanced
CMTRX: Technical 
replicates created from an 
aliquot of all client study 
samples
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Figure E1.  Preparation of client-specific technical replicates.  A small aliquot of each study 
sample (colored cylinders) is pooled to create a CMTRX technical replicate sample (multi-
colored cylinder), which is then injected periodically throughout the platform run.  Variability 
among consistently detected biochemicals are used to calculate an estimate of overall process 
and platform variability. 
 
Ultrahigh performance liquid chromatography-tandem mass spectroscopy (UPLC-
MS/MS):  The LC/MS portion of the platform was based on a Waters ACQUITY ultra-
performance liquid chromatography (UPLC) and a Thermo Scientific Q-Exactive high 
resolution/accurate mass spectrometer interfaced with a heated electrospray ionization 
(HESI-II) source and Orbitrap mass analyzer operated at 35,000 mass resolution (E3).  The 
sample extract was dried then reconstituted in acidic or basic LC-compatible solvents, each 
of which contained 8 or more injection standards at fixed concentrations to ensure injection 
and chromatographic consistency.  One aliquot was analyzed using acidic positive ion 
optimized conditions and the other using basic negative ion optimized conditions in two 
independent injections using separate dedicated columns (Waters UPLC BEH C18-2.1x100 
mm, 1.7 µm).  Extracts reconstituted in acidic conditions were gradient eluted from a C18 
column using water and methanol containing 0.1% formic acid. The basic extracts were 
similarly eluted from C18 using methanol and water, however with 6.5mM Ammonium 
Bicarbonate. The third aliquot was analyzed via negative ionization following elution from a 
HILIC column (Waters UPLC BEH Amide 2.1x150 mm, 1.7 µm) using a gradient consisting 
of water and acetonitrile with 10mM Ammonium Formate. The MS analysis alternated 
between MS and data-dependent MS2 scans using dynamic exclusion, and the scan range 
was from 80-1000 m/z.  Raw data files are archived and extracted as described below. 
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Gas chromatography-mass spectroscopy (GC-MS):  The samples destined for analysis by 
GC-MS were dried under vacuum for a minimum of 18 h prior to being derivatized under 
dried nitrogen using bistrimethyl-silyltrifluoroacetamide.  Derivatized samples were 
separated on a 5% diphenyl / 95% dimethyl polysiloxane fused silica column (20 m x 0.18 
mm ID; 0.18 um film thickness) with helium as carrier gas and a temperature ramp from 60° 
to 340°C in a 17.5 min period.  Samples were analyzed on a Thermo-Finnigan Trace DSQ 
fast-scanning single-quadrupole mass spectrometer using electron impact ionization (EI) and 
operated at unit mass resolving power.  The scan range was from 50–750 m/z.  Raw data files 
are archived and extracted as described below. 
Bioinformatics:  The informatics system consisted of four major components, the 
Laboratory Information Management System (LIMS), the data extraction and peak-
identification software, data processing tools for QC and compound identification, and a 
collection of information interpretation and visualization tools for use by data analysts.  The 
hardware and software foundations for these informatics components were the LAN 
backbone, and a database server running Oracle 10.2.0.1 Enterprise Edition. 
LIMS:  The purpose of the Metabolon LIMS system was to enable fully auditable laboratory 
automation through a secure, easy to use, and highly specialized system.  The scope of the 
Metabolon LIMS system encompasses sample accessioning, sample preparation and 
instrumental analysis and reporting and advanced data analysis.  All of the subsequent 
software systems are grounded in the LIMS data structures.  It has been modified to leverage 
and interface with the in-house information extraction and data visualization systems, as well 
as third party instrumentation and data analysis software. 
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Data extraction and compound identification:  Raw data was extracted, peak-identified 
and QC processed using Metabolon’s hardware and software.  These systems are built on a 
web-service platform utilizing Microsoft’s .NET technologies, which run on high-
performance application servers and fiber-channel storage arrays in clusters to provide active 
failover and load-balancing.  Compounds were identified by comparison to library entries of 
purified standards or recurrent unknown entities.  Metabolon maintains a library based on 
authenticated standards that contains the retention time/index (RI), mass to charge ratio (m/z), 
and chromatographic data (including MS/MS spectral data) on all molecules present in the 
library.  Furthermore, biochemical identifications are based on three criteria: retention index 
within a narrow RI window of the proposed identification, accurate mass match to the library 
+/- 0.005 amu, and the MS/MS forward and reverse scores between the experimental data 
and authentic standards.  The MS/MS scores are based on a comparison of the ions present in 
the experimental spectrum to the ions present in the library spectrum.  While there may be 
similarities between these molecules based on one of these factors, the use of all three data 
points can be utilized to distinguish and differentiate biochemicals.  More than 3300 
commercially available purified standard compounds have been acquired and registered into 
LIMS for distribution to both the LC-MS and GC-MS platforms for determination of their 
analytical characteristics.  Additional mass spectral entries have been created for structurally 
unnamed biochemicals, which have been identified by virtue of their recurrent nature (both 
chromatographic and mass spectral).  These compounds have the potential to be identified by 
future acquisition of a matching purified standard or by classical structural analysis.  
Curation:  A variety of curation procedures were carried out to ensure that a high quality 
data set was made available for statistical analysis and data interpretation.  The QC and 
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curation processes were designed to ensure accurate and consistent identification of true 
chemical entities, and to remove those representing system artifacts, mis-assignments, and 
background noise.  Metabolon data analysts use proprietary visualization and interpretation 
software to confirm the consistency of peak identification among the various samples.  
Library matches for each compound were checked for each sample and corrected if 
necessary. 
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Metabolite quantification and data normalization:  Peaks were quantified using area-under-
the-curve.  A data normalization step was performed to correct variation resulting from 
instrument inter-day tuning differences.  Essentially, each compound was corrected in run-day 
blocks by registering the medians to equal one (1.00) and normalizing each data point 
proportionately (termed the “block correction”; Figure E2).    
 
 
Figure E2: Visualization of data normalization steps for a multiday platform run. 
Statistical analysis of metabolomic analysis: Statistical analysis included log 
transformation and imputation followed by one way analysis of variance (ANOVA) with 
repeated measures to identify biochemicals that differed significantly between experimental 
groups. An estimate of the false discovery rate (q-value) was calculated to take into account 
the multiple comparisons that normally occur in metabolomic-based studies. Pathways were 
assigned for each metabolite, allowing examination of overrepresented pathways.  Significant 
(p<0.05) pathway enrichment output (cumulative hypergeometric distribution) was assessed 
Day
1      2        3        4      5       6        7
Day
1      2        3        4      5       6        7
A. B. 
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for each of the selected contrasts using MetaboLync (E4) to determine the metabolic 
processes impacted by ozone.  
Results 
Figure E3 shows the line plots of systolic blood pressure and heart rate data of subjects as 
determined prior to their air or ozone exposure, immediately after exposure (within 1hr) and 
during their next day morning follow-up visit to the clinic. These were no significant 
differences as determined by paired t-test between air and ozone exposure when compared 
immediately post exposure. Note that only 1 subject during clinical visit had increased heart 
rate prior to the start of air exposure, however, this was not apparent during their visit for 
ozone exposure. The heart rate and blood pressure in subjects did not appear to deviate 
between the three time points.    
Figure E4 shows the line plots for levels of serum glucose, cholesterol, triglycerides, HDL 
and LDL determined prior to, immediately post air or ozone exposure and the next day 
follow-up visit. While the time of measurement does not appear to change HDL, LDL and 
cholesterol levels in subjects, the levels of glucose seem to vary among subjects when 
measured prior to exposure. This variability between subjects seen prior to the start of 
exposure was reduced for the measurements performed on the next day morning. This could 
be due to the fact that during the first visit, subjects were not fasted while during the second 
day follow up visit, subjects were fasted overnight as they underwent bronchoscopy at that 
time (E1). Individual subject variations between pre and post exposure times in triglycerides 
and cholesterols appeared to be minimal. No ozone-related effects were observed in these 
parameters when data were normalized to pre-exposure levels.   
The graphs in Figure E5 shows line plots of leptin, insulin and HOMA-IR post-air and post-
ozone exposure. As shown in the top panel, one individual had very high leptin levels 
relative to all other individuals regardless of air or ozone exposure. No significant differences 
were noted between air and ozone exposure. Insulin and HOMA-IR levels varied between 
subjects regardless of air or ozone exposure. Mostly these variations were noted in two or 
three individuals but all others did not appear to vary markedly between air and ozone 
exposure. No significant differences were evident between air and ozone HOMA-IR, insulin 
or leptin as determined using a paired t-test. 
In Figures E6A-E, the fold increases after ozone exposure (ratios of ozone/air) for selected 
individual lipid metabolites and stress hormones that significantly changed (except for 
cortisone) were plotted against individual subject BMI to determine if high BMI could be 
linked to increased susceptibility to ozone-induced changes. These exploratory scatter plots 
appear to show no consistent relationship between the BMI value of subjects and ozone-
induced changes in individual metabolites. As in the case of Figure E6, in Figure E7A-E, 
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ozone-induced fold changes in these same metabolites were correlated with subjects prior 
exercise habit. The level of exercise routinely performed by each subject was rated as mild 
(1), moderate (2) or heavy (3) obtained through questionnaire. The scatter plots between 
individuals with different exercise habits and ozone-induced changes in lipid metabolites as 
well as steroid hormones did not appear to be related to individual’s prior exercise habit. 
However, these correlations were made with very few subjects in each exercise intensity 
group, and thus the data are limited. There were only 4 females in the study, nevertheless, we 
decided to explore any potential relationship between sex and significant ozone-induced fold 
changes in lipid metabolites and steroid hormones (Figure E8A-E). Because of the limited 
number of female subjects in this study, no inferences can be drawn from these data for 
potential sex differences in ozone-induced metabolic alterations; however, the plots suggest 
that some relationships are likely.  
Since we had the clinical chemistry data available which included serum levels of glucose, 
and lipids, such as triglycerides and cholesterols, we explored the potential relationship 
between levels of glucose as well as these lipids post air or post ozone exposure and 1) BMI 
in Figure E9A-B; 2) the prior exercise level (1, 2, or 3) in Figure E10A-B; and 3) sex in 
Figure E11A-B using scatter plots. Surprisingly, in these healthy subjects, the BMI appear 
not to correlate with post exposure circulating triglycerides, cholesterols or glucose, 
regardless of air or ozone exposure. The correlations might exist in some measured lipids 
with the level of exercise and gender, however, there seem to be no differences between post 
air and post ozone exposure.  
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Figure E3: Line plots of cardiac physiological measurements taken prior to the start, post 
exposure, and during next day morning follow up visit (post-air, left; post-ozone, right)*.  
 
 
 
* The data for systolic blood pressure and heart rate have been published by Devlin et al (E1) 
as group means. We explored the time-related individual subject differences in these 
parameters from the clinical data available to us. This was a randomized clinical assessment 
where each subject arrived to the clinic at two different times (separated by at least two 
weeks) for either air or ozone exposure and for the follow up visit, next-day morning. Thus, 
each subject visited clinic 4 times (for air exposure, follow up visit next day, for ozone 
exposure, follow up visit next day). Subjects were exposed to either 0.3 ppm ozone or clean 
air for 2hr in the morning time in a blinded manner. Heart rate and blood pressure were 
monitored prior to the start of exposure, immediately post exposure (within 1hr) and next day 
morning, in addition to continuous Holter monitoring (E1). Note that subjects were fasted 
overnight when they arrived next day morning for a follow up visit. The plots indicate values 
for each subject (n=24; 20 males and 4 females). 
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Figure E4: Line plots of serum glucose and lipid measurements taken prior to the start, post 
exposure, and next day morning during follow up visit (post-air, left; post-ozone, right)*.  
 
*The data for serum cholesterol have been published previously by Devlin et al (E1) as group 
means. We explored the time-related differences in these parameters from the clinical data 
available to us. In this clinical assessment, each subject arrived for either air or ozone 
exposure on separate days (each visit separated by more than two weeks) and for a follow up 
visit next-day morning. Thus, each subject visited clinic 4 times (for air exposure, follow up 
visit next day, for ozone exposure, follow up visit next day). Subjects were exposed to either 
0.3 ppm ozone or clean air for 2hr in the morning time in a blinded manner. Serum samples 
collected prior to the start of exposure, immediately post exposure (within 1hr) and next day 
morning and assessed for glucose and lipids by LabCorp Inc (Durham, NC). Note subjects 
were fasted overnight when they arrived next day morning for a follow up visit. The plots 
indicate values for each subject (n=24; 20 males and 4 females). 
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Figure E5: Line plots of serum leptin, insulin and HOMA-IR as determined immediately 
post-air or post-ozone exposure.*  
 
* Insulin and leptin levels were measure in serum samples collected post air or ozone 
exposure using antibody-based assays as indicated in methods within this supplement. 
Subjects were exposed to either 0.3 ppm ozone or clean air for 2hr in the morning time in a 
blinded manner prior to collecting blood samples. The data for serum glucose from the 
clinical data set and insulin measured from archived post air or post ozone exposure serum 
samples, were used to calculate HOMA-IR. HOMA-IR was calculated by multiplying 
glucose value (mmol/L) with insulin value (mU/L) and dividing with 22.5. The plots indicate 
values for each subject (n=24; 20 males and 4 females). 
 
 
 258 
 
Figure E6A-E. Exlporatory correlation plots showing the relationship between body mass 
index (BMI) and ozone-induced fold change in various lipid metabolites as well as stress 
hormones (as determined using metabolomics). 
Figure E6A 
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Figure E6B 
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Figure E6C 
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Figure E6D 
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Figure E6E 
 
 
*The data for various metabolites were derived from metabolomic assessment of serum 
samples collected post air or post ozone exposure. The ratio of ozone/air values that were 
found to be significantly increased (except for cortisone) were plotted against BMI to 
determine if ozone effects were influenced by increased BMI. This is a randomized clinical 
assessment where each subject arrived to the clinic for either air or ozone exposure during 
two separate clinical visits (each separated by at least two weeks). In this study, each subject 
was exposed to either 0.3 ppm ozone or clean air for 2hr in the morning time in a blinded 
manner (n=24; 20 males and 4 females). Serum samples collected immediately post exposure 
(within 1hr) were subjected to global metabolomic assessment (complete data provided in 
online supplement #2).  
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Figure E7A-E.  Exploratory correlation plots showing the relationship between each 
subject’s prior exercise habit (mild, 1; moderate, 2; or heavy, 3) and fold change in various 
lipid metabolites post ozone relative to air exposure. 
 
Figure E7A 
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Figure E7B 
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Figure E7C 
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Figure E7D 
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Figure E7E 
 
*The data for various metabolites were derived from metabolomic assessment of serum 
samples collected post air or post ozone exposure. The ratio of ozone/air values that were 
found to be significantly increased (except for cortisone) were plotted against each subjects 
prior exercise habit scaled based on questionnarre (mild, 1; moderate, 2; or heavy, 3) to 
determine if ozone effects were influenced by individuals prior exercise habits. Each subject 
arrived for either air or ozone exposure during two clinical visits, each were separated by at 
least two weeks. During each visit, subjects were exposed to either 0.3 ppm ozone or clean 
air for 2hr in the morning time in a blinded manner (n=24; 20 males and 4 females). Serum 
samples collected immediately post exposure (within 1hr) were subjected to global 
metabolomic assessment (complete data provided in online supplement #2). Note that these 
correlations are limited due to small number of subjects in each exercise group. 
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Figure E8A-E. Exploratory correlation plots showing the relationship between sex 
(1=female; 2=males) and fold ozone-induced change in various lipid metabolites post 
exposure. 
 
Figure E8A
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Figure E8B
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Figure E8C
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Figure E8D
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Figure E8E
 
 
* The data for various metabolites were derived from metabolomic assessment of serum 
samples collected post air or post ozone exposure. The ratio of ozone/air values that were 
found to be significantly increased (except for cortisone) were plotted against sex (female, 1; 
males; 2) to determine if ozone effects were influenced by individual’s sex. In the study, each 
subject arrived for either air or ozone exposure during two clinical visits, each separated by at 
least two weeks. During each visit, subjects were exposed to either 0.3 ppm ozone or clean 
air for 2hr in the morning time in a blinded manner (n=24; 20 males and 4 females). Serum 
samples were collected immediately post exposure (within 1hr) were subjected to global 
metabolomic assessment (data provided in online supplement #2). Note that these 
correlations are limited since there were only 4 females subjects included in this study 
whereas 20 were males.   
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Figure E9A-B. Exploratory correlation plots showing the relationship between body mass 
index (BMI) and levels of clinical markers in subjects post air or post ozone exposure. 
Figure E9A 
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Figure E9B  
 
*The data available to us for clinical markers of glucose and lipids collected post air 
exposure (left panel) or post ozone exposure (right panel) are plotted against BMI for all 24 
subjects. In this study each subject arrived for either air or ozone exposure during two 
clinical visits, each separated by at least two weeks. During each visit, the subjects were 
exposed to either 0.3 ppm ozone or clean air during intermittent exercise for 2hr in the 
morning time in a blinded manner. Serum samples were collected immediately post exposure 
(within 1hr) and analyzed for lipids by LabCorp Inc (Durham, NC; complete data provided in 
online supplement #2). The plots indicate correlation between BMI values and the levels of 
lipid metabolites after air or ozone exposure (n=24; 20 males and 4 females).  
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Figure E10A-B. Exploratory correlation plots showing the relationship between each 
subject’s prior exercise habit (mild, 1; moderate, 2; or heavy, 3) and levels of clinical markers 
in subjects post air or post ozone exposure. 
Figure E10A 
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Figure E10B 
 
* The data available to us for clinical markers of glucose and lipids collected post air 
exposure (left panel) or post ozone exposure (right panel) are plotted against each subject’s 
prior exercise habit (mild, 1; moderate, 2; or heavy, 3) for all 24 subjects. In this study, each 
subject arrived for either air or ozone exposure during two clinical visits, each separated by at 
least two weeks. During each visit, subjects were exposed to either 0.3 ppm ozone or clean 
air during intermittent exercise for 2hr in the morning time in a blinded manner. Serum 
samples were collected immediately post exposure (within 1hr) and analyzed for clinical 
chemistry by LabCorp Inc (Durham, NC; complete data provided in online supplement #2). 
Note that the exploratory correlations includes limited number of subjects for each exercise 
level.  
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Figure E11A-B. Exploratory correlation plots showing the relationship between sex and the 
levels of clinical markers in subjects post air or post ozone exposure. 
Figure E11A 
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Figure 11B 
 
*The data available to us for clinical markers of glucose and lipids collected post air 
exposure (left panel) or post ozone exposure (right panel) are plotted against sex (1, females; 
2, males). In this study, each subject arrived for either air or ozone exposure during two 
clinical visits, each separated by at least two weeks. During each visit, the subjects were 
exposed to either 0.3 ppm ozone or clean air during intermittent exercise for 2hr in the 
morning time in a blinded manner. Serum samples were collected immediately post exposure 
(within 1hr) and analyzed for glucose and lipids by LabCorp Inc (Durham, NC; complete 
data provided in online supplement #2). Note that there were only 4 females in the study and 
therefore, the data are highly limited.  
  
 279 
 
REFERENCES 
E1. Devlin RB, Duncan KE, Jardim M, Schmitt MT, Rappold AG, Diaz-Sanchez D.  
Controlled exposure of healthy young volunteers to ozone causes cardiovascular 
effects. Circulation. 2012; 126:104-11. 
 
E2. Hernandez ML, Lay JC, Harris B, Esther CR Jr, Brickey WJ, Bromberg PA, Diaz-
Sanchez D, Devlin RB, Kleeberger SR, Alexis NE, Peden DB. Atopic asthmatic 
subjects but not atopic subjects without asthma have enhanced inflammatory response 
to ozone. J Allergy Clin Immunol. 2010; 126:537-44. 
 
E3. Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. (2009). Integrated, 
nontargeted ultrahigh performance liquid chromatography/electrospray ionization 
tandem mass spectrometry platform for the identification and relative quantification of 
the small-molecule complement of biological systems. Anal Chem 81: 6656-6667.  
E4. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski 
B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular 
interaction networks. Genome Research 2003 Nov; 13(11):2498-504. 
 
 
